<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Cellular Neuroscience</journal-title></journal-title-group><issn pub-type="epub">1662-5102</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12098645</article-id><article-id pub-id-type="doi">10.3389/fncel.2025.1570596</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Mitochondria: the hidden engines of traumatic brain injury-driven neurodegeneration</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Olatona</surname><given-names>Olusola A.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/2744847/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Sterben</surname><given-names>Sydney P.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/3004842/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Kansakar</surname><given-names>Sahan B. S.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/3029974/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Symes</surname><given-names>Aviva J.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><xref rid="fn003" ref-type="author-notes">
<sup>&#x02021;</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/147577/overview"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Liaudanskaya</surname><given-names>Volha</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="c002" ref-type="corresp">
<sup>*</sup>
</xref><xref rid="fn003" ref-type="author-notes">
<sup>&#x02021;</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/2579660/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Biomedical Engineering, University of Cincinnati</institution>, <addr-line>Cincinnati, OH</addr-line>, <country>United States</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Pharmacology and Molecular Therapeutics, Uniformed Services University</institution>, <addr-line>Bethesda, MD</addr-line>, <country>United States</country></aff><aff id="aff3"><sup>3</sup><institution>Neuroscience Graduate Program, University of Cincinnati, College of Medicine</institution>, <addr-line>Cincinnati, OH</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Monokesh K. Sen, The University of Sydney, Australia</p></fn><fn fn-type="edited-by"><p>Reviewed by: Lai Wang, Henan University, China</p><p>Ganapathi Kandasamy, University of Miami, United States</p><p>Marla Tipping, Providence College, United States</p></fn><corresp id="c001">*Correspondence: Aviva J. Symes, <email>aviva.symes@usuhs.edu</email></corresp><corresp id="c002">Volha Liaudanskaya, <email>liaudava@ucmail.uc.edu</email></corresp><fn fn-type="equal" id="fn002"><p><sup>&#x02020;</sup>These authors share first authorship</p></fn><fn fn-type="equal" id="fn003"><p><sup>&#x02021;</sup>These authors share senior authorship</p></fn></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>19</volume><elocation-id>1570596</elocation-id><history><date date-type="received"><day>03</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>16</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Olatona, Sterben, Kansakar, Symes and Liaudanskaya.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Olatona, Sterben, Kansakar, Symes and Liaudanskaya</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Mitochondria play a critical role in brain energy metabolism, cellular signaling, and homeostasis, making their dysfunction a key driver of secondary injury progression in traumatic brain injury (TBI). This review explores the relationship between mitochondrial bioenergetics, metabolism, oxidative stress, and neuroinflammation in the post-TBI brain. Mitochondrial dysfunction disrupts adenosine triphosphate (ATP) production, exacerbates calcium dysregulation, and generates reactive oxygen species, triggering a cascade of neuronal damage and neurodegenerative processes. Moreover, damaged mitochondria release damage-associated molecular patterns (DAMPs) such as mitochondrial DNA (mtDNA), Cytochrome C, and ATP, triggering inflammatory pathways that amplify tissue injury. We discuss the metabolic shifts that occur post-TBI, including the transition from oxidative phosphorylation to glycolysis and the consequences of metabolic inflexibility. Potential therapeutic interventions targeting mitochondrial dynamics, bioenergetic support, and inflammation modulation are explored, highlighting emerging strategies such as mitochondrial-targeted antioxidants, metabolic substrate supplementation, and pharmacological regulators of mitochondrial permeability transition pores. Understanding these mechanisms is crucial for developing novel therapeutic approaches to mitigate neurodegeneration and enhance recovery following brain trauma.</p></abstract><kwd-group><kwd>brain injury</kwd><kwd>mitochondria</kwd><kwd>neurodegeneration</kwd><kwd>metabolism</kwd><kwd>bioenergetics</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by the NIH and DoD HU00012420075.</funding-statement></funding-group><counts><fig-count count="6"/><table-count count="1"/><equation-count count="0"/><ref-count count="242"/><page-count count="22"/><word-count count="18556"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Cellular Neuropathology</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="S1"><title>1 Mitochondria structure and function</title><p>The adult human brain accounts for about 2% of total body weight but consumes approximately 20% of the body&#x02019;s energy supply to sustain its high metabolic activity. The energy demand is even higher in young and developing brains; a newborn consumes about 60% of the body&#x02019;s daily energy, while a 10 years-old child&#x02019;s brain uses around 50% of the body&#x02019;s total basal metabolic rate (<xref rid="B79" ref-type="bibr">Goyal et al., 2014</xref>; <xref rid="B205" ref-type="bibr">Steiner, 2019</xref>). Neurons account for 75%&#x02013;80% of the brain&#x02019;s energy consumption (<xref rid="B15" ref-type="bibr">Belenguer et al., 2019</xref>; <xref rid="B29" ref-type="bibr">Chakrabarty and Chandel, 2021</xref>; <xref rid="B31" ref-type="bibr">Chen W. et al., 2023</xref>; <xref rid="B41" ref-type="bibr">Collier et al., 2023</xref>) and rely heavily on mitochondria, the primary producers of cellular energy, generating up to 95% of a eukaryotic cell&#x02019;s ATP to support essential functions such as action potential generation, ion homeostasis, neurotransmitter cycling, and synaptic remodeling for learning and memory.</p><p>Over the last decade, it has become appreciated that mitochondria are better understood as &#x0201c;cell processors&#x0201d; rather than simply energy-generating &#x0201c;powerhouses&#x0201d; (<xref rid="B175" ref-type="bibr">Picard and Shirihai, 2022</xref>). Numerous studies have demonstrated mitochondria as dynamic organelles that transform energy, synthesize biomolecules, and act as critical signaling hubs to transduce and integrate biological information (<xref rid="B11" ref-type="bibr">Bader and Winklhofer, 2020</xref>; <xref rid="B123" ref-type="bibr">Lamade et al., 2020</xref>; <xref rid="B164" ref-type="bibr">Norat et al., 2020</xref>; <xref rid="B175" ref-type="bibr">Picard and Shirihai, 2022</xref>). In this role, in coordination with the nucleus and other organelles, mitochondria form the mitochondrial information processing system (<xref rid="B175" ref-type="bibr">Picard and Shirihai, 2022</xref>). This system is composed of three steps (<xref rid="F1" ref-type="fig">Figure 1</xref>): mitochondria (1) sense internal and environmental stimuli through changes in morphology and function; (2) integrate information via dynamic, network-based physical interactions and diffusion mechanisms; and (3) regulate the functions of other organelles and systemically modulate physiology. This complex multistep system enables mitochondria to transduce metabolic, biochemical, neuroendocrine, and other local or systemic signals that enhance the organism&#x02019;s adaptability. As a result, mitochondria have been recognized as critical regulators of ATP production, inflammation, death progression, metabolism, and epigenetic state.</p><fig position="float" id="F1"><label>FIGURE 1</label><caption><p>Mitochondrial signal transduction in traumatic brain injury (TBI). This figure illustrates the sequential role of mitochondria in TBI across three critical phases: Sensing, Integration, and Signaling. In the Sensing phase <bold>(1A&#x02013;1C)</bold>, the initial trauma triggers glutamate release and activation of membrane ion channels, initiating the early cellular responses. During the Integration phase <bold>(2A&#x02013;2E)</bold>, mitochondria interpret injury signals through calcium influx, reactive oxygen species (ROS) production, and mitochondria permeability pore (mPTP) opening while also interacting with other cellular components. The Signaling phase <bold>(3A&#x02013;3E)</bold> demonstrates how these integrated responses lead to mitochondria membrane rupture, necrosis, and inflammatory propagation to surrounding tissues. Overall, this figure depicts the central role of mitochondria as information processors that detect initial injury signals, integrate biochemical responses, and ultimately determine cellular fate in the progressive pathophysiology of TBI. Figure created in <ext-link xlink:href="https://www.Biorender.com" ext-link-type="uri">Biorender.com</ext-link>.</p></caption><graphic xlink:href="fncel-19-1570596-g001" position="float"/></fig><p>Mitochondria are double membrane organelles, with each membrane playing distinct and crucial roles (<xref rid="B71" ref-type="bibr">Giorgi et al., 2015</xref>). The outer membrane (OMM) is a &#x0201c;bodyguard,&#x0201d; containing porins that regulate the ions, nutrients, and small molecules (up to about 5 kDa) flowing into the intermembrane space. This permeability is essential for exchanging metabolites and ions between the mitochondria and the cytosol. Additionally, the OMM plays a significant role in host defense and regulation of apoptosis. It houses proteins such as B-cell lymphoma 2 (Bcl-2) family members that control Cytochrome C release from the intermembrane space into the cytosol, triggering the intrinsic apoptosis pathway [for a detailed review, see <xref rid="B47" ref-type="bibr">Desagher and Martinou (2000)</xref>]. Furthermore, the OMM engages in lipid synthesis and the import of lipids from the endoplasmic reticulum, facilitating lipid exchange with other organelles (<xref rid="B42" ref-type="bibr">Crompton, 1999</xref>; <xref rid="B71" ref-type="bibr">Giorgi et al., 2015</xref>; <xref rid="B70" ref-type="bibr">Giacomello et al., 2020</xref>). Finally, the OMM initiates, regulates, and executes mitochondrial fission, fusion, and mitophagy, critical components of mitochondrial homeostasis (<xref rid="B134" ref-type="bibr">Liesa and Shirihai, 2013</xref>; <xref rid="B49" ref-type="bibr">Di Pietro et al., 2017</xref>; <xref rid="B91" ref-type="bibr">Herst et al., 2017</xref>; <xref rid="B154" ref-type="bibr">Misgeld and Schwarz, 2017</xref>; <xref rid="B70" ref-type="bibr">Giacomello et al., 2020</xref>; <xref rid="B31" ref-type="bibr">Chen W. et al., 2023</xref>).</p><p>The inner mitochondrial membrane (IMM), tightly packed into the membrane cristae, is the site of oxidative phosphorylation (OXPHOS), the primary ATP production machinery. The IMM contains the electron transport chain (ETC) and ATP synthase protein complexes, which conduct this process (see chapter &#x0201c;2.1 Brain bioenergetics&#x0201d; for more details) (<xref rid="B120" ref-type="bibr">K&#x000fc;hlbrandt, 2015</xref>; <xref rid="B10" ref-type="bibr">Audano et al., 2020</xref>; <xref rid="B70" ref-type="bibr">Giacomello et al., 2020</xref>). Unlike the OMM, the IMM is impermeable to most ions and molecules, a feature critical for maintaining the proton gradient established by the ETC. This proton gradient drives ATP synthesis through ATP synthase (<xref rid="B172" ref-type="bibr">Paumard et al., 2002</xref>). Additionally, the IMM is equipped with numerous transport systems that regulate the movement of metabolites across the membrane, ensuring the efficient production and distribution of energy within the cell (<xref rid="B175" ref-type="bibr">Picard and Shirihai, 2022</xref>).</p></sec><sec id="S2"><title>2 Mitochondria dysfunction as primary damage post-traumatic brain injury</title><p>Mitochondrial dysfunction refers to mitochondria failing to perform one of their critical functions: sensing, integration, or signaling (<xref rid="B175" ref-type="bibr">Picard and Shirihai, 2022</xref>). When mitochondrial function is compromised, altered bioenergetic and metabolic processes can lead to increased oxidative stress, inflammation and/or cell death. Mitochondrial dysfunction has many potential causes, including genetic mutations, oxidative stress, environmental toxins, aging, or trauma. Mitochondrial dysfunction and defective mitochondrial dynamics are proposed as key mechanisms with functional importance in the early stages of Alzheimer&#x02019;s disease, Parkinson&#x02019;s disease, Amyotrophic lateral sclerosis, and other neurodegenerative diseases, as well as after TBI (<xref rid="B137" ref-type="bibr">Lin and Beal, 2006</xref>; <xref rid="B165" ref-type="bibr">Nunnari and Suomalainen, 2012</xref>; <xref rid="B162" ref-type="bibr">Nicolson, 2014</xref>; <xref rid="B92" ref-type="bibr">Hiebert et al., 2015</xref>; <xref rid="B150" ref-type="bibr">McGovern and Barreto, 2021</xref>; <xref rid="B175" ref-type="bibr">Picard and Shirihai, 2022</xref>; <xref rid="B208" ref-type="bibr">Strope et al., 2022</xref>; <xref rid="B191" ref-type="bibr">Schmitt et al., 2023</xref>). Specifically, TBI (<xref rid="B11" ref-type="bibr">Bader and Winklhofer, 2020</xref>) disrupts key processes such as energy production, metabolic regulation, calcium homeostasis, and oxidative stress management. Damage to the electron transport chain (ETC) impairs oxidative phosphorylation (OXPHOS), leading to ATP depletion and bioenergetic failure (<xref rid="B92" ref-type="bibr">Hiebert et al., 2015</xref>; <xref rid="B116" ref-type="bibr">Kilbaugh et al., 2015</xref>; <xref rid="B91" ref-type="bibr">Herst et al., 2017</xref>; <xref rid="B98" ref-type="bibr">Hubbard et al., 2018</xref>; <xref rid="B127" ref-type="bibr">Leipnitz et al., 2018</xref>; <xref rid="B142" ref-type="bibr">Lyons et al., 2018</xref>; <xref rid="B15" ref-type="bibr">Belenguer et al., 2019</xref>; <xref rid="B99" ref-type="bibr">Hubbard et al., 2019</xref>; <xref rid="B2" ref-type="bibr">Ahluwalia et al., 2021</xref>; <xref rid="B169" ref-type="bibr">Pandya et al., 2021</xref>; <xref rid="B20" ref-type="bibr">Bhatti et al., 2022</xref>; <xref rid="B35" ref-type="bibr">Cheng et al., 2022</xref>; <xref rid="B208" ref-type="bibr">Strope et al., 2022</xref>; <xref rid="B100" ref-type="bibr">Hubbard et al., 2023</xref>), while disruptions in mitochondrial dynamics hinder neuronal repair and survival (<xref rid="B234" ref-type="bibr">Yonutas et al., 2016</xref>; <xref rid="B142" ref-type="bibr">Lyons et al., 2018</xref>; <xref rid="B99" ref-type="bibr">Hubbard et al., 2019</xref>; <xref rid="B124" ref-type="bibr">Lazzarino et al., 2019</xref>; <xref rid="B2" ref-type="bibr">Ahluwalia et al., 2021</xref>). Excessive oxidative stress (<xref rid="B214" ref-type="bibr">Tavazzi et al., 2005</xref>; <xref rid="B196" ref-type="bibr">Shi and Gibson, 2007</xref>; <xref rid="B92" ref-type="bibr">Hiebert et al., 2015</xref>; <xref rid="B98" ref-type="bibr">Hubbard et al., 2018</xref>), excitotoxicity, and metabolic dysregulation (<xref rid="B9" ref-type="bibr">Arun et al., 2013</xref>; <xref rid="B234" ref-type="bibr">Yonutas et al., 2016</xref>; <xref rid="B98" ref-type="bibr">Hubbard et al., 2018</xref>; <xref rid="B142" ref-type="bibr">Lyons et al., 2018</xref>; <xref rid="B99" ref-type="bibr">Hubbard et al., 2019</xref>) further exacerbate neuronal damage, contributing to neurodegeneration and prolonged functional deficits (<xref rid="B38" ref-type="bibr">Choi et al., 2004</xref>; <xref rid="B40" ref-type="bibr">Clark et al., 2006</xref>; <xref rid="B137" ref-type="bibr">Lin and Beal, 2006</xref>; <xref rid="B196" ref-type="bibr">Shi and Gibson, 2007</xref>; <xref rid="B218" ref-type="bibr">Trushina and McMurray, 2007</xref>; <xref rid="B114" ref-type="bibr">Keating, 2008</xref>; <xref rid="B19" ref-type="bibr">Bhat et al., 2015</xref>; <xref rid="B21" ref-type="bibr">Bhatti et al., 2017</xref>; <xref rid="B184" ref-type="bibr">Rana et al., 2020</xref>; <xref rid="B2" ref-type="bibr">Ahluwalia et al., 2021</xref>; <xref rid="B62" ref-type="bibr">Fesharaki-Zadeh, 2022</xref>). In the next two chapters, we will explore these mitochondrial impairments in the context of brain trauma, highlighting their impact on neuronal survival and potential therapeutic targets.</p><sec id="S2.SS1"><title>2.1 Brain bioenergetics</title><p>Brain cells generate energy through four main mechanisms: glycolysis, the tricarboxylic acid (TCA) cycle, OXPHOS, and fatty acid oxidation (<xref rid="B15" ref-type="bibr">Belenguer et al., 2019</xref>; <xref rid="B16" ref-type="bibr">Benaroya, 2020</xref>). Neuronal cells rely on OXPHOS, and proliferating glial cells predominantly utilize glycolysis for ATP production.</p><p>Glycolysis - is a fundamental metabolic pathway crucial in cellular energy production (<xref rid="F2" ref-type="fig">Figure 2A</xref>). It involves the breakdown of glucose, a six-carbon sugar, into two pyruvate molecules, each containing three carbons (<xref rid="B79" ref-type="bibr">Goyal et al., 2014</xref>; <xref rid="B25" ref-type="bibr">Carpenter et al., 2015</xref>; <xref rid="B205" ref-type="bibr">Steiner, 2019</xref>; <xref rid="B48" ref-type="bibr">Devanney et al., 2020</xref>; <xref rid="B231" ref-type="bibr">Xu et al., 2021</xref>; <xref rid="B224" ref-type="bibr">Wei et al., 2023</xref>). This cytoplasmic process is the first step in both aerobic and anaerobic respiration. The glycolytic pathway begins with the phosphorylation of glucose to form glucose-6-phosphate, a reaction catalyzed by the enzyme hexokinase (<xref rid="B138" ref-type="bibr">Liu et al., 2023</xref>). This initial step requires ATP, which invests energy to activate glucose for further breakdown. The pathway proceeds through a series of enzymatic steps, ultimately splitting the six-carbon molecule into two three-carbon molecules of glyceraldehyde-3-phosphate. Each glyceraldehyde-3-phosphate molecule then undergoes further transformations, resulting in the production of pyruvate.</p><fig position="float" id="F2"><label>FIGURE 2</label><caption><p>Metabolic pathways and bioenergetics. <bold>(A)</bold> Glycolysis, <bold>(B)</bold> The Tricarboxylic acid cycle (TCA) cycle and <bold>(C)</bold> Fatty Acid &#x003b2;-Oxidation are metabolically interconnected, with key intermediates serving as inputs for downstream pathways. In glycolysis <bold>(A)</bold>, glucose is converted into pyruvate through 10 enzymatically controlled steps, producing adenosine triphosphate (ATP) and reduced nicotinamide adenine dinucleotide (NADH). Pyruvate subsequently enters the TCA cycle <bold>(B)</bold> as acetyl-CoA, driving the production of NADH and FADH<sub>2</sub> (reduced flavin adenine dinucleotide) for oxidative phosphorylation. Fatty acid &#x003b2;-oxidation <bold>(C)</bold> degrades fatty acids into acetyl-CoA, further fueling the TCA cycle and linking lipid metabolism to energy production. Together, these pathways sustain cellular bioenergetics by integrating carbohydrate and lipid metabolism. Figure created in <ext-link xlink:href="https://www.Biorender.com" ext-link-type="uri">Biorender.com</ext-link>.</p></caption><graphic xlink:href="fncel-19-1570596-g002" position="float"/></fig><p>Throughout glycolysis, several key reactions generate energy-rich molecules. Specifically, two molecules of NAD<sup>+</sup> (nicotinamide adenine dinucleotide, oxidized) are reduced to NADH, capturing high-energy electrons. Additionally, substrate-level phosphorylation occurs twice, producing four ATP molecules. Since two ATP molecules are consumed in the initial steps, the net gain from glycolysis is two ATP molecules per glucose molecule. This modest ATP yield is critical for cells, particularly under anaerobic conditions where oxygen is absent and oxidative phosphorylation cannot occur.</p><p>The fate of the pyruvate produced in glycolysis depends on oxygen availability. Under aerobic conditions, pyruvate is transported into the mitochondria, where it is converted into acetyl-CoA by the enzyme pyruvate dehydrogenase. Acetyl-CoA then enters the TCA cycle (<xref rid="F2" ref-type="fig">Figure 2B</xref>), producing additional reduced nicotinamide adenine dinucleotide (NADH) and (reduced flavin adenine dinucleotide) (FADH<sub>2</sub>) molecules. These molecules donate electrons to the electron transport chain, synthesizing significant ATP through oxidative phosphorylation. This pathway underscores the importance of glycolysis as a precursor to the more efficient aerobic respiration process. In anaerobic conditions, such as in muscle cells during intense exercise, pyruvate is instead converted into lactate by the enzyme lactate dehydrogenase (<xref rid="B192" ref-type="bibr">Schurr and Rigor, 1998</xref>). This conversion regenerates NAD<sup>+</sup>, allowing glycolysis to continue and produce ATP without oxygen. This anaerobic pathway, known as lactic acid fermentation, provides a rapid but less efficient means of ATP production.</p><p>The mitochondrial tricarboxylic acid (TCA) cycle (also called Krebs or citric acid cycle) is essential for energy production in all organs, including the brain. This cycle oxidizes acetyl-CoA into carbon dioxide and high-energy molecules, including ATP, NADH, and FADH<sub>2</sub>. In the first step (<xref rid="F2" ref-type="fig">Figure 2B</xref>), acetyl-CoA combines with oxaloacetate to form citrate (<xref rid="B147" ref-type="bibr">Mart&#x000ed;nez-Reyes and Chandel, 2020</xref>; <xref rid="B1" ref-type="bibr">Abdullah et al., 2022</xref>). Through a series of enzyme-catalyzed reactions, citrate is converted back to oxaloacetate, generating various crucial intermediate metabolites (alpha-ketoglutarate, succinyl CoA, succinate, fumarate, malate) and energy-rich molecules (NADH and FADH<sub>2</sub>) in the process. The TCA cycle also produces intermediates used in other biosynthetic pathways, highlighting its central role in cellular metabolism (<xref rid="B159" ref-type="bibr">Nelson et al., 2018</xref>) (see section &#x0201c;2.2 Mitochondrial dysfunction and cellular metabolism&#x0201d; for metabolic details).</p><p>Oxidative phosphorylation <bold>-</bold> The primary energy-producing mechanism in neurons is oxidative phosphorylation (OXPHOS), which occurs in the mitochondria (<xref rid="B87" ref-type="bibr">Harris et al., 2012</xref>; <xref rid="B185" ref-type="bibr">Rangaraju et al., 2014</xref>; <xref rid="B144" ref-type="bibr">Magistretti and Allaman, 2015</xref>). During this process, electrons from reduced cofactors, such as NADH and FADH<sub>2</sub> - produced during glycolysis, the TCA cycle, and fatty acid oxidation - are transferred through the electron transport chain (ETC). The ETC comprises a series of protein complexes located in the inner mitochondrial membrane that facilitate the transfer of electrons from electron donors like NADH and FADH<sub>2</sub> to oxygen, the final electron acceptor. As electrons pass through Complexes I, II, III, and IV, protons are pumped from the mitochondrial matrix to the intermembrane space, creating a proton gradient. The proton motive force drives the synthesis of ATP as protons flow back into the matrix through ATP synthase. The ETC&#x02019;s role in creating a proton gradient is essential for ATP production through oxidative phosphorylation, and its proper function is vital for cellular energy homeostasis (<xref rid="B120" ref-type="bibr">K&#x000fc;hlbrandt, 2015</xref>; <xref rid="B160" ref-type="bibr">Neupane et al., 2019</xref>). OXPHOS is highly efficient, yielding approximately 30&#x02013;36 ATP molecules per glucose molecule, compared to two ATP molecules generated by glycolysis alone.</p><p>Fatty acid oxidation (FAO) &#x02013; FAO within the mitochondria is vital for maintaining mitochondrial bioenergetic capacity (<xref rid="F2" ref-type="fig">Figure 2C</xref>). Cytoplasmic fatty acids are processed to form acyl-CoA molecules (<xref rid="B229" ref-type="bibr">Xiong, 2018</xref>; <xref rid="B188" ref-type="bibr">Rose et al., 2020</xref>). The carnitine shuttle system transports the acyl-CoA molecules into the mitochondria through the sequential action of carnitine palmitoyltransferase I (CPT I) located on the outer mitochondrial membrane and carnitine-acylcarnitine translocase on the inner mitochondrial membrane. CPT I converts acyl-CoA to acyl-carnitine, which is converted back to acyl-CoA by carnitine palmitoyltransferase II (CPT II) inside the mitochondria. Within the mitochondria, acyl-CoA undergoes &#x003b2;-oxidation, a cyclic process that sequentially removes two-carbon units to form acetyl-CoA. Each cycle of &#x003b2;-oxidation generates acetyl-CoA, NADH, and FADH<sub>2</sub>, which are crucial for cellular energy production. The acetyl-CoA produced then enters the citric acid cycle. FAO is critical to ensure a continuous supply of acetyl-CoA for the TCA cycle and NADH/FADH<sub>2</sub> for the electron transport chain, particularly during increased energy demands such as exercise or fasting. The complete oxidation of a 16-carbon fatty acid, such as palmitate, results in the net production of 106 ATP molecules, with three ATP generated per cycle of fatty acid oxidation, followed by additional ATP production through NADH and FADH2 in the electron transport chain and acetyl-CoA entering the TCA cycle.</p><p>To summarize, glycolysis converts one glucose molecule into two pyruvate molecules, yielding a net gain of two ATP molecules. It provides intermediates for downstream metabolic pathways essential for cellular homeostasis and stress response. These pyruvate molecules then fuel OXPHOS in the mitochondria, where electron transfer coupled with ATP synthase activity in the respiratory chain generates an additional 30&#x02013;36 ATP molecules. Its regulation ensures cells adapt to varying energy demands and oxygen availability, maintaining energy homeostasis under diverse physiological conditions (<xref rid="B87" ref-type="bibr">Harris et al., 2012</xref>; <xref rid="B25" ref-type="bibr">Carpenter et al., 2015</xref>; <xref rid="B147" ref-type="bibr">Mart&#x000ed;nez-Reyes and Chandel, 2020</xref>; <xref rid="B189" ref-type="bibr">Santos, 2021</xref>; <xref rid="B126" ref-type="bibr">Lee et al., 2023</xref>; <xref rid="B206" ref-type="bibr">Stovell et al., 2023</xref>).</p><p>Brain cells&#x02019; ability to switch their metabolism depending on overall substrate availability and stress conditions underscores the complexity of brain energy metabolism. Alterations of this metabolism after TBI are integral to the brain&#x02019;s response to trauma. Understanding these responses can help tailor interventions that support cellular energy production, mitigate damage, and promote recovery following traumatic brain injury.</p><sec id="S2.SS1.SSS1"><title>2.1.1 TBI-induced changes in brain bioenergetics</title><p>Many human and animal studies have shown that TBI leads to an acute phase of hyper-glycolysis followed by a prolonged phase of metabolic depression (<xref rid="B25" ref-type="bibr">Carpenter et al., 2015</xref>; <xref rid="B207" ref-type="bibr">Stovell et al., 2017</xref>; <xref rid="B48" ref-type="bibr">Devanney et al., 2020</xref>; <xref rid="B231" ref-type="bibr">Xu et al., 2021</xref>). In adult patients, this hyper-glycolytic phase lasts several hours to days, and the subsequent hypometabolic phase can persist for weeks, correlating with the severity of the injury and functional deficits (<xref rid="B112" ref-type="bibr">Kansakar et al., 2025</xref>). In models of younger animals, the recovery from these metabolic changes is faster than in adults, suggesting age-related differences in the metabolic response to TBI. The acute phase involves increased glucose utilization due to ionic fluxes and neurotransmitter release, while the chronic phase is marked by reduced glucose metabolism, which can be influenced by impaired glycolytic flux and mitochondrial dysfunction (<xref rid="B25" ref-type="bibr">Carpenter et al., 2015</xref>; <xref rid="B207" ref-type="bibr">Stovell et al., 2017</xref>; <xref rid="B130" ref-type="bibr">Li et al., 2020</xref>; <xref rid="B181" ref-type="bibr">Rabinowitz and Enerb&#x000e4;ck, 2020</xref>; <xref rid="B188" ref-type="bibr">Rose et al., 2020</xref>; <xref rid="B231" ref-type="bibr">Xu et al., 2021</xref>).</p><p>A recent human study (<xref rid="B177" ref-type="bibr">Pinggera et al., 2021b</xref>) using Phosphorus-31 Magnetic Resonance Spectroscopy (31P-MRS) imaging in TBI patients highlighted significant alterations in ATP resynthesis, reflected by changes in phosphocreatine (PCr) to ATP ratios (PCr/ATP). Increased PCr/ATP ratios observed in the subacute phase may indicate adaptive responses to energy failure or altered glial activity. Furthermore, decreased inorganic phosphate (Pi) to ATP ratios (Pi/ATP) suggest impaired ATP turnover and hydrolysis, a direct consequence of mitochondrial dysfunction (<xref rid="B177" ref-type="bibr">Pinggera et al., 2021b</xref>). However, the devastating nature of brain injury is not restricted to the damaged area with altered bioenergetics, but its spread to healthy surrounding tissue, as shown in two other human studies (<xref rid="B176" ref-type="bibr">Pinggera et al., 2021a</xref>; <xref rid="B208" ref-type="bibr">Strope et al., 2022</xref>).</p><p>While human studies are scarce due to the high expense and lack of tools to perform such analysis, numerous <italic>in vivo</italic> animal studies in both blunt and blast injuries reported devastating alterations to OXPHOS post-injury. A study by <xref rid="B99" ref-type="bibr">Hubbard et al. (2019)</xref> demonstrated a significant decrease in mitochondrial respiration 48 h after a single or repetitive closed-head injury in rats suggesting early mitochondrial dysfunction as a key factor in cellular vulnerability to repeated head impacts. Additionally, this group showed that a mitochondrial uncoupler drug, MP201 (<xref rid="B98" ref-type="bibr">Hubbard et al., 2018</xref>), significantly improved mitochondrial function, histopathology, and cognitive outcomes (<xref rid="B100" ref-type="bibr">Hubbard et al., 2023</xref>). These findings suggest that acute mitochondrial dysfunction can be targeted to provide neuroprotection from reactive oxygen species.</p><p>Blast injury also alters mitochondrial function. After blast injury in rats, decreased OXPHOS proteins and increased oxidative stress markers were observed, indicating bioenergetic failure. These findings suggest that targeting mitochondrial function could be a viable therapeutic strategy for blast-induced TBI (<xref rid="B184" ref-type="bibr">Rana et al., 2020</xref>; <xref rid="B179" ref-type="bibr">Priemer et al., 2022</xref>; <xref rid="B197" ref-type="bibr">Siedhoff et al., 2022</xref>; <xref rid="B82" ref-type="bibr">Guilhaume-Correa et al., 2023</xref>; <xref rid="B100" ref-type="bibr">Hubbard et al., 2023</xref>; <xref rid="B191" ref-type="bibr">Schmitt et al., 2023</xref>).</p><p>In a rat severe TBI model (penetrating TBI - PTBI), there was a differential response to injury in different brain regions (<xref rid="B170" ref-type="bibr">Pandya et al., 2019</xref>; <xref rid="B169" ref-type="bibr">Pandya et al., 2021</xref>). Isolated mitochondria from the frontal cortex and striatum rapidly responded, with significant dysregulation detected within 30 min of injury. However, the mitochondrial response resolved to baseline levels before a second, more robust phase of bioenergetic dysregulation was found at 24 h that persisted up to 14 days post-injury. In contrast, mitochondria from the hippocampus, more distal to the lesion, only showed dysfunction starting at 7 days and remaining evident up to 14 days post-PTBI. The results indicated that PTBI-induced mitochondrial dysfunction is time- and region-specific with this severe TBI model. In a rat controlled cortical impact (CCI) model, there was decreased respiration associated with increased oxidative damage to cortical mitochondria. Synaptic mitochondria were more vulnerable than non-synaptic organelles (<xref rid="B93" ref-type="bibr">Hill et al., 2018</xref>). Thus, there appear to be significant changes in mitochondrial bioenergetic function after many different types of traumatic brain injury in people and in animal models.</p></sec><sec id="S2.SS1.SSS2"><title>2.1.2 Treatment for bioenergetics</title><p>This review focuses on potential bioenergetic biological targets that have not yet been explored for TBI patients. Treatments that are already in clinical trials or FDA-approved are reviewed elsewhere (<xref rid="B2" ref-type="bibr">Ahluwalia et al., 2021</xref>). Addressing bioenergetic dysfunction following TBI is a critical component of potential treatments aimed at mitigating neuronal damage and promoting recovery. Several therapeutic approaches target restoring mitochondrial function and overall cellular energy metabolism. The treatment options are summarized in <xref rid="T1" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p>Different potential treatments for mitochondrial dysfunction associated with traumatic brain injury (TBI).</p></caption><table frame="box" rules="all" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1"/><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Treatment</td><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Outcomes</td></tr></thead><tbody><tr><td valign="top" align="center" rowspan="7" colspan="1">Bioenergetics</td><td valign="top" align="left" rowspan="1" colspan="1">Antioxidants (MitoQ and SS-31)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Decrease ROS &#x02219; Preserve mitochondrial function and integrity</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Resveratrol and nicotinamide riboside</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Promote mitochondrial biogenesis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ketone supplementation</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Improve mitochondrial function &#x02219; Reduce oxidative stress &#x02219; Neuroprotective effects</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cyclosporine A</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Preserve membrane potential &#x02219; Decrease calcium influx &#x02219; Prevent release of pro-apoptotic factors</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Methylene blue</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Preserve mitochondrial function &#x02219; Reduce neuronal apoptosis &#x02219; Decrease cerebral edema and lesion volume &#x02219; Decrease ROS &#x02219; Promote autophagy and inhibits microglial activation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Intermittent fasting with ketogenesis</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Decrease calcium influx and lipid peroxidation &#x02219; Elevate antioxidant levels &#x02219; Improve mitochondrial respiratory complex activity &#x02219; Improves cognitive function</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Photobiomodulation</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Stimulate cytochrome C oxidase in ETC &#x02219; Enhance ATP production &#x02219; Improve membrane potential &#x02219; Neuroprotective effects &#x02219; Decrease neuroinflammation and promote neuroplasicity</td></tr><tr><td valign="top" align="center" rowspan="4" colspan="1">Metabolism</td><td valign="top" align="left" rowspan="1" colspan="1">Glucose</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Prevents hypoglycemia &#x02219; Improve metabolism &#x02219; Decrease axonal injury</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pyruvate</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Increase ATP production &#x02219; Improve metabolism</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Succinate</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Improve TCA functionality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Omega-3 fatty acids</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Inhibit neuroinflammation &#x02219; Decrease necroptosis</td></tr><tr><td valign="top" align="center" rowspan="2" colspan="1">Ion homeostasis</td><td valign="top" align="left" rowspan="1" colspan="1">Ru360 and minocycline</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Decrease calcium uptake &#x02219; Suppress production of ROS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Antioxidants (circumin, vitamin E, resveratrol)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Neutralize ROS &#x02219; Lower lipid peroxidation &#x02219; Modulate inflammatory pathways</td></tr><tr><td valign="top" align="center" rowspan="2" colspan="1">Inflammation</td><td valign="top" align="left" rowspan="1" colspan="1">Hydrogen sulfide</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Decrease ROS &#x02219; Reduce production of pro-inflammatory cytokines</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cytokine C</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02022; Improve lactose clearance &#x02219; Lower lipid peroxidation &#x02219; Increase antioxidant activity</td></tr></tbody></table><table-wrap-foot><fn><p>A better understanding of the role of mitochondrial dysfunction in the underlying biological events associated with TBI will allow for the development of specific therapeutics for TBI.</p></fn></table-wrap-foot></table-wrap><p>One promising strategy involves the use of <italic>mitochondrial-targeted antioxidants</italic>, such as MitoQ and SS-31 (<xref rid="B168" ref-type="bibr">Oyewole and Birch-Machin, 2015</xref>; <xref rid="B64" ref-type="bibr">Fields et al., 2023</xref>; <xref rid="B54" ref-type="bibr">Du et al., 2024</xref>). These compounds specifically accumulate in the mitochondria, where they can effectively neutralize ROS and reduce oxidative stress. They thereby preserve mitochondrial integrity and function by mitigating oxidative damage, ultimately enhancing ATP production and cellular energy balance (<xref rid="B201" ref-type="bibr">Smith and Murphy, 2010</xref>; <xref rid="B210" ref-type="bibr">Szeto, 2014</xref>). Another drug that targets mitochondria is the mitochondrial uncoupler, MP201, a pro-drug of 2,4-dintrophenol. In a rodent model of mild blast TBI, MP201 improved mitochondrial function and enhanced behavioral recovery (<xref rid="B100" ref-type="bibr">Hubbard et al., 2023</xref>).</p><p>Another approach focuses on enhancing mitochondrial biogenesis, the process of forming new mitochondria (<xref rid="B110" ref-type="bibr">Jia et al., 2020</xref>; <xref rid="B199" ref-type="bibr">Simmons et al., 2020</xref>; <xref rid="B221" ref-type="bibr">Vekaria et al., 2020</xref>; <xref rid="B105" ref-type="bibr">Jamwal et al., 2021</xref>). Agonists of the peroxisome proliferator activated receptor gamma coactivator 1-alpha (PGC-1&#x003b1;) have shown promise in preclinical studies. PGC-1&#x003b1; is a key regulator of mitochondrial biogenesis and oxidative metabolism. Activating this pathway can increase the number of functional mitochondria, thereby improving bioenergetic capacity. Drugs such as resveratrol and nicotinamide riboside have been explored for their potential to activate PGC-1&#x003b1; and promote mitochondrial biogenesis, offering a means to counteract the mitochondrial deficits induced by TBI (<xref rid="B28" ref-type="bibr">Cerutti et al., 2014</xref>; <xref rid="B77" ref-type="bibr">Gordon et al., 2018</xref>).</p><p><italic>Ketogenic diets and ketone supplementation</italic> have also emerged as potential therapies for bioenergetic dysfunction post-TBI (<xref rid="B56" ref-type="bibr">Eiden et al., 2019</xref>; <xref rid="B17" ref-type="bibr">Bernini et al., 2020</xref>; <xref rid="B194" ref-type="bibr">Shaito et al., 2020</xref>; <xref rid="B86" ref-type="bibr">Har-Even et al., 2021</xref>; <xref rid="B215" ref-type="bibr">Thau-Zuchman et al., 2021</xref>). These diets are high in fats and low in carbohydrates, producing ketone bodies such as &#x003b2;-hydroxybutyrate. Ketone bodies can serve as an alternative energy substrate for the brain, bypassing the glycolytic pathway and directly entering the citric acid cycle to produce ATP. Preclinical animal studies indicate that ketone bodies may improve mitochondrial function, reduce oxidative stress, and enhance energy metabolism in the injured brain (<xref rid="B56" ref-type="bibr">Eiden et al., 2019</xref>; <xref rid="B17" ref-type="bibr">Bernini et al., 2020</xref>; <xref rid="B194" ref-type="bibr">Shaito et al., 2020</xref>; <xref rid="B86" ref-type="bibr">Har-Even et al., 2021</xref>; <xref rid="B215" ref-type="bibr">Thau-Zuchman et al., 2021</xref>). Early-phase clinical trials have demonstrated that ketogenic interventions are safe, feasible, and capable of inducing ketosis in patients with acute and subacute TBI (<xref rid="B8" ref-type="bibr">Arora et al., 2022</xref>; <xref rid="B55" ref-type="bibr">Edwards et al., 2024</xref>). Although current clinical evidence is primarily based on small-scale feasibility and metabolic response studies, they provide preliminary support for the neuroprotective potential observed in preclinical models. Larger randomized controlled trials are needed to validate clinical efficacy, optimize treatment protocols, and establish ketogenic approaches as standard care for supporting the brain&#x02019;s energy needs during the critical post-injury period.</p><p>Intermittent fasting (IF) and calorie restriction represent complementary approaches to ketogenic diets that may offer synergistic benefits for restoring mitochondrial function post-TBI. While animal studies demonstrate that IF enhances mitochondrial biogenesis via cAMP response element-binding protein (CREB) and PGC-1&#x003b1; activation, reduces oxidative stress through Nrf2 (nuclear factor erythroid - 2 related factor 2) pathways, and improves circadian regulation (<xref rid="B5" ref-type="bibr">Anderson et al., 2008</xref>; <xref rid="B3" ref-type="bibr">Alirezaei et al., 2010</xref>; <xref rid="B61" ref-type="bibr">Fernandez-Marcos and Auwerx, 2011</xref>; <xref rid="B156" ref-type="bibr">Moro et al., 2016</xref>; <xref rid="B148" ref-type="bibr">Mattson et al., 2018</xref>; <xref rid="B209" ref-type="bibr">Sutton et al., 2018</xref>; <xref rid="B104" ref-type="bibr">Jamshed et al., 2019</xref>; <xref rid="B128" ref-type="bibr">Lettieri-Barbato et al., 2020</xref>; <xref rid="B88" ref-type="bibr">Haupt et al., 2021</xref>), critical translational gaps remain. While a single 24 h fast post-TBI shows neuroprotection in male rodents, a 48 h fast did not demonstrate a comparable result (<xref rid="B44" ref-type="bibr">Davis et al., 2008</xref>), suggesting a need for validating duration-dependent effects in humans, particularly regarding risks of energy deficits during acute recovery phases. Notably, most evidence comes from pre-clinical models using pre-injury IF regimens with limited clinical applicability for accidental TBI (<xref rid="B81" ref-type="bibr">Gudden et al., 2021</xref>; <xref rid="B24" ref-type="bibr">Cao et al., 2022</xref>; <xref rid="B232" ref-type="bibr">Xu et al., 2022</xref>). Studies indicate that active-phase fasting demonstrates superior neuroprotection in animals, though human circadian variations need characterization (<xref rid="B66" ref-type="bibr">Froy et al., 2009</xref>; <xref rid="B139" ref-type="bibr">Longo and Panda, 2016</xref>; <xref rid="B109" ref-type="bibr">Jeong et al., 2024</xref>). While IF improves adenosine monophosphate-activated protein kinase (AMPK)-mediated autophagy and stress resistance, contraindications exist for patients with metabolic disorders or specific nutritional requirements (<xref rid="B22" ref-type="bibr">Bujak et al., 2015</xref>; <xref rid="B220" ref-type="bibr">Vasim et al., 2022</xref>; <xref rid="B193" ref-type="bibr">Shabkhizan et al., 2023</xref>; <xref rid="B58" ref-type="bibr">Eliopoulos et al., 2025</xref>). These findings suggest that combining ketogenic diets with circadian-aligned IF protocols may present a mechanistically promising strategy for mitochondrial recovery but requires personalized assessment of an individual&#x02019;s metabolic status, injury severity, and temporal implementation windows to ensure treatment efficacy and safety.</p><p>Methylene blue (MB) represents a promising therapeutic agent for mitochondrial bioenergetic dysfunction post-TBI. MB [3,7-bis (dimethylamino)-phenothiazin-5-ium chloride] is an FDA-approved medication with established safety profiles for treating conditions such as cyanide poisoning and methemoglobinemia (<xref rid="B190" ref-type="bibr">Schirmer et al., 2011</xref>). Studies have shown that intravenous administration provides optimal delivery, allowing MB to readily cross the blood-brain barrier and accumulate in brain tissue at concentrations 10&#x02013;20 times higher than in circulation (<xref rid="B174" ref-type="bibr">Peter et al., 2000</xref>). Upon reaching the brain, MB preferentially localizes to neuronal mitochondria, where it serves as a catalytic redox cycler, shuttling electrons directly from NADH to Cytochrome C oxidase (Complex IV) in the ETC. This mechanism effectively bypasses dysfunctional complexes I and III that are commonly impaired post-TBI, thereby potentially restoring electron flow, mitochondrial respiration, and energy metabolism in injured neurons (<xref rid="B187" ref-type="bibr">Rojas et al., 2012</xref>). Preclinical studies in TBI models demonstrate that low-dose MB treatments (0.5&#x02013;5 mg/kg) significantly reduce cerebral edema, attenuate lesion volume, increase neuronal survival, and improve behavioral outcomes with no adverse effects (<xref rid="B212" ref-type="bibr">Talley Watts et al., 2014</xref>). In an oxygen-glucose deprivation injury model mimicking TBI conditions, MB treatment inhibited excessive neuronal ROS production, maintained mPTP potential, and increased ATP generation (<xref rid="B125" ref-type="bibr">Lee et al., 2002</xref>). Although human clinical trials examining MB for TBI are limited, its established safety profile and promising results in preclinical models warrant further investigation into optimizing treatment timing, delivery methods, and dosing regimens for utmost neuroprotection after TBI injury.</p><p>Photobiomodulation therapy (PBMT), using red, near-infrared light, and short-wave infrared light (600&#x02013;1,870 nm), has emerged as a promising non-invasive therapeutic approach for mitochondrial bioenergetic dysfunction post-TBI, with potential for deeper tissue penetration and enhanced therapeutic outcomes (<xref rid="B74" ref-type="bibr">Golovynskyi et al., 2018</xref>; <xref rid="B52" ref-type="bibr">Dos Santos Cardoso et al., 2021</xref>; <xref rid="B53" ref-type="bibr">Dos Santos Cardoso et al., 2022</xref>; <xref rid="B158" ref-type="bibr">Nairuz et al., 2024</xref>). PBMT primarily stimulates Cytochrome C oxidase (Complex IV) in the ETC with specific absorption peaks between 660 and 870 nm wavelengths, facilitating nitric oxide (NO) dissociation and enhancing electron transfer efficiency, oxygen utilization, mitochondrial membrane potential, and ATP production (<xref rid="B226" ref-type="bibr">Wong-Riley et al., 2005</xref>; <xref rid="B157" ref-type="bibr">Naeser et al., 2011</xref>; <xref rid="B216" ref-type="bibr">Thunshelle and Hamblin, 2016</xref>; <xref rid="B94" ref-type="bibr">Hipskind et al., 2018</xref>; <xref rid="B75" ref-type="bibr">Gong et al., 2021</xref>; <xref rid="B163" ref-type="bibr">Nonarath et al., 2021</xref>). When PBMT is applied at appropriate wavelengths, even brief exposures of 60&#x02013;240 s can boost antioxidant enzyme activity, reducing ROS production and inflammatory processes (<xref rid="B237" ref-type="bibr">Zhang et al., 2014</xref>; <xref rid="B198" ref-type="bibr">Silva Macedo et al., 2016</xref>; <xref rid="B85" ref-type="bibr">Hamblin, 2017</xref>; <xref rid="B90" ref-type="bibr">Heo et al., 2019</xref>; <xref rid="B102" ref-type="bibr">Jahani Sherafat et al., 2020</xref>). PBMT also modulates mitochondrial dynamics by suppressing fission-related proteins (dynamin-related protein 1, fission 1) while promoting fusion-related proteins (mitofusin 1 and 2), preserving mitochondrial integrity crucial for energy production (<xref rid="B76" ref-type="bibr">Gopalakrishnan et al., 2020</xref>; <xref rid="B108" ref-type="bibr">Jeong et al., 2021</xref>; <xref rid="B131" ref-type="bibr">Li et al., 2023</xref>). Additionally, PBMT activates neuroprotective mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) and phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathways, which contribute to its anti-inflammatory and anti-apoptotic effects (<xref rid="B13" ref-type="bibr">Bathini et al., 2022</xref>; <xref rid="B129" ref-type="bibr">Li and Wang, 2022</xref>; <xref rid="B195" ref-type="bibr">Shamloo et al., 2023</xref>). Preclinical studies have shown efficacy in TBI models, including reduced edema, improved motor recovery, and lifespan extension in Drosophila (<xref rid="B14" ref-type="bibr">Begum et al., 2015</xref>). Clinically, near-infrared wavelengths can penetrate human skull tissues sufficiently to stimulate cortical neurons non-invasively; however, achieving optimal therapeutic efficacy remains challenging due to variability in treatment parameters like wavelength selection, dosing regimens, timing post-injury, pulse frequency modulation, and delivery methods (<xref rid="B12" ref-type="bibr">Barrett and Gonzalez-Lima, 2013</xref>; <xref rid="B84" ref-type="bibr">Hamblin, 2016</xref>; <xref rid="B89" ref-type="bibr">Henderson, 2024</xref>; <xref rid="B135" ref-type="bibr">Lim, 2024</xref>). Future directions should include artificial intelligence (AI)-driven protocols and nanoparticle-enhanced delivery (e.g., intracranial/implantable LEDs) to overcome penetration barriers.</p><p>Pharmacological agents that <italic>modulate the mitochondrial permeability transition pore (mPTP)</italic> have also shown potential in treating bioenergetic dysfunction post-TBI (<xref rid="B200" ref-type="bibr">Skemiene et al., 2020</xref>; <xref rid="B97" ref-type="bibr">Huang et al., 2021</xref>; <xref rid="B115" ref-type="bibr">Kent et al., 2021</xref>; <xref rid="B233" ref-type="bibr">Yang et al., 2022</xref>; <xref rid="B171" ref-type="bibr">Pandya et al., 2023</xref>). The mPTP is a key player in mitochondrial dysfunction, and its prolonged opening can lead to cell death. Cyclosporine A and other mPTP inhibitors can prevent the opening of this pore, thereby preserving mitochondrial membrane potential, reducing calcium overload, and preventing the release of pro-apoptotic factors. This approach aims to stabilize mitochondrial function and enhance cell survival following TBI (<xref rid="B230" ref-type="bibr">Xiong et al., 1997</xref>; <xref rid="B42" ref-type="bibr">Crompton, 1999</xref>).</p><p>In conclusion, treatments targeting bioenergetic dysfunction post-TBI focus on reducing oxidative stress, promoting mitochondrial biogenesis, providing alternative energy substrates, and stabilizing mitochondrial membrane integrity. These strategies hold promise in preserving mitochondrial function, enhancing energy production, and improving neurological outcomes in individuals with traumatic brain injury. Continued research and clinical trials are necessary to further validate these approaches and integrate them into comprehensive TBI treatment protocols.</p></sec></sec><sec id="S2.SS2"><title>2.2 Mitochondrial dysfunction and cellular metabolism</title><p>In addition to energy production mitochondria are critical for other cellular homeostasis functions. The ATP generating pathways also produce molecules that are important as building blocks for biomolecule synthesis, as regulators of genomic DNA and as modifiers of post translational modifications. Mitochondria play a central role in cellular metabolism and energy production, making them key mediators in signal propagation for different cellular outcomes (<xref rid="F3" ref-type="fig">Figure 3A</xref>). Mitochondrial dysfunction in metabolism occurs when oxygen and amino acids are available for normal cellular processes, but the mitochondria cannot utilize them effectively due to external trauma (<xref rid="F3" ref-type="fig">Figure 3B</xref>; <xref rid="B4" ref-type="bibr">Amorini et al., 2017</xref>; <xref rid="B21" ref-type="bibr">Bhatti et al., 2017</xref>). The TCA cycle, glycolysis, and fatty acid oxidation play crucial roles in the biosynthesis of macromolecules and cellular bioenergetics (<xref rid="F2" ref-type="fig">Figures 2A&#x02013;C</xref>). While most focus on the bioenergetic value of OXPHOS, fatty acid oxidation, or glycolysis pathways, it is vital to explore further the underlying mechanisms of these processes and their link to mitochondrial dysfunction (<xref rid="F3" ref-type="fig">Figures 3A, B</xref>).</p><fig position="float" id="F3"><label>FIGURE 3</label><caption><p>Comparison of metabolism and bioenergetics pre- and post-injury. <bold>(A)</bold> Pre-injury: Under normal conditions, cellular metabolism is well-regulated, with neurons relying on oxidative phosphorylation (OXPHOS) for adenosine triphosphate (ATP) production, while glial cells (microglia and astrocytes) preferentially utilize glycolysis. Key metabolic pathways - including glycolysis, the tricarboxylic acid (TCA) cycle, and OXPHOS &#x02013; operate efficiently to maintain cellular homeostasis and energy balance. <bold>(B)</bold> Post-injury: Following injury, metabolic activity shifts toward glycolysis as the dominant energy source, enabling rapid ATP production under stress conditions. This metabolic reprogramming results in glucose depletion, intracellular acidosis, increased reactive oxygen species (ROS) and nitric oxide synthase levels, and overall hypo-metabolism. Green and red arrows indicate upregulation or downregulation of specific pathways following injury. Figure created in <ext-link xlink:href="https://www.Biorender.com" ext-link-type="uri">Biorender.com</ext-link>.</p></caption><graphic xlink:href="fncel-19-1570596-g003" position="float"/></fig><p>Glycolysis and Mitochondrial Dysfunction - An overall decrease in energy production is observed during mitochondrial dysfunction (<xref rid="B181" ref-type="bibr">Rabinowitz and Enerb&#x000e4;ck, 2020</xref>; <xref rid="B67" ref-type="bibr">Garone et al., 2024</xref>). This is due to reduced OXPHOS, ETC malfunction, and increased glycolysis (<xref rid="F3" ref-type="fig">Figure 3B</xref>). Cells will rely on glycolysis for energy production to maintain energy levels during oxidative stress and mitochondria malfunction. While glycolysis is a much faster method of producing energy, it is less efficient and only produces two ATP per glucose molecule. The reliance on glycolysis leads to a high lactate/pyruvate ratio (LPR) due to the reduction of pyruvate into the waste product lactate, which is associated with hypoxia. Continued glycolysis forces the cells to be inflexible in their metabolic processes, leading to continued dysfunction (<xref rid="B25" ref-type="bibr">Carpenter et al., 2015</xref>; <xref rid="B103" ref-type="bibr">Jalloh et al., 2017</xref>). This hypermetabolism of glucose can lead to hypometabolism in chronic stages, perpetuating mitochondrial dysfunction.</p><p>In both mild and severe TBI, two phases occur: hypermetabolism followed by hypometabolism. The initial hypermetabolism state is a response to the influx of glutamate into the synaptic cleft, increasing the amount of ATP needed to activate ion channels. In this state of hypermetabolism, the increased oxygen and glucose demand become too great, and they become depleted (<xref rid="B103" ref-type="bibr">Jalloh et al., 2017</xref>; <xref rid="B170" ref-type="bibr">Pandya et al., 2019</xref>; <xref rid="B202" ref-type="bibr">Sowers et al., 2021</xref>). Once these resources are depleted, the brain switches to anaerobic metabolism, specifically glycolysis, to meet energy demands. This explains why hypoxia is generally associated with increased glycolysis and mitochondria dysfunction in TBI. During this glycolytic state, there is an observed increase in the LPR, leading to acidosis and the breaking down of the cellular membrane, further perpetuating the damaging cycle (<xref rid="B25" ref-type="bibr">Carpenter et al., 2015</xref>). Also, a high LPR is associated with poor clinical outcomes in the chronic stages post-injury. Lactate levels are elevated in blast TBI as well (<xref rid="B122" ref-type="bibr">Kumari et al., 2023</xref>). High lactate levels also damage the metabolic connection between neurons and glia. Generally, neurons take up astrocytic lactate, which is then converted into pyruvate for the TCA cycle. Increased lactate will accumulate in the extracellular space if this connection is damaged. During chronic stages after TBI, the brain enters a state of hypometabolism and glycolytic depression. In this state, glucose cannot be converted into pyruvate, reducing the amount of acetyl-CoA available for the TCA cycle and leading to depletion of ATP and activation of death pathways.</p><p>Fatty Acid Oxidation and Mitochondrial Dysfunction - Fatty acid oxidation (FAO) is a key component of the molecular and metabolic machinery of the brain. FAO is important when glucose levels are low and glycolysis cannot be performed (<xref rid="B211" ref-type="bibr">Szrok-Jurga et al., 2023</xref>). Mitochondrial dysfunction affects &#x003b2;-oxidation due to the impairment of the ETC, decreased activity of &#x003b2;-oxidation enzymes, altered metabolite levels, increased reliance on glycolysis, and decreased ATP production (<xref rid="F3" ref-type="fig">Figure 3B</xref>). The NADH and FADH<sub>2</sub> produced by &#x003b2;-oxidation can accumulate under impaired electron transport chain activity conditions, leading to feedback inhibition of &#x003b2;-oxidation and a significant slowing of the TCA cycle due to high levels of NADH (<xref rid="B147" ref-type="bibr">Mart&#x000ed;nez-Reyes and Chandel, 2020</xref>; <xref rid="B175" ref-type="bibr">Picard and Shirihai, 2022</xref>). Along with this, there is an increase in ROS due to the leaking of electrons from the faulty ETC, leading to mitochondrial DNA (mtDNA) damage, inflammation, activation of apoptotic pathways, and further mitochondrial impairment (see section &#x0201c;3 Brain injury-induced secondary mitochondrial dysfunction&#x0201d; for detailed explanation). During mitochondrial dysfunction, there are deficiencies in &#x003b2;-oxidation enzymes like acyl-CoA dehydrogenase, reducing the efficiency of fatty acid oxidation and disrupting metabolic signaling, exacerbating metabolic dysfunction.</p><p>Polyunsaturated fatty acids are abundant in brain phospholipids with highly oxidizable structures, making them a target for lipid peroxidation, which is increased due to TBI. However, there is little information on the exact products of lipid peroxidation, their location, or their possible effects. Research shows that both neurotoxic and neuroprotective effects are associated with lipid peroxidation in TBI, so it is critical to understand and identify specific therapeutic targets to develop treatment. After TBI, the accumulation of products from lipid peroxidation contributes to poor clinical outcomes (<xref rid="B6" ref-type="bibr">Anthonymuthu et al., 2017</xref>). Also, increases in medium-chain fatty acids, specifically decanoic and octanoic acids, have been associated with poor patient outcomes (<xref rid="B167" ref-type="bibr">Ore&#x00161;i&#x0010d; et al., 2016</xref>). Decanoic and octanoic acids are also associated with mitochondrial dysfunction by uncoupling metabolic inhibitors of OXPHOS and inducing lipid and protein oxidative damage. Modulations in fatty acid metabolism and astrocytic function occur in blast TBI, as astrocytes attempt to save neurons from oxidative stress by providing non-glucose fuel (<xref rid="B17" ref-type="bibr">Bernini et al., 2020</xref>).</p><p>Tricarboxylic acid Cycle and ETC - The TCA cycle is the central cellular metabolism and bioenergetics hub (<xref rid="F3" ref-type="fig">Figure 3A</xref>). It is a tightly coordinated series of reactions that drives metabolism within cells (<xref rid="B103" ref-type="bibr">Jalloh et al., 2017</xref>; <xref rid="B219" ref-type="bibr">Vakifahmetoglu-Norberg et al., 2017</xref>; <xref rid="B147" ref-type="bibr">Mart&#x000ed;nez-Reyes and Chandel, 2020</xref>; <xref rid="B175" ref-type="bibr">Picard and Shirihai, 2022</xref>; <xref rid="B67" ref-type="bibr">Garone et al., 2024</xref>) (please see the pathway details in see section &#x0201c;2.1 Brain bioenergetics&#x0201d;). Mitochondrial dysfunction significantly impacts the functionality of the TCA cycle (<xref rid="F3" ref-type="fig">Figure 3B</xref>). Damaged mitochondria increase the production of ROS and show metabolite imbalances with altered metabolic flux. Increased levels of ROS damage TCA cycle enzymes and further impair mitochondrial function. Impairment of the ETC results in a backlog of NADH and FADH<sub>2</sub> produced by the TCA cycle, hampering the progression of the TCA cycle due to the cycle&#x02019;s reliance on the generation of NAD<sup>+</sup> and FAD created by the ETC. Alterations in the levels of TCA intermediates result in numerous other sequelae as these intermediates have key functions associated with chromatin modifications, DNA methylation, hypoxic response, and cellular immunity. Metabolism is also shifted from the TCA cycle to glycolysis to meet bioenergetic demands during stress (<xref rid="B147" ref-type="bibr">Mart&#x000ed;nez-Reyes and Chandel, 2020</xref>).</p><p>TBI-induced changes in the TCA cycle are not fully understood. Alterations in indicators such as the ATP: ADP and NADH: NAD<sup>+</sup> ratios after TBI are thought to be related to mitochondrial dysfunction. However, there is little research on the more in-depth details associated with each step of the TCA cycle. Generally post-injury, many have found that Complex I and Complex III of the ETC are damaged, leading to increased ROS and cellular damage (<xref rid="B112" ref-type="bibr">Kansakar et al., 2025</xref>). ETC malfunction results in an abundance of NADH from &#x003b2;-oxidation and the formation of &#x003b1;-ketoglutarate (&#x003b1;-KG) shutting down the TCA cycle (<xref rid="B219" ref-type="bibr">Vakifahmetoglu-Norberg et al., 2017</xref>; <xref rid="B175" ref-type="bibr">Picard and Shirihai, 2022</xref>). This halts the neurons&#x02019; main form of energy production. In the hypermetabolic state previously discussed, excess succinyl CoA and acetyl CoA may lead to decreased enzyme function, associated with decreased electron flux. Increased succinate has also been reported in blast TBI, which indicates hypoxia, decreased enzyme activity, and lower ETC functionality (<xref rid="B217" ref-type="bibr">Tretter et al., 2016</xref>; <xref rid="B184" ref-type="bibr">Rana et al., 2020</xref>).</p><p>Glutamate excitotoxicity - Glutamate plays a crucial role in mitochondrial dysfunction in TBI (<xref rid="F3" ref-type="fig">Figures 3</xref>&#x02013;<xref rid="F5" ref-type="fig">5</xref>). Under normal conditions, astrocytes play a central role in regulating glutamate levels in the brain, facilitating neuronal-astrocyte communication to maintain metabolic homeostasis (<xref rid="F4" ref-type="fig">Figure 4</xref>). Glutamate is primarily converted to glutamine by astrocytes and subsequently released into the extracellular space for neuronal uptake and metabolism. Additionally, astrocytes contribute to the TCA cycle by converting glutamate into &#x003b1;-KG, a process essential for energy balance, as it compensates for the ATP expenditure required to maintain sodium and potassium gradients during glutamate uptake (<xref rid="F4" ref-type="fig">Figure 4A</xref>; <xref rid="B202" ref-type="bibr">Sowers et al., 2021</xref>). However, TBI disrupts this tightly regulated system, leading to excessive extracellular glutamate accumulation, observed in both mild and severe TBI (<xref rid="B4" ref-type="bibr">Amorini et al., 2017</xref>). This dysregulation results in excitotoxicity and metabolic failure, as neurons require increased ATP-dependent ion pump activity to restore ionic equilibrium. The increased mitochondrial demand exacerbates dysfunction, leading to ETC impairments, ROS overproduction, apoptotic signaling, and inflammatory pathway activation (<xref rid="B202" ref-type="bibr">Sowers et al., 2021</xref>). In blast-induced TBI, glutamate levels decrease, further compromising metabolism, bioenergetics, and neurotransmission (<xref rid="B184" ref-type="bibr">Rana et al., 2020</xref>; <xref rid="B122" ref-type="bibr">Kumari et al., 2023</xref>).</p><fig position="float" id="F4"><label>FIGURE 4</label><caption><p>Glutamate-glutamine cycle and its disruption following acute traumatic brain injury (TBI). <bold>(A)</bold> Pre-TBI: Under normal physiological conditions, glutamate released from presynaptic neurons is efficiently taken up by astrocytes via Excitatory Amino Acids Transporters (EAATs). Within astrocytes, glutamate is either converted to glutamine &#x02013; subsequently shuttled back to neurons for reuse - or metabolized into &#x003b1;-ketoglutarate (&#x003b1;-KG), which enters the tricarboxylic acid (TCA) cycle to support astrocytic energy metabolism and maintain cellular homeostasis. <bold>(B)</bold> Post-TBI: Following TBI, mechanical forces trigger excessive glutamate release and impair astrocytic uptake via EAATs. This dysregulation leads to extracellular glutamate accumulation, resulting in excitotoxicity, mitochondrial dysfunction, and progressive neuronal injury. Figure created in <ext-link xlink:href="https://www.Biorender.com" ext-link-type="uri">Biorender.com</ext-link>.</p></caption><graphic xlink:href="fncel-19-1570596-g004" position="float"/></fig><fig position="float" id="F5"><label>FIGURE 5</label><caption><p>Cellular and mitochondrial ionic dysregulation in response to acute brain injury. <bold>(A)</bold> Pre-traumatic brain injury (TBI): Under normal physiological conditions, ionic homeostasis is maintained at the synapse. Glutamate is released from the presynaptic neuron and binds to N-methyl-D-Aspartate receptor (NMDA) and &#x003b1;- Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors on the post-synaptic membrane, facilitating the controlled influx of calcium (Ca<sup>2+</sup>) and Sodium (Na<sup>+</sup>). Mitochondria play a key role in maintaining ionic balance and supporting neuronal function through efficient energy production. <bold>(B)</bold> Post-TBI: TBI disrupts this homeostatic balance, causing excessive glutamate release and overactivation of NMDA and AMPA receptors. This results in uncontrolled Na<sup>+</sup> influx, pathological Ca<sup>2+</sup> accumulation, mitochondrial dysfunction, ROS production, and initiation of apoptotic signaling pathways. These disturbances contribute to excitotoxicity, oxidative stress, and progressive neuronal injury. Figure created in <ext-link xlink:href="https://www.Biorender.com" ext-link-type="uri">Biorender.com</ext-link>.</p></caption><graphic xlink:href="fncel-19-1570596-g005" position="float"/></fig><sec id="S2.SS2.SSS1"><title>2.2.1 Metabolic regulation as treatment post-TBI</title><p>Due to the innate complexity of the metabolic machinery and lack of understanding of the biological mechanisms associated with TBI, finding treatments or therapies based on metabolic dysfunction is difficult. However, there have been some promising possible targets that can mitigate the damage associated with secondary injury progression and mitochondrial dysfunction. Some of these treatments are associated with metabolism, including glucose, pyruvate, TCA components (specifically succinate), and &#x003a9;-3 fatty acids. Each of these compounds target different sections of metabolism with varying results. The treatment options are summarized in <xref rid="T1" ref-type="table">Table 1</xref>.</p><p>Glucose supplementation has been a controversial topic as there is no clear understanding of glucose metabolism in traumatized brains. Additionally, both hyper and hypoglycemia have a negative effect on the brain post-TBI. In a study where glucose was supplemented to the brain post-TBI, it was found that patients were limited in their ability to metabolize glucose, even when directly delivered into the brain (<xref rid="B206" ref-type="bibr">Stovell et al., 2023</xref>). On the other hand, it is important to note that the glucose was delivered into the brain&#x02019;s extracellular fluid rather than the brain&#x02019;s natural circulatory system route of obtaining glucose.</p><p>Pyruvate has also been suggested as a possible therapeutic for TBI due to its crucial role in metabolism and bioenergetics. Supplementing with pyruvate should push the TCA cycle forward and increase ATP production and metabolism in the hypometabolic state post-injury. Unfortunately, pyruvate supplementation has had mixed results. There were improvements in mitochondrial complex I enzyme but no improvement in motor and sensory performance (<xref rid="B7" ref-type="bibr">Ariyannur et al., 2021</xref>).</p><p>Succinate&#x02019;s role in metabolism and ATP production cannot be understated, making it a potential treatment for mitochondrial dysfunction. Direct TCA supplementation of succinate improved metabolism post-TBI in <italic>in vitro</italic> cultures and in humans, thus making it a potential therapeutic for mitochondrial dysfunction in TBI (<xref rid="B72" ref-type="bibr">Giorgi-Coll et al., 2017</xref>; <xref rid="B103" ref-type="bibr">Jalloh et al., 2017</xref>).</p><p>Lastly, supplementation with <italic>&#x003a9;-3 fatty acids</italic> has the potential to kick-start the metabolic machinery due to their importance in producing acetyl-CoA for the TCA cycle. Fatty acid supplementation has been found to inhibit neuroinflammation and necroptosis in TBI (<xref rid="B227" ref-type="bibr">Wu et al., 2023</xref>) and alleviate neurological impairment, specifically in mice (<xref rid="B236" ref-type="bibr">Zhang et al., 2020</xref>). While these are promising results, it is important to remember that successful treatment in mice might not be replicated in people.</p></sec></sec></sec><sec id="S3"><title>3 Brain injury-induced secondary mitochondrial dysfunction</title><p>Mitochondrial bioenergetic and metabolic dysfunction play critical roles in TBI&#x02019;s primary and secondary pathophysiology (<xref rid="F5" ref-type="fig">Figures 5A, B</xref>). The disruption of OXPHOS and ATP production within the mitochondria leads to a cascade of detrimental effects, including ionic imbalances, progression of neuroinflammation, and cellular death. Compromised mitochondria fail to produce sufficient ATP to maintain cellular ion gradients, impairing ion pumps like the sodium (Na<sup>+</sup>)/potassium (K<sup>+</sup>)-ATPase, leading to an accumulation of intracellular calcium (Ca<sup>2+</sup>) and Na<sup>+</sup> ions (<xref rid="B99" ref-type="bibr">Hubbard et al., 2019</xref>; <xref rid="B228" ref-type="bibr">Wu et al., 2022</xref>). The ionic imbalance caused by mitochondrial dysfunction further exacerbates neuronal damage through Ca<sup>2+</sup> overload, which disrupts the mitochondrial membrane potential and boosts the production of ROS. The increased ROS levels contribute to oxidative stress, damaging mitochondrial DNA (mtDNA), proteins, and lipids, thus perpetuating mitochondrial dysfunction and cellular injury (<xref rid="B228" ref-type="bibr">Wu et al., 2022</xref>). ROS and damaged mtDNA released from dysfunctional mitochondria serve as damage-associated molecular patterns (DAMPs), triggering the activation of microglia and astrocytes, the primary immune cells in the brain. This activation releases pro-inflammatory cytokines and chemokines, propagating a neuroinflammatory response (<xref rid="B173" ref-type="bibr">Peng et al., 2022</xref>). At last, damaged mitochondria-released Cytochrome C triggers apoptotic processes by activating caspases (<xref rid="B47" ref-type="bibr">Desagher and Martinou, 2000</xref>; <xref rid="B68" ref-type="bibr">Garrido et al., 2006</xref>). Apoptotic signaling, oxidative stress, and mtDNA damage collectively exacerbate neuroinflammation and neurodegeneration (<xref rid="B11" ref-type="bibr">Bader and Winklhofer, 2020</xref>; <xref rid="B150" ref-type="bibr">McGovern and Barreto, 2021</xref>) propagation in the long term (<xref rid="B45" ref-type="bibr">De Gaetano et al., 2021</xref>; <xref rid="B96" ref-type="bibr">Hu et al., 2022</xref>). The resulting inflammatory environment perpetuates a vicious cycle of mitochondrial dysfunction, oxidative damage, inflammation, and neurodegeneration (<xref rid="B218" ref-type="bibr">Trushina and McMurray, 2007</xref>; <xref rid="B62" ref-type="bibr">Fesharaki-Zadeh, 2022</xref>; <xref rid="B133" ref-type="bibr">Liaudanskaya et al., 2023</xref>; <xref rid="B239" ref-type="bibr">Zhang et al., 2024</xref>). The interplay between mitochondrial dysfunction, ionic imbalance, and neuroinflammation highlights secondary injury mechanisms&#x02019; complex and interconnected nature following TBI (<xref rid="B99" ref-type="bibr">Hubbard et al., 2019</xref>; <xref rid="B173" ref-type="bibr">Peng et al., 2022</xref>). The following section will further review the cycle of secondary mitochondrial dysfunction following TBI (<xref rid="B99" ref-type="bibr">Hubbard et al., 2019</xref>; <xref rid="B17" ref-type="bibr">Bernini et al., 2020</xref>; <xref rid="B228" ref-type="bibr">Wu et al., 2022</xref>).</p><sec id="S3.SS1"><title>3.1 Ionic disbalance as a consequence of bioenergetic failure</title><p>The pathophysiological mechanisms underpinning the neuronal damage caused by the interplay between glutamate and ion flux post-traumatic brain injury and mitochondrial bioenergetic and metabolic dysfunction are still poorly understood. Studies suggest that post-TBI, excessive release of glutamate (see section &#x0201c;2.2 Mitochondrial dysfunction and cellular metabolism&#x0201d;), an excitatory neurotransmitter, overstimulates glutamate receptors, such as voltage-gated calcium channels (VGCC) and N-methyl-D-aspartate (NMDA), a-amino-3-hydroxy-5-methyl-isoxazolepropionic acid (AMPA), and Kainate receptors, leading to an influx of Ca<sup>2 +</sup> and Na<sup>+</sup> ions into neurons (<xref rid="B204" ref-type="bibr">Stanika et al., 2012</xref>; <xref rid="B223" ref-type="bibr">Weber, 2012</xref>; <xref rid="B141" ref-type="bibr">Luo et al., 2019</xref>; <xref rid="B95" ref-type="bibr">Hoffe and Holahan, 2022</xref>). The resultant ionic imbalance and increased intracellular calcium concentration further alter mitochondrial function, creating a vicious cycle of metabolic dysfunction and excitotoxicity, where mitochondrial impairment not only exacerbates glutamate excitotoxicity but is also initially driven by ion flux and glutamate release following TBI (<xref rid="B107" ref-type="bibr">Jeffs et al., 2007</xref>; <xref rid="B204" ref-type="bibr">Stanika et al., 2012</xref>; <xref rid="B207" ref-type="bibr">Stovell et al., 2017</xref>; <xref rid="B80" ref-type="bibr">Granzotto et al., 2020</xref>).</p><p>A potential mechanism that drives ionic imbalance involves the ionotropic glutamate receptors, specifically the NMDA receptors. After the injury, these receptors cause a massive influx of Ca<sup>2+</sup> and Na<sup>+</sup> ions into neurons, setting off a series of events leading to mitochondrial dysfunction and neuronal death (<xref rid="B141" ref-type="bibr">Luo et al., 2019</xref>; <xref rid="F5" ref-type="fig">Figure 5B</xref>). The cytosolic Ca<sup>2+</sup> levels ([Ca<sup>2+</sup>]<sub><italic>c</italic></sub>) rise quickly and persistently due to an excessive Ca<sup>2+</sup> influx via NDMA receptors and VGCC. The mitochondrial calcium uniporter (MCU) absorbs this increased [Ca<sup>2+</sup>]<sub><italic>c</italic></sub>, ultimately resulting in mitochondrial Ca<sup>2+</sup> overload (<xref rid="B33" ref-type="bibr">Cheng et al., 2013</xref>).</p><p>The elevated levels of mitochondrial Ca<sup>2+</sup> ([Ca<sup>2+</sup>]<sub><italic>m</italic></sub>) disrupt mitochondrial function through several mechanisms. <italic>Mitochondrial permeability transition pore</italic> - elevated [Ca<sup>2+</sup>]<sub><italic>m</italic></sub> can cause the inner mitochondrial membrane&#x02019;s non-selective channel, the mitochondrial permeability transition pore (mPTP), to open. This allows pro-apoptotic molecules, like Cytochrome C, to be released from the mitochondrial intermembrane space into the cytosol, initiating the intrinsic apoptotic pathway (<xref rid="B203" ref-type="bibr">Springer et al., 2018</xref>). <italic>Oxidative stress</italic> - enhancing the electron transport chain&#x02019;s activity and decoupling oxidative phosphorylation may encourage the generation of ROS. ROS are produced mainly by the mitochondrial respiratory chain, particularly complexes I and III (<xref rid="B32" ref-type="bibr">Cheng et al., 2010</xref>). Superoxide anions are created when these complexes experience increased electron leakage. This anion can then be further transformed into hydroxyl radicals and hydrogen peroxide (<xref rid="B171" ref-type="bibr">Pandya et al., 2023</xref>). The resultant oxidative stress intensifies mitochondrial dysfunction and brain damage by destroying mitochondrial proteins, lipids, and DNA. <italic>Mitochondrial dynamics</italic> - excessive mitochondrial fission and fragmentation can result from the influx and overload of [Ca<sup>2+</sup>]<sub><italic>m</italic></sub>, which can contribute to the disturbance of mitochondrial dynamics. Mitochondria are dynamic organelles that constantly fuse and divide to preserve function and homeostasis and adjust to the cell&#x02019;s energy requirements. However, in the case of TBI, the equilibrium between fusion and fission is disrupted, which causes the mitochondria to fragment (<xref rid="B34" ref-type="bibr">Cheng et al., 2012</xref>; <xref rid="B82" ref-type="bibr">Guilhaume-Correa et al., 2023</xref>; <xref rid="B133" ref-type="bibr">Liaudanskaya et al., 2023</xref>; <xref rid="B239" ref-type="bibr">Zhang et al., 2024</xref>). This fragmentation impairs the production of ATP and facilitates the release of pro-apoptotic factors, further contributing to neuronal dysfunction and death (<xref rid="F5" ref-type="fig">Figure 5B</xref>).</p><p>Among these mechanisms, the glutamate/Ca<sup>2+</sup>/ROS axis is a detrimental cycle that prolongs and sustains neuronal injury (<xref rid="B80" ref-type="bibr">Granzotto et al., 2020</xref>; <xref rid="B153" ref-type="bibr">Mira et al., 2023</xref>). The ROS generated by mitochondria could further induce Ca<sup>2+</sup> release from the endoplasmic reticulum, partly by modulating the activity of stromal interaction molecule (STIM) proteins. The ROS can oxidize STIM 1 and STIM 2, which act as Ca<sup>2+</sup> sensors in the endoplasmic reticulum, potentially modifying their ability to regulate store-operated calcium entry (SOCE) (<xref rid="B159" ref-type="bibr">Nelson et al., 2018</xref>). STIM oxidation may increase Ca<sup>2+</sup> influx through the Orai channels, further amplifying the excitotoxic cascade. Additionally, ROS can elevate phospholipase C activity, which produces inositol triphosphate (IP3), triggering more Ca<sup>2+</sup> release from the endoplasmic reticulum. This process may involve STIM2, which is more sensitive to small changes in the endoplasmic reticulum Ca<sup>2+</sup> levels than STIM1 (<xref rid="B186" ref-type="bibr">Rao et al., 2015</xref>). The positive feedback loop between Ca<sup>2+</sup> and ROS exacerbates the excitotoxic cascade and mitochondrial dysfunction (<xref rid="B183" ref-type="bibr">Rana et al., 2019</xref>; <xref rid="B62" ref-type="bibr">Fesharaki-Zadeh, 2022</xref>). ROS can also directly damage cellular membranes, proteins, and DNA, further compromising neuronal viability (<xref rid="B145" ref-type="bibr">Maher et al., 2018</xref>). Downregulation of STIM2 has been shown to reduce calcium overload, decrease mitochondrial fragmentation, lower ROS levels, prevent mitochondrial membrane potential loss, and improve ATP synthesis impairment. STIM2 is, therefore, a crucial regulator of SOCE in cortical neurons, and targeting STIM2 could be a viable therapeutic strategy for reducing calcium dysregulation and subsequent mitochondrial dysfunction after TBI (<xref rid="B186" ref-type="bibr">Rao et al., 2015</xref>).</p><sec id="S3.SS1.SSS1"><title>3.1.1 Targeting the mitochondrial ion homeostasis post-TBI</title><p>Calcium Uniporter: Given the central role [Ca<sup>2+</sup>]<sub><italic>m</italic></sub> overload plays in TBI-induced neuronal injury, targeting the MCU has emerged as a promising treatment strategy. Pharmacological inhibition of the MCU using compounds such as Ru360 and minocycline has shown neuroprotective effects in several human and animal TBI models and models of neurodegenerative diseases (<xref rid="B34" ref-type="bibr">Cheng et al., 2012</xref>; <xref rid="B36" ref-type="bibr">Chitturi et al., 2021</xref>; <xref rid="B118" ref-type="bibr">Koulaeinejad et al., 2019</xref>; <xref rid="B27" ref-type="bibr">Celorrio et al., 2022</xref>). These inhibitors lower [Ca<sup>2+</sup>]<sub><italic>m</italic></sub> uptake, suppress the production of ROS, and prevent the mPTP from opening, thereby mitigating neuronal death. Genetic deletion of the MCU can confer neuroprotection in animal models of TBI (<xref rid="B161" ref-type="bibr">Nichols et al., 2018</xref>). However, the potential impact of inhibiting MCU on physiological [Ca<sup>2+</sup>]<sub><italic>m</italic></sub> signaling and energy production must be carefully evaluated. Selective inhibition of the MCU only during the acute phase of TBI may provide a therapeutic window for intervention without compromising long-term neuronal function.</p><p>Mitochondrial Fission and Fusion: Mitochondrial dynamics encompass fusion and fission processes, which are pertinent in maintaining mitochondrial function and adapting to cellular energy demands. The excessive fission of the mitochondria and fragmentation have been observed to contribute to neuronal dysfunction and death in TBI (<xref rid="B65" ref-type="bibr">Fischer et al., 2016</xref>; <xref rid="B49" ref-type="bibr">Di Pietro et al., 2017</xref>; <xref rid="B166" ref-type="bibr">Omelchenko et al., 2019</xref>; <xref rid="B82" ref-type="bibr">Guilhaume-Correa et al., 2023</xref>; <xref rid="B133" ref-type="bibr">Liaudanskaya et al., 2023</xref>). Targeting proteins such as dynamin-related protein 1, known to be involved in mitochondrial dynamics, may represent a novel therapeutic approach for mitigating TBI-induced neuronal injury (<xref rid="B180" ref-type="bibr">Qi et al., 2013</xref>; <xref rid="B65" ref-type="bibr">Fischer et al., 2016</xref>). Mitophagy and other mitochondrial quality control systems are critical in further maintaining cellular homeostasis and eliminating damaged mitochondria. Impaired mitophagy has been implicated in the pathogenesis of many neurodegenerative disorders, including TBI (<xref rid="B241" ref-type="bibr">Zhu et al., 2022</xref>; <xref rid="B140" ref-type="bibr">Luan et al., 2023</xref>). Therefore, enhancing mitophagy through genetic or pharmacological interventions may promote the elimination of dysfunctional or damaged mitochondria and attenuate neuronal damage in TBI.</p><p>Oxidative Stress: Oxidative stress, resulting from the imbalance between ROS production and antioxidant defenses, is another key contributor to TBI-induced neuronal injury. Antioxidant strategies aimed at scavenging ROS and bolstering endogenous antioxidant systems have shown promise in mitigating the deleterious effects of TBI (<xref rid="B62" ref-type="bibr">Fesharaki-Zadeh, 2022</xref>). Natural antioxidants such as curcumin, vitamin E, and resveratrol have demonstrated neuroprotective effects in animal models of TBI (<xref rid="B51" ref-type="bibr">Dong et al., 2018</xref>; <xref rid="B30" ref-type="bibr">Chen B. et al., 2023</xref>). These compounds benefit by neutralizing ROS, attenuating lipid peroxidation, and modulating inflammatory pathways. Also, developing targeted antioxidants, such as the mitochondria-targeted compound MitoQ, has gained significant attention (<xref rid="B240" ref-type="bibr">Zhou et al., 2018</xref>). These compounds accumulate specifically within mitochondria and offer improved defense against oxidative damage. In addition to exogenous antioxidants, strategies aimed at enhancing endogenous antioxidant defenses have also shown promise. For instance, the activation of nuclear factor erythroid 2-related factor 2, a master regulator of antioxidant gene expression, can confer neuroprotection in TBI models (<xref rid="B51" ref-type="bibr">Dong et al., 2018</xref>). Pharmacological activators of nuclear factor erythroid 2-related factor 2, such as sulforaphane and dimethyl fumarate, may represent novel therapeutic approaches to combat oxidative stress in TBI.</p><p>Integrative Approach: The complexity of the excitotoxic cascade and the multifaceted nature of mitochondrial dysfunction in TBI pose significant drawbacks for developing robust and effective therapies. Targeting a single ion channel or pathway may not be sufficient in stopping the progression of neuronal damage. Rather, an integrative and robust approach that combines the modulation of multiple targets, such as NMDA receptors, MCU, voltage-gated calcium channels, and antioxidant systems, may be necessary to achieve optimal neuroprotection. Also, the timing of the intervention is very critical in the context of TBI. While early intervention may be essential to prevent initial excitotoxic damage, sustained treatment may be necessary to tackle or address the progressive and chronic nature of the condition.</p></sec></sec><sec id="S3.SS2"><title>3.2 Mitochondria dysfunction-induced neuroinflammation</title><p>Neuroinflammation occurs after TBI and in neurodegenerative disease. Multiple molecular pathways lead to acute and chronic inflammation in almost all diseases; thus, inflammation has been a pharmacological target for decades. However, TBI clinical trials that completely inhibited inflammation demonstrated detrimental outcomes, indicating that inflammation can benefit the brain&#x02019;s ability to recover post-trauma (<xref rid="B182" ref-type="bibr">Ramlackhansingh et al., 2011</xref>; <xref rid="B146" ref-type="bibr">Mannix and Whalen, 2012</xref>; <xref rid="B83" ref-type="bibr">Gyoneva and Ransohoff, 2015</xref>; <xref rid="B37" ref-type="bibr">Chiu et al., 2016</xref>; <xref rid="B106" ref-type="bibr">Jassam et al., 2017</xref>; <xref rid="B39" ref-type="bibr">Clark et al., 2019</xref>; <xref rid="B111" ref-type="bibr">Johnson et al., 2023</xref>). Thus, understanding the context-dependent mechanisms of inflammation and their effect on brain degeneration or regeneration is crucial for targeted therapy in TBI patients. We will focus here on mitochondrial-induced inflammation in the brain.</p><p>Mitochondrial-induced neuroinflammation post-TBI is a critical aspect of the pathological response, characterized by the release of mtDNA, Cytochrome C, and ATP into the cytosol and extracellular space (<xref rid="F6" ref-type="fig">Figure 6</xref>). These molecules act as DAMPs that activate immune responses, including the STING (stimulator of interferon genes) pathway in microglia, promoting an acute inflammatory phenotype and the release of pro-inflammatory cytokines such as TNF-&#x003b1; and IL-1&#x003b2;. This inflammatory cascade exacerbates neuronal damage and contributes to the chronic phase of TBI pathology.</p><fig position="float" id="F6"><label>FIGURE 6</label><caption><p>Inflammatory cascade following traumatic brain injury (TBI). Following TBI, damaged neurons release mitochondrial damage-associated molecular patterns (DAMPs) &#x02013; including adenosine triphosphate (ATP), Cytochrome C, and mitochondrial DNA (mtDNA) - into the extracellular space. These DAMPs activate surrounding glial cells (both microglia and astrocytes) through distinct signaling pathways. ATP binds to purinergic receptors (e.g., P2X7) on microglia, promoting NLRP3 inflammasome formation and cytokine release. Cytochrome C activates TLR4, triggering apoptosome assembly and caspase activation, leading to apoptosis and neuroinflammation. mtDNA stimulates the cGAS-STING pathway in microglia, resulting in IRF3 phosphorylation and IFN-1 production. Additionally, mtDNA engages TLR9 receptors in endosomes, activating nuclear factor kappa B (NF-&#x003ba;B) pathway in both microglia and astrocytes, driving pro-inflammatory cytokine release (IL-1&#x003b2;, IL-6, TNF-&#x003b1;). Together, these processes amplify neuroinflammation through a positive feedback loop, perpetuating mitochondrial dysfunction and sustaining the inflammatory response in injured brain tissue. cGAMP, cyclic guanosine monophosphate&#x02013;adenosine monophosphate; cGAS, cyclic GMP-AMP synthase; IFN-1, type I interferons; IL, interleukin; IRF3, interferon regulatory factor 3; LPS, lipopolysaccharide; MYD88, myeloid differentiation primary response 88; NLRP3, nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3; P2x7, purinoreceptor 7; ROS, reactive oxygen species; STING, stimulator of interferon genes; TBK1, TANK-binding kinase 1; TLR, toll-like receptor; TNF-&#x003b1;, tumor necrosis factor alpha; TRAF6, TNF receptor-associated factor 6. Figure created in <ext-link xlink:href="https://www.Biorender.com" ext-link-type="uri">Biorender.com</ext-link>.</p></caption><graphic xlink:href="fncel-19-1570596-g006" position="float"/></fig><p>ATP dysregulation: The central nervous system (CNS) is a key site for purinergic signaling as all brain cell types express purinergic P2 receptors that sense ATP. Extracellular ATP (eATP) maintains CNS homeostasis by modulating microglia, astrocyte, and oligodendrocyte responses. Astrocytic ATP can modulate neuronal excitability, synaptic transmission, and CNS plasticity through exocytotic (vesicular) and non-exocytotic (channels/transporters) mechanisms (<xref rid="B43" ref-type="bibr">Davalos et al., 2005</xref>; <xref rid="B26" ref-type="bibr">Cekic and Linden, 2016</xref>; <xref rid="B101" ref-type="bibr">Illes et al., 2019</xref>). Astrocyte-derived ATP can activate purinergic P2X and P2Y receptors on neurons and other glial cells, depolarizing neurons, increasing neuronal firing, and modulating neurotransmitter release. These effects can be transient or long-lasting, allowing for immediate and sustained modulation of neuronal circuits (<xref rid="B151" ref-type="bibr">Mei et al., 2010</xref>; <xref rid="B235" ref-type="bibr">Zarrinmayeh and Territo, 2020</xref>). The precise regulation of astrocytic ATP signaling ensures its involvement in physiological processes like neurovascular coupling and synaptic plasticity, as well as pathological conditions such as epilepsy and neuroinflammation (<xref rid="B101" ref-type="bibr">Illes et al., 2019</xref>). Microglia, the brain&#x02019;s resident immune cells, respond rapidly to injury through processes modulated by ATP. The presence of eATP stimulates microglial production of pro-inflammatory cytokines such as TNF-&#x003b1; and IL-1&#x003b2; (<xref rid="F6" ref-type="fig">Figure 6</xref>). Additionally, ATP release can affect astrocytic signaling, influencing neuroinflammatory responses and neuronal survival (<xref rid="B26" ref-type="bibr">Cekic and Linden, 2016</xref>; <xref rid="B23" ref-type="bibr">Cao et al., 2018</xref>).</p><p>During TBI, there is a significant release of ATP, which acts as a danger signal. This release occurs immediately after injury, contributing to the inflammatory response (<xref rid="B155" ref-type="bibr">Moro et al., 2021</xref>). For instance, in a controlled cortical impact (CCI) model, a large release of ATP was observed in the cortex and hippocampus, along with increases in glutamate and lactate and decreases in glucose. Blockade of P2Y1 receptors or store-operated calcium channels significantly reduced ATP and glutamate levels post-CCI, indicating the role of these pathways in regulating extracellular ATP (<xref rid="B155" ref-type="bibr">Moro et al., 2021</xref>). Overall, ATP plays a dual role in the CNS, participating in both physiological and pathological processes. Its regulation is crucial for maintaining cellular energy balance, modulating inflammation, and ensuring proper neuronal function. Therapeutic strategies targeting ATP signaling pathways hold promise for treating neuroinflammation and other CNS disorders (<xref rid="B43" ref-type="bibr">Davalos et al., 2005</xref>; <xref rid="B63" ref-type="bibr">Fiebich et al., 2014</xref>; <xref rid="B152" ref-type="bibr">Meyrat and von Ballmoos, 2019</xref>; <xref rid="B160" ref-type="bibr">Neupane et al., 2019</xref>; <xref rid="B73" ref-type="bibr">Giuliani et al., 2021</xref>).</p><p>Cytochrome C as a trigger of neuroinflammation: Cytochrome C is an essential protein of the ETC, functioning as an electron shuttle between complex III and complex IV. Under normal conditions, Cytochrome C is in the mitochondrial intermembrane space, playing a vital role in cellular energy production and differentiation. However, during stressed conditions, Cytochrome C can be released into the cytosol, where it activates apoptosis by interacting with apoptosis-protease activating factor 1 and caspases that dismantle the cell (<xref rid="B18" ref-type="bibr">Bertini et al., 2006</xref>; <xref rid="B68" ref-type="bibr">Garrido et al., 2006</xref>; <xref rid="B225" ref-type="bibr">Wenzel et al., 2019</xref>; <xref rid="F6" ref-type="fig">Figure 6</xref>).</p><p>Extracellular Cytochrome C (eCytC) significantly affects inflammation and oxidative stress. When released into the extracellular space by damaged astrocytic and microglial cells, Cytochrome C acts as a DAMP, activating immune responses. For instance, eCytC can induce the production of reactive oxygen and nitrogen species by mononuclear phagocytes, enhancing the secretion of cytotoxins. This process is mediated at least partially by toll-like receptor 4 (TLR4) and the JNK signaling pathway, which are crucial for modulating microglial functions (<xref rid="B78" ref-type="bibr">Gouveia et al., 2017</xref>; <xref rid="B225" ref-type="bibr">Wenzel et al., 2019</xref>; <xref rid="F6" ref-type="fig">Figure 6</xref>). In neuroinflammation, Cytochrome C released from cells undergoing apoptosis can interact with astrocytes, inducing the production of pro-inflammatory cytokines such as IL-1&#x003b2; and IL-8 (<xref rid="F6" ref-type="fig">Figure 6</xref>). Blocking TLR4 with specific antibodies or using TAK 242 can mitigate these effects, highlighting the role of TLR4 in CytC-induced inflammation (<xref rid="B225" ref-type="bibr">Wenzel et al., 2019</xref>).</p><p>Interestingly, studies have shown that the administration of Cytochrome C can have protective effects in certain conditions. In a model of hemorrhagic shock and reperfusion injury, Cytochrome C administration improved lactate clearance, indicating reduced acidosis. It also decreased hepatic lipid peroxidation, a marker of oxidative stress, and increased the activity of the antioxidant enzyme glutathione peroxidase (<xref rid="B178" ref-type="bibr">Powell et al., 2017</xref>). Furthermore, Cytochrome C restored pulmonary levels of the inflammatory cytokine TNF-&#x003b1; to non-injured levels and enhanced the activity of mitochondrial complex I in the liver. These findings suggest that Cytochrome C can limit oxidative stress and inflammation, providing a potential therapeutic approach for oxidative damage and mitochondrial dysfunction (<xref rid="B178" ref-type="bibr">Powell et al., 2017</xref>). Moreover, elevated levels of plasma Cytochrome C upon hospital admission in patients with blunt trauma have been correlated with injury severity and survival probability, suggesting its utility as a biomarker for assessing trauma severity and predicting outcomes. Higher plasma Cytochrome C levels were observed in patients with more severe injuries, indicating its potential role in clinical diagnostics and patient management (<xref rid="B57" ref-type="bibr">Eleftheriadis et al., 2016</xref>). In summary, Cytochrome C plays a dual role in cellular function and stress response. While it is crucial for electron transport and apoptosis under normal and stressed conditions, its extracellular presence can significantly modulate immune responses and inflammation. Understanding these mechanisms opens up new avenues for therapeutic interventions in diseases characterized by mitochondrial dysfunction and oxidative stress.</p><p>mtDNA as a devastating trigger: Mitochondrial dysfunction, often resulting from acute or chronic events such as mutated mtDNA, oxidative stress, drug exposure, compromised mitochondrial dynamics, and aging, plays a significant role in neuroinflammation (<xref rid="B19" ref-type="bibr">Bhat et al., 2015</xref>; <xref rid="B21" ref-type="bibr">Bhatti et al., 2017</xref>; <xref rid="B62" ref-type="bibr">Fesharaki-Zadeh, 2022</xref>; <xref rid="B242" ref-type="bibr">Zong et al., 2024</xref>). Cytosolic mtDNA, which refers to the presence of mtDNA in the cytosol, is a major contributor to this inflammatory response. Under normal conditions, DNase prevents an accumulation of cytosolic mtDNA through digestion. However, various mechanisms allow mtDNA to escape into the cytosol or extracellular matrix, including the mPTP, BAX/BAK macropores, and exosome-mediated release, among others (<xref rid="B162" ref-type="bibr">Nicolson, 2014</xref>). The opening of the mPTP under stress conditions allows the free movement of small molecules and metabolites into the cytoplasm, including mtDNA, leading to calcium overload, reduced ATP production, and cell death (<xref rid="B59" ref-type="bibr">Elustondo et al., 2016</xref>). Similarly, BAX/BAK macropores can form in the mitochondrial membrane, facilitating the release of mtDNA into the cytosol. These events contribute to the neuroinflammatory milieu by activating various immune pathways, including the STING pathway (<xref rid="B46" ref-type="bibr">Decout et al., 2021</xref>; <xref rid="B50" ref-type="bibr">Ding et al., 2022</xref>; <xref rid="B96" ref-type="bibr">Hu et al., 2022</xref>; <xref rid="B117" ref-type="bibr">Kong et al., 2022</xref>). Upon detection of cytosolic mtDNA by cGAS (cyclic GMP-AMP synthase), ATP and GTP are converted to cGAMP, which activates the STING pathway, leading to an inflammatory response (<xref rid="B149" ref-type="bibr">McArthur et al., 2018</xref>; <xref rid="B45" ref-type="bibr">De Gaetano et al., 2021</xref>; <xref rid="B96" ref-type="bibr">Hu et al., 2022</xref>; <xref rid="F6" ref-type="fig">Figure 6</xref>).</p><p>Traumatic brain injury induces significant mitochondrial dysfunction not only in the brain but also systemically. Raised levels of mtDNA in blood and cerebrospinal fluid after brain injury can be used as biomarkers to determine the severity of injury and the inflammatory cytokine response. Studies have shown that mtDNA can be detected in blood and cerebrospinal fluid post-TBI, providing a means to monitor injury severity and systemic inflammatory responses (<xref rid="B113" ref-type="bibr">Kayhanian et al., 2022</xref>). Research using a middle cerebral artery occlusion (MCAO) model in mice showed that the mtDNA-STING axis directs microglial polarization toward a pro-inflammatory phenotype. Inhibition of STING reduced this pro-inflammatory polarization, suggesting that targeting the mtDNA-STING axis could shift microglial polarization toward an anti-inflammatory phenotype, offering potential therapeutic benefits for ischemic stroke and TBI (<xref rid="B117" ref-type="bibr">Kong et al., 2022</xref>).</p><p>Astrocytes contribute to the inflammatory response post-TBI by releasing mtDNA exosomes. These astrocyte-derived exosomes have been shown to alleviate TBI-induced neuronal defects by reducing oxidative stress and neuronal apoptosis via the activation of Nrf2/HO-1 (heme oxygenase (1) signaling. This mechanism highlights the protective role of astrocyte-derived exosomes in mitigating the effects of TBI (<xref rid="B238" ref-type="bibr">Zhang et al., 2021</xref>). Additionally, extracellular vesicles (EVs) containing mtDNA and specific proteins can serve as biomarkers for detecting TBI. A study identified serum amyloid A (SAA) and mtDNA in EVs as novel markers for TBI. Profiling EV content and dynamics through liquid biopsies could revolutionize TBI diagnostics, offering a non-invasive method to assess injury severity and progression (<xref rid="B121" ref-type="bibr">Kumar et al., 2017</xref>; <xref rid="B213" ref-type="bibr">Tang et al., 2024</xref>). In conclusion, mitochondrial dysfunction and the release of mtDNA play pivotal roles in the neuroinflammatory response following TBI. Understanding the mechanisms of mtDNA release and its impact on immune cell activation opens new avenues for therapeutic interventions and diagnostic tools in managing TBI and related neurological disorders.</p><sec id="S3.SS2.SSS1"><title>3.2.1 Targeting mitochondria-induced neuroinflammation</title><p>Anti-inflammatory Strategies: Neuroinflammation plays a significant role in the pathology of TBI and neurodegenerative diseases. However, complete inhibition of inflammation can have adverse effects, as controlled inflammation is necessary for recovery. One promising approach is the use of hydrogen sulfide (H<sub>2</sub>S) donors. H<sub>2</sub>S has been shown to reduce the production of ROS and pro-inflammatory cytokines such as TNF-&#x003b1; and IL-1&#x003b2; in microglia, demonstrating its potential to mitigate neuroinflammation and provide neuroprotection (<xref rid="B119" ref-type="bibr">Kshirsagar et al., 2021</xref>; <xref rid="B136" ref-type="bibr">Lin et al., 2024</xref>).</p><p>Targeting ATP Signaling: Drugs that modulate eATP concentrations in the CNS are emerging as potential therapies for neuroinflammation, given eATP&#x02019;s roles in synaptic transmission, mood disorders, cortical spreading depression, and microbiota-gut-brain axis signaling (<xref rid="B43" ref-type="bibr">Davalos et al., 2005</xref>; <xref rid="B63" ref-type="bibr">Fiebich et al., 2014</xref>; <xref rid="B73" ref-type="bibr">Giuliani et al., 2021</xref>). eATP is crucial in neuroinflammation and neuronal function. Targeting purinergic receptors (P2X and P2Y), which mediate ATP signaling, can help modulate inflammation and protect neurons. For instance, blocking P2Y1 receptors significantly reduces ATP and glutamate levels, decreasing excitotoxicity and inflammation post-TBI (<xref rid="B60" ref-type="bibr">Engel et al., 2021</xref>; <xref rid="B136" ref-type="bibr">Lin et al., 2024</xref>). These therapeutic strategies aim to restore ATP homeostasis, reducing neuroinflammatory responses and promoting neuronal recovery.</p><p>Modulating Cytochrome C: Cytochrome C release from mitochondria can trigger apoptosis and inflammation. Blocking Toll-like receptor 4 (TLR4) with specific antibodies or using inhibitors like TAK-242 can reduce Cytochrome C-induced inflammation. Additionally, strategies enhancing mitochondrial function and preventing Cytochrome C release, such as antioxidants and mitochondrial stabilizers, can protect against neuroinflammation. These interventions target the pathways activated by eCytC, which acts as a DAMP (<xref rid="B57" ref-type="bibr">Eleftheriadis et al., 2016</xref>; <xref rid="B119" ref-type="bibr">Kshirsagar et al., 2021</xref>).</p><p>Inhibiting the mtDNA-STING Pathway: mtDNA released into the cytosol acts as a danger signal, activating the STING pathway and promoting inflammation. Targeting this pathway offers a therapeutic approach to reduce inflammation. STING inhibitors can reduce pro-inflammatory microglial polarization, as demonstrated in models of ischemic stroke and TBI. This approach can shift the inflammatory response toward a more anti-inflammatory phenotype, potentially improving outcomes (<xref rid="B132" ref-type="bibr">Liao et al., 2020</xref>; <xref rid="B46" ref-type="bibr">Decout et al., 2021</xref>; <xref rid="B50" ref-type="bibr">Ding et al., 2022</xref>; <xref rid="B96" ref-type="bibr">Hu et al., 2022</xref>; <xref rid="B143" ref-type="bibr">Ma et al., 2023</xref>).</p><p>Utilizing Astrocyte-Derived Exosomes: Astrocytes release exosomes containing mtDNA, which can modulate the inflammatory response. These exosomes have been shown to alleviate neuronal defects post-TBI by reducing oxidative stress and apoptosis by activating the Nrf2/HO-1 signaling pathway. Harnessing the protective effects of astrocyte-derived exosomes represents a novel therapeutic strategy to mitigate neuroinflammation and promote neuronal survival (<xref rid="B69" ref-type="bibr">Gharbi et al., 2020</xref>; <xref rid="B238" ref-type="bibr">Zhang et al., 2021</xref>; <xref rid="B222" ref-type="bibr">Wan et al., 2022</xref>; <xref rid="B242" ref-type="bibr">Zong et al., 2024</xref>).</p><p>Addressing the pathways involved in mitochondrial dysfunction and neuroinflammation post-TBI is crucial for developing effective treatments. By targeting inflammation, ATP signaling, Cytochrome C, and the mtDNA-STING pathway, as well as leveraging astrocyte-derived exosomes, researchers can create combinatorial therapies that reduce neuronal damage and enhance recovery. Continued research into these mechanisms is essential for advancing therapeutic strategies and improving outcomes for patients with TBI and neurodegenerative disorders (<xref rid="B242" ref-type="bibr">Zong et al., 2024</xref>).</p></sec></sec></sec><sec id="S4"><title>4 Future directions</title><p>Addressing mitochondrial dysfunction post-traumatic brain injury requires continued research into several key areas to develop effective treatments and improve patient outcomes. Future research should focus on detailed mechanistic studies to investigate the precise molecular pathways involved in mitochondrial bioenergetic and metabolic dysfunction and their relationship with neuroinflammation and oxidative stress, including the role of mitochondrial permeability transition pores and their inhibitors in mitigating mitochondrial damage and apoptosis. Elucidating the specific contributions of different mitochondrial components such as mtDNA, Cytochrome C, and ATP in triggering and sustaining neuroinflammation is essential.</p><p>Targeting mitochondrial mechanisms to develop therapeutics will be critical. Specifically, targeting mitochondrial bioenergetics with PGC-1&#x003b1; agonists, mitochondrial-targeted antioxidants like MitoQ and SS-31, and modulators of mitochondrial biogenesis should yield effective therapies (<xref rid="T1" ref-type="table">Table 1</xref>). The efficacy of ketone bodies and ketogenic diets in enhancing mitochondrial function and reducing oxidative stress in the injured brain warrants further investigation. The potential of hydrogen sulfide (H<sub>2</sub>S) donors, purinergic receptor blockers, and STING pathway inhibitors in reducing neuroinflammation and promoting neuronal recovery should be explored.</p><p>Understanding cell-specific responses is important for comprehending how different cell types (neurons, astrocytes, microglia, oligodendrocytes) respond to mitochondrial dysfunction and contribute to the overall pathology of TBI. It is crucial to analyze the impact of mitochondrial dysfunction on astrocyte-derived exosomes and their role in modulating neuroinflammatory responses and neuronal survival. Characterizing the temporal dynamics of mitochondrial dysfunction across different brain regions and cell types following TBI, including studying the biphasic response in mitochondrial bioenergetics dysfunction in regions like the frontal cortex and striatum compared to the delayed dysfunction in the hippocampus, is vital for understanding long-term effects on neuronal plasticity, cognitive deficits, and neurodegeneration.</p><p>Developing biomarkers reflecting mitochondrial status is another promising area for TBI research. EV-containing biomarkers such as mtDNA, Cytochrome C, and serum amyloid A may effectively diagnose and monitor TBI&#x02019;s severity early. Utilizing advanced imaging and molecular techniques to profile mitochondrial and metabolic changes <italic>in vivo</italic> and correlate them with clinical outcomes is essential for advancing our understanding of mitochondrial dysfunction in TBI. By addressing these future directions and unresolved mechanisms, researchers can develop targeted therapies to mitigate the effects of mitochondrial dysfunction, ultimately improving TBI patients&#x02019; recovery and quality of life.</p></sec><sec sec-type="conclusion" id="S5"><title>5 Conclusion</title><p>Mitochondrial dysfunction is a pivotal factor in the pathogenesis of TBI, driving neuroinflammation, oxidative stress, and metabolic disturbances. The release of mitochondrial components such as mtDNA, Cytochrome C, and ATP into the cytosol and extracellular space activates inflammatory pathways, exacerbating neuronal damage and contributing to chronic TBI pathology. Addressing mitochondrial dysfunction is crucial for mitigating secondary brain injury and improving outcomes for TBI patients. Continued research into the underlying mechanisms and therapeutic approaches is essential for advancing clinical treatments for TBI and neurodegenerative diseases.</p></sec></body><back><sec sec-type="author-contributions" id="S6"><title>Author contributions</title><p>OO: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Resources, Visualization, Writing &#x02013; original draft, Writing &#x02013; review and editing. SS: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Resources, Visualization, Writing &#x02013; original draft, Writing &#x02013; review and editing. SK: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Resources, Visualization, Writing &#x02013; original draft, Writing &#x02013; review and editing. AS: Funding acquisition, Project administration, Resources, Validation, Writing &#x02013; original draft, Writing &#x02013; review and editing. VL: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing &#x02013; original draft, Writing &#x02013; review and editing.</p></sec><sec sec-type="COI-statement" id="S8"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="S9"><title>Generative AI statement</title><p>The authors declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="S10"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdullah</surname><given-names>M.</given-names></name><name><surname>Zeng</surname><given-names>R.</given-names></name><name><surname>Margerum</surname><given-names>C.</given-names></name><name><surname>Papadopoli</surname><given-names>D.</given-names></name><name><surname>Monnin</surname><given-names>C.</given-names></name><name><surname>Punter</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Mitochondrial hyperfusion via metabolic sensing of regulatory amino acids.</article-title>
<source><italic>Cell Rep.</italic></source>
<volume>40</volume>:<fpage>111198</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2022.111198</pub-id>
<pub-id pub-id-type="pmid">35977476</pub-id>
</mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahluwalia</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>M.</given-names></name><name><surname>Ahluwalia</surname><given-names>P.</given-names></name><name><surname>Rahimi</surname><given-names>S.</given-names></name><name><surname>Vender</surname><given-names>J.</given-names></name><name><surname>Raju</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Rescuing mitochondria in traumatic brain injury and intracerebral hemorrhages - A potential therapeutic approach.</article-title>
<source><italic>Neurochem. Int.</italic></source>
<volume>150</volume>:<fpage>105192</fpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2021.105192</pub-id>
<pub-id pub-id-type="pmid">34560175</pub-id>
</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alirezaei</surname><given-names>M.</given-names></name><name><surname>Kemball</surname><given-names>C.</given-names></name><name><surname>Flynn</surname><given-names>C.</given-names></name><name><surname>Wood</surname><given-names>M.</given-names></name><name><surname>Whitton</surname><given-names>J.</given-names></name><name><surname>Kiosses</surname><given-names>W.</given-names></name></person-group> (<year>2010</year>). <article-title>Short-term fasting induces profound neuronal autophagy.</article-title>
<source><italic>Autophagy</italic></source>
<volume>6</volume>
<fpage>702</fpage>&#x02013;<lpage>710</lpage>. <pub-id pub-id-type="doi">10.4161/auto.6.6.12376</pub-id>
<pub-id pub-id-type="pmid">20534972</pub-id>
</mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amorini</surname><given-names>A.</given-names></name><name><surname>Lazzarino</surname><given-names>G.</given-names></name><name><surname>Di Pietro</surname><given-names>V.</given-names></name><name><surname>Signoretti</surname><given-names>S.</given-names></name><name><surname>Lazzarino</surname><given-names>G.</given-names></name><name><surname>Belli</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Severity of experimental traumatic brain injury modulates changes in concentrations of cerebral free amino acids.</article-title>
<source><italic>J. Cell Mol. Med.</italic></source>
<volume>21</volume>
<fpage>530</fpage>&#x02013;<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.12998</pub-id>
<pub-id pub-id-type="pmid">27696676</pub-id>
</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>R.</given-names></name><name><surname>Barger</surname><given-names>J.</given-names></name><name><surname>Edwards</surname><given-names>M.</given-names></name><name><surname>Braun</surname><given-names>K.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>C.</given-names></name><name><surname>Prolla</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response.</article-title>
<source><italic>Aging Cell.</italic></source>
<volume>7</volume>
<fpage>101</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2007.00357.x</pub-id>
<pub-id pub-id-type="pmid">18031569</pub-id>
</mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthonymuthu</surname><given-names>T.</given-names></name><name><surname>Kenny</surname><given-names>E.</given-names></name><name><surname>Amoscato</surname><given-names>A.</given-names></name><name><surname>Lewis</surname><given-names>J.</given-names></name><name><surname>Kochanek</surname><given-names>P.</given-names></name><name><surname>Kagan</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Global assessment of oxidized free fatty acids in brain reveals an enzymatic predominance to oxidative signaling after trauma.</article-title>
<source><italic>Biochim. Biophys. Acta Mol. Basis Dis.</italic></source>
<volume>1863</volume>(<issue>10 Pt B</issue>), <fpage>2601</fpage>&#x02013;<lpage>2613</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2017.03.015</pub-id>
<pub-id pub-id-type="pmid">28347845</pub-id>
</mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariyannur</surname><given-names>P.</given-names></name><name><surname>Xing</surname><given-names>G.</given-names></name><name><surname>Barry</surname><given-names>E.</given-names></name><name><surname>Benford</surname><given-names>B.</given-names></name><name><surname>Grunberg</surname><given-names>N.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name></person-group> (<year>2021</year>). <article-title>Effects of pyruvate administration on mitochondrial enzymes, neurological behaviors, and neurodegeneration after traumatic brain injury.</article-title>
<source><italic>Aging Dis.</italic></source>
<volume>12</volume>
<fpage>983</fpage>&#x02013;<lpage>999</lpage>. <pub-id pub-id-type="doi">10.14336/AD.2020.1015</pub-id>
<pub-id pub-id-type="pmid">34221543</pub-id>
</mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>N.</given-names></name><name><surname>Litofsky</surname><given-names>N.</given-names></name><name><surname>Golzy</surname><given-names>M.</given-names></name><name><surname>Aneja</surname><given-names>R.</given-names></name><name><surname>Staudenmyer</surname><given-names>D.</given-names></name><name><surname>Qualls</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Phase I single center trial of ketogenic diet for adults with traumatic brain injury.</article-title>
<source><italic>Clin. Nutr. ESPEN</italic></source>
<volume>47</volume>
<fpage>339</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnesp.2021.11.015</pub-id>
<pub-id pub-id-type="pmid">35063224</pub-id>
</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arun</surname><given-names>P.</given-names></name><name><surname>Abu-Taleb</surname><given-names>R.</given-names></name><name><surname>Oguntayo</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Valiyaveettil</surname><given-names>M.</given-names></name><name><surname>Long</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Acute mitochondrial dysfunction after blast exposure: Potential role of mitochondrial glutamate oxaloacetate transaminase.</article-title>
<source><italic>J. Neurotrauma.</italic></source>
<volume>30</volume>
<fpage>1645</fpage>&#x02013;<lpage>1651</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2012.2834</pub-id>
<pub-id pub-id-type="pmid">23600763</pub-id>
</mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Audano</surname><given-names>M.</given-names></name><name><surname>Pedretti</surname><given-names>S.</given-names></name><name><surname>Ligorio</surname><given-names>S.</given-names></name><name><surname>Crestani</surname><given-names>M.</given-names></name><name><surname>Caruso</surname><given-names>D.</given-names></name><name><surname>De Fabiani</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>&#x0201c;The Loss of Golden Touch&#x0201d;: Mitochondria-organelle interactions, metabolism, and Cancer.</article-title>
<source><italic>Cells</italic></source>
<volume>9</volume>:<fpage>2519</fpage>. <pub-id pub-id-type="doi">10.3390/cells9112519</pub-id>
<pub-id pub-id-type="pmid">33233365</pub-id>
</mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bader</surname><given-names>V.</given-names></name><name><surname>Winklhofer</surname><given-names>K.</given-names></name></person-group> (<year>2020</year>). <article-title>Mitochondria at the interface between neurodegeneration and neuroinflammation.</article-title>
<source><italic>Semin. Cell Dev. Biol.</italic></source>
<volume>99</volume>
<fpage>163</fpage>&#x02013;<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2019.05.028</pub-id>
<pub-id pub-id-type="pmid">31154011</pub-id>
</mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>D.</given-names></name><name><surname>Gonzalez-Lima</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans.</article-title>
<source><italic>Neuroscience</italic></source>
<volume>230</volume>
<fpage>13</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.11.016</pub-id>
<pub-id pub-id-type="pmid">23200785</pub-id>
</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bathini</surname><given-names>M.</given-names></name><name><surname>Raghushaker</surname><given-names>C.</given-names></name><name><surname>Mahato</surname><given-names>K.</given-names></name></person-group> (<year>2022</year>). <article-title>The molecular mechanisms of action of photobiomodulation against neurodegenerative diseases: A systematic review.</article-title>
<source><italic>Cell Mol. Neurobiol.</italic></source>
<volume>42</volume>
<fpage>955</fpage>&#x02013;<lpage>971</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-020-01016-9</pub-id>
<pub-id pub-id-type="pmid">33301129</pub-id>
</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begum</surname><given-names>R.</given-names></name><name><surname>Calaza</surname><given-names>K.</given-names></name><name><surname>Kam</surname><given-names>J.</given-names></name><name><surname>Salt</surname><given-names>T.</given-names></name><name><surname>Hogg</surname><given-names>C.</given-names></name><name><surname>Jeffery</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Near-infrared light increases ATP, extends lifespan and improves mobility in aged Drosophila melanogaster.</article-title>
<source><italic>Biol. Lett.</italic></source>
<volume>11</volume>:<fpage>20150073</fpage>. <pub-id pub-id-type="doi">10.1098/rsbl.2015.0073</pub-id>
<pub-id pub-id-type="pmid">25788488</pub-id>
</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belenguer</surname><given-names>P.</given-names></name><name><surname>Duarte</surname><given-names>J.</given-names></name><name><surname>Schuck</surname><given-names>P.</given-names></name><name><surname>Ferreira</surname><given-names>G.</given-names></name></person-group> (<year>2019</year>). <article-title>Mitochondria and the brain: Bioenergetics and beyond.</article-title>
<source><italic>Neurotox Res.</italic></source>
<volume>36</volume>
<fpage>219</fpage>&#x02013;<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-019-00061-7</pub-id>
<pub-id pub-id-type="pmid">31152314</pub-id>
</mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benaroya</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>Brain energetics, mitochondria, and traumatic brain injury.</article-title>
<source><italic>Rev. Neurosci.</italic></source>
<volume>31</volume>
<fpage>363</fpage>&#x02013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1515/revneuro-2019-0086</pub-id>
<pub-id pub-id-type="pmid">32004148</pub-id>
</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernini</surname><given-names>A.</given-names></name><name><surname>Masoodi</surname><given-names>M.</given-names></name><name><surname>Solari</surname><given-names>D.</given-names></name><name><surname>Miroz</surname><given-names>J.</given-names></name><name><surname>Carteron</surname><given-names>L.</given-names></name><name><surname>Christinat</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Modulation of cerebral ketone metabolism following traumatic brain injury in humans.</article-title>
<source><italic>J. Cereb. Blood Flow Metab.</italic></source>
<volume>40</volume>
<fpage>177</fpage>&#x02013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X18808947</pub-id>
<pub-id pub-id-type="pmid">30353770</pub-id>
</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertini</surname><given-names>I.</given-names></name><name><surname>Cavallaro</surname><given-names>G.</given-names></name><name><surname>Rosato</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Cytochrome c: Occurrence and functions.</article-title>
<source><italic>Chem. Rev.</italic></source>
<volume>106</volume>
<fpage>90</fpage>&#x02013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1021/cr050241v</pub-id>
<pub-id pub-id-type="pmid">16402772</pub-id>
</mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>A.</given-names></name><name><surname>Dar</surname><given-names>K.</given-names></name><name><surname>Anees</surname><given-names>S.</given-names></name><name><surname>Zargar</surname><given-names>M.</given-names></name><name><surname>Masood</surname><given-names>A.</given-names></name><name><surname>Sofi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight.</article-title>
<source><italic>Biomed. Pharmacother.</italic></source>
<volume>74</volume>
<fpage>101</fpage>&#x02013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2015.07.025</pub-id>
<pub-id pub-id-type="pmid">26349970</pub-id>
</mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatti</surname><given-names>G.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Pahwa</surname><given-names>P.</given-names></name><name><surname>Khullar</surname><given-names>N.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Navik</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases.</article-title>
<source><italic>Biomed. J.</italic></source>
<volume>45</volume>
<fpage>733</fpage>&#x02013;<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1016/j.bj.2022.05.002</pub-id>
<pub-id pub-id-type="pmid">35568318</pub-id>
</mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatti</surname><given-names>J.</given-names></name><name><surname>Bhatti</surname><given-names>G.</given-names></name><name><surname>Reddy</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.</article-title>
<source><italic>Biochim. Biophys. Acta Mol. Basis Dis.</italic></source>
<volume>1863</volume>
<fpage>1066</fpage>&#x02013;<lpage>1077</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2016.11.010</pub-id>
<pub-id pub-id-type="pmid">27836629</pub-id>
</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bujak</surname><given-names>A.</given-names></name><name><surname>Crane</surname><given-names>J.</given-names></name><name><surname>Lally</surname><given-names>J.</given-names></name><name><surname>Ford</surname><given-names>R.</given-names></name><name><surname>Kang</surname><given-names>S.</given-names></name><name><surname>Rebalka</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>21</volume>
<fpage>883</fpage>&#x02013;<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.05.016</pub-id>
<pub-id pub-id-type="pmid">26039451</pub-id>
</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Nagpure</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Hydrogen sulfide inhibits ATP-induced neuroinflammation and A&#x003b2;1-42 synthesis by suppressing the activation of STAT3 and cathepsin S.</article-title>
<source><italic>Brain Behav. Immun.</italic></source>
<volume>73</volume>
<fpage>603</fpage>&#x02013;<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2018.07.005</pub-id>
<pub-id pub-id-type="pmid">29981830</pub-id>
</mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Intermittent fasting enhances hippocampal NPY expression to promote neurogenesis after traumatic brain injury.</article-title>
<source><italic>Nutrition</italic></source>
<volume>97</volume>:<fpage>111621</fpage>. <pub-id pub-id-type="doi">10.1016/j.nut.2022.111621</pub-id>
<pub-id pub-id-type="pmid">35255397</pub-id>
</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>K.</given-names></name><name><surname>Jalloh</surname><given-names>I.</given-names></name><name><surname>Hutchinson</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Glycolysis and the significance of lactate in traumatic brain injury.</article-title>
<source><italic>Front. Neurosci.</italic></source>
<volume>9</volume>:<fpage>112</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2015.00112</pub-id>
<pub-id pub-id-type="pmid">25904838</pub-id>
</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cekic</surname><given-names>C.</given-names></name><name><surname>Linden</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Purinergic regulation of the immune system.</article-title>
<source><italic>Nat. Rev. Immunol.</italic></source>
<volume>16</volume>
<fpage>177</fpage>&#x02013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2016.4</pub-id>
<pub-id pub-id-type="pmid">26922909</pub-id>
</mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celorrio</surname><given-names>M.</given-names></name><name><surname>Shumilov</surname><given-names>K.</given-names></name><name><surname>Payne</surname><given-names>C.</given-names></name><name><surname>Vadivelu</surname><given-names>S.</given-names></name><name><surname>Friess</surname><given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Acute minocycline administration reduces brain injury and improves long-term functional outcomes after delayed hypoxemia following traumatic brain injury.</article-title>
<source><italic>Acta Neuropathol. Commun.</italic></source>
<volume>10</volume>:<fpage>10</fpage>. <pub-id pub-id-type="doi">10.1186/s40478-022-01310-1</pub-id>
<pub-id pub-id-type="pmid">35090569</pub-id>
</mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerutti</surname><given-names>R.</given-names></name><name><surname>Pirinen</surname><given-names>E.</given-names></name><name><surname>Lamperti</surname><given-names>C.</given-names></name><name><surname>Marchet</surname><given-names>S.</given-names></name><name><surname>Sauve</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>19</volume>
<fpage>1042</fpage>&#x02013;<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2014.04.001</pub-id>
<pub-id pub-id-type="pmid">24814483</pub-id>
</mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarty</surname><given-names>R.</given-names></name><name><surname>Chandel</surname><given-names>N.</given-names></name></person-group> (<year>2021</year>). <article-title>Mitochondria as signaling organelles control mammalian stem cell fate.</article-title>
<source><italic>Cell Stem Cell</italic></source>
<volume>28</volume>
<fpage>394</fpage>&#x02013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2021.02.011</pub-id>
<pub-id pub-id-type="pmid">33667360</pub-id>
</mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Nie</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Curcumin alleviates oxidative stress, neuroinflammation, and promotes behavioral recovery after traumatic brain injury.</article-title>
<source><italic>Curr. Neurovasc. Res.</italic></source>
<volume>20</volume>
<fpage>43</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.2174/1567202620666230303144323</pub-id>
<pub-id pub-id-type="pmid">36872351</pub-id>
</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group> (<year>2023</year>). <article-title>Mitochondrial dynamics in health and disease: mechanisms and potential targets.</article-title>
<source><italic>Signal Transduct Target Ther.</italic></source>
<volume>8</volume>:<fpage>333</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-023-01547-9</pub-id>
<pub-id pub-id-type="pmid">37669960</pub-id>
</mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>A.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Mattson</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondria and neuroplasticity.</article-title>
<source><italic>ASN Neuro.</italic></source>
<volume>2</volume>:<fpage>e00045</fpage>. <pub-id pub-id-type="doi">10.1042/AN20100019</pub-id>
<pub-id pub-id-type="pmid">20957078</pub-id>
</mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>G.</given-names></name><name><surname>Fu</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of mitochondrial calcium uniporter in neuroprotection in traumatic brain injury.</article-title>
<source><italic>Med. Hypotheses</italic></source>
<volume>80</volume>
<fpage>115</fpage>&#x02013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2012.11.004</pub-id>
<pub-id pub-id-type="pmid">23200456</pub-id>
</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>G.</given-names></name><name><surname>Kong</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies.</article-title>
<source><italic>Br. J. Pharmacol.</italic></source>
<volume>167</volume>
<fpage>699</fpage>&#x02013;<lpage>719</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2012.02025.x</pub-id>
<pub-id pub-id-type="pmid">23003569</pub-id>
</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Sheng</surname><given-names>Z.</given-names></name></person-group> (<year>2022</year>). <article-title>Programming axonal mitochondrial maintenance and bioenergetics in neurodegeneration and regeneration.</article-title>
<source><italic>Neuron</italic></source>
<volume>110</volume>
<fpage>1899</fpage>&#x02013;<lpage>1923</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2022.03.015</pub-id>
<pub-id pub-id-type="pmid">35429433</pub-id>
</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chitturi</surname><given-names>J.</given-names></name><name><surname>Santhakumar</surname><given-names>V.</given-names></name><name><surname>Kannurpatti</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Traumatic brain injury metabolome and mitochondrial impact after early stage Ru360 treatment.</article-title>
<source><italic>Mitochondrion</italic></source>
<volume>57</volume>
<fpage>192</fpage>&#x02013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2021.01.003</pub-id>
<pub-id pub-id-type="pmid">33484870</pub-id>
</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>C.</given-names></name><name><surname>Liao</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Tweedie</surname><given-names>D.</given-names></name><name><surname>Karnati</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Neuroinflammation in animal models of traumatic brain injury.</article-title>
<source><italic>J. Neurosci. Methods</italic></source>
<volume>272</volume>
<fpage>38</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2016.06.018</pub-id>
<pub-id pub-id-type="pmid">27382003</pub-id>
</mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J.</given-names></name><name><surname>Levey</surname><given-names>A.</given-names></name><name><surname>Weintraub</surname><given-names>S.</given-names></name><name><surname>Rees</surname><given-names>H.</given-names></name><name><surname>Gearing</surname><given-names>M.</given-names></name><name><surname>Chin</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson&#x02019;s and Alzheimer&#x02019;s diseases.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>279</volume>
<fpage>13256</fpage>&#x02013;<lpage>13264</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M314124200</pub-id>
<pub-id pub-id-type="pmid">14722078</pub-id>
</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>D.</given-names></name><name><surname>Perreau</surname><given-names>V.</given-names></name><name><surname>Shultz</surname><given-names>S.</given-names></name><name><surname>Brady</surname><given-names>R.</given-names></name><name><surname>Lei</surname><given-names>E.</given-names></name><name><surname>Dixit</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Inflammation in traumatic brain injury: Roles for toxic A1 astrocytes and microglial-astrocytic crosstalk.</article-title>
<source><italic>Neurochem. Res.</italic></source>
<volume>44</volume>
<fpage>1410</fpage>&#x02013;<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-019-02721-8</pub-id>
<pub-id pub-id-type="pmid">30661228</pub-id>
</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>J.</given-names></name><name><surname>Doepke</surname><given-names>A.</given-names></name><name><surname>Filosa</surname><given-names>J.</given-names></name><name><surname>Wardle</surname><given-names>R.</given-names></name><name><surname>Lu</surname><given-names>A.</given-names></name><name><surname>Meeker</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>N-acetylaspartate as a reservoir for glutamate.</article-title>
<source><italic>Med. Hypotheses</italic></source>
<volume>67</volume>
<fpage>506</fpage>&#x02013;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2006.02.047</pub-id>
<pub-id pub-id-type="pmid">16730130</pub-id>
</mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collier</surname><given-names>J.</given-names></name><name><surname>Ol&#x000e1;hov&#x000e1;</surname><given-names>M.</given-names></name><name><surname>McWilliams</surname><given-names>T.</given-names></name><name><surname>Taylor</surname><given-names>R.</given-names></name></person-group> (<year>2023</year>). <article-title>Mitochondrial signalling and homeostasis: From cell biology to neurological disease.</article-title>
<source><italic>Trends Neurosci.</italic></source>
<volume>46</volume>
<fpage>137</fpage>&#x02013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2022.12.001</pub-id>
<pub-id pub-id-type="pmid">36635110</pub-id>
</mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crompton</surname><given-names>M.</given-names></name></person-group> (<year>1999</year>). <article-title>The mitochondrial permeability transition pore and its role in cell death.</article-title>
<source><italic>Biochem. J.</italic></source>
<volume>341</volume>(<issue>Pt 2</issue>), <fpage>233</fpage>&#x02013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1042/bj3410233</pub-id><pub-id pub-id-type="pmid">10393078</pub-id>
</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davalos</surname><given-names>D.</given-names></name><name><surname>Grutzendler</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Zuo</surname><given-names>Y.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>ATP mediates rapid microglial response to local brain injury in vivo.</article-title>
<source><italic>Nat. Neurosci.</italic></source>
<volume>8</volume>
<fpage>752</fpage>&#x02013;<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1038/nn1472</pub-id>
<pub-id pub-id-type="pmid">15895084</pub-id>
</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>L.</given-names></name><name><surname>Pauly</surname><given-names>J.</given-names></name><name><surname>Readnower</surname><given-names>R.</given-names></name><name><surname>Rho</surname><given-names>J.</given-names></name><name><surname>Sullivan</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>Fasting is neuroprotective following traumatic brain injury.</article-title>
<source><italic>J. Neurosci. Res.</italic></source>
<volume>86</volume>
<fpage>1812</fpage>&#x02013;<lpage>1822</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.21628</pub-id>
<pub-id pub-id-type="pmid">18241053</pub-id>
</mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Gaetano</surname><given-names>A.</given-names></name><name><surname>Solodka</surname><given-names>K.</given-names></name><name><surname>Zanini</surname><given-names>G.</given-names></name><name><surname>Selleri</surname><given-names>V.</given-names></name><name><surname>Mattioli</surname><given-names>A.</given-names></name><name><surname>Nasi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Molecular mechanisms of mtDNA-Mediated inflammation.</article-title>
<source><italic>Cells</italic></source>
<volume>10</volume>:<fpage>2898</fpage>. <pub-id pub-id-type="doi">10.3390/cells10112898</pub-id>
<pub-id pub-id-type="pmid">34831121</pub-id>
</mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decout</surname><given-names>A.</given-names></name><name><surname>Katz</surname><given-names>J.</given-names></name><name><surname>Venkatraman</surname><given-names>S.</given-names></name><name><surname>Ablasser</surname><given-names>A.</given-names></name></person-group> (<year>2021</year>). <article-title>The cGAS-STING pathway as a therapeutic target in inflammatory diseases.</article-title>
<source><italic>Nat. Rev. Immunol.</italic></source>
<volume>21</volume>
<fpage>548</fpage>&#x02013;<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-021-00524-z</pub-id>
<pub-id pub-id-type="pmid">33833439</pub-id>
</mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desagher</surname><given-names>S.</given-names></name><name><surname>Martinou</surname><given-names>J.</given-names></name></person-group> (<year>2000</year>). <article-title>Mitochondria as the central control point of apoptosis.</article-title>
<source><italic>Trends Cell Biol.</italic></source>
<volume>10</volume>
<fpage>369</fpage>&#x02013;<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1016/s0962-8924(00)01803-1</pub-id>
<pub-id pub-id-type="pmid">10932094</pub-id>
</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devanney</surname><given-names>N.</given-names></name><name><surname>Stewart</surname><given-names>A.</given-names></name><name><surname>Gensel</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Microglia and macrophage metabolism in CNS injury and disease: The role of immunometabolism in neurodegeneration and neurotrauma.</article-title>
<source><italic>Exp. Neurol.</italic></source>
<volume>329</volume>:<fpage>113310</fpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2020.113310</pub-id>
<pub-id pub-id-type="pmid">32289316</pub-id>
</mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Pietro</surname><given-names>V.</given-names></name><name><surname>Lazzarino</surname><given-names>G.</given-names></name><name><surname>Amorini</surname><given-names>A.</given-names></name><name><surname>Signoretti</surname><given-names>S.</given-names></name><name><surname>Hill</surname><given-names>L.</given-names></name><name><surname>Porto</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Fusion or fission: The destiny of mitochondria in traumatic brain injury of different severities.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>7</volume>:<fpage>9189</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-09587-2</pub-id>
<pub-id pub-id-type="pmid">28835707</pub-id>
</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Ou</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Chai</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Activating cGAS-STING axis contributes to neuroinflammation in CVST mouse model and induces inflammasome activation and microglia pyroptosis.</article-title>
<source><italic>J. Neuroinflammation</italic></source>
<volume>19</volume>:<fpage>137</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-022-02511-0</pub-id>
<pub-id pub-id-type="pmid">35689216</pub-id>
</mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Curcumin plays neuroprotective roles against traumatic brain injury partly via Nrf2 signaling.</article-title>
<source><italic>Toxicol. Appl. Pharmacol.</italic></source>
<volume>346</volume>
<fpage>28</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2018.03.020</pub-id>
<pub-id pub-id-type="pmid">29571711</pub-id>
</mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos Cardoso</surname><given-names>F.</given-names></name><name><surname>Dos Santos</surname><given-names>J.</given-names></name><name><surname>Gonzalez-Lima</surname><given-names>F.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>B.</given-names></name><name><surname>Lopes-Martins</surname><given-names>R.</given-names></name><name><surname>Gomes da Silva</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Effects of chronic photobiomodulation with transcranial near-infrared laser on brain metabolomics of young and aged rats.</article-title>
<source><italic>Mol. Neurobiol.</italic></source>
<volume>58</volume>
<fpage>2256</fpage>&#x02013;<lpage>2268</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-020-02247-z</pub-id>
<pub-id pub-id-type="pmid">33417219</pub-id>
</mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos Cardoso</surname><given-names>F.</given-names></name><name><surname>Mansur</surname><given-names>F.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>B.</given-names></name><name><surname>Gonzalez-Lima</surname><given-names>F.</given-names></name><name><surname>Gomes da Silva</surname><given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Photobiomodulation improves the inflammatory response and intracellular signaling proteins linked to vascular function and cell survival in the brain of aged rats.</article-title>
<source><italic>Mol. Neurobiol.</italic></source>
<volume>59</volume>
<fpage>420</fpage>&#x02013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-021-02606-4</pub-id>
<pub-id pub-id-type="pmid">34708330</pub-id>
</mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>X.</given-names></name><name><surname>Zeng</surname><given-names>Q.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Application research of novel peptide mitochondrial-targeted antioxidant SS-31 in mitigating mitochondrial dysfunction.</article-title>
<source><italic>Mitochondrion</italic></source>
<volume>75</volume>:<fpage>101846</fpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2024.101846</pub-id>
<pub-id pub-id-type="pmid">38237649</pub-id>
</mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>M.</given-names></name><name><surname>Andersen</surname><given-names>J.</given-names></name><name><surname>Curtis</surname><given-names>D.</given-names></name><name><surname>Riberholt</surname><given-names>C.</given-names></name><name><surname>Poulsen</surname><given-names>I.</given-names></name></person-group> (<year>2024</year>). <article-title>Diet-induced ketosis in adult patients with subacute acquired brain injury: A feasibility study.</article-title>
<source><italic>Front. Med.</italic></source>
<volume>10</volume>:<fpage>1305888</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2023.1305888</pub-id>
<pub-id pub-id-type="pmid">38571572</pub-id>
</mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eiden</surname><given-names>M.</given-names></name><name><surname>Christinat</surname><given-names>N.</given-names></name><name><surname>Chakrabarti</surname><given-names>A.</given-names></name><name><surname>Sonnay</surname><given-names>S.</given-names></name><name><surname>Miroz</surname><given-names>J.</given-names></name><name><surname>Cuenoud</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Discovery and validation of temporal patterns involved in human brain ketometabolism in cerebral microdialysis fluids of traumatic brain injury patients.</article-title>
<source><italic>EBioMedicine</italic></source>
<volume>44</volume>
<fpage>607</fpage>&#x02013;<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2019.05.054</pub-id>
<pub-id pub-id-type="pmid">31202815</pub-id>
</mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eleftheriadis</surname><given-names>T.</given-names></name><name><surname>Pissas</surname><given-names>G.</given-names></name><name><surname>Liakopoulos</surname><given-names>V.</given-names></name><name><surname>Stefanidis</surname><given-names>I.</given-names></name></person-group> (<year>2016</year>). <article-title>Cytochrome c as a potentially clinical useful marker of mitochondrial and cellular damage.</article-title>
<source><italic>Front. Immunol.</italic></source>
<volume>7</volume>:<fpage>279</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2016.00279</pub-id>
<pub-id pub-id-type="pmid">27489552</pub-id>
</mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eliopoulos</surname><given-names>A.</given-names></name><name><surname>Gkouskou</surname><given-names>K.</given-names></name><name><surname>Tsioufis</surname><given-names>K.</given-names></name><name><surname>Sanoudou</surname><given-names>D.</given-names></name></person-group> (<year>2025</year>). <article-title>A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy.</article-title>
<source><italic>Front. Nutr.</italic></source>
<volume>12</volume>:<fpage>1524125</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2025.1524125</pub-id>
<pub-id pub-id-type="pmid">39895836</pub-id>
</mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elustondo</surname><given-names>P.</given-names></name><name><surname>Nichols</surname><given-names>M.</given-names></name><name><surname>Negoda</surname><given-names>A.</given-names></name><name><surname>Thirumaran</surname><given-names>A.</given-names></name><name><surname>Zakharian</surname><given-names>E.</given-names></name><name><surname>Robertson</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Mitochondrial permeability transition pore induction is linked to formation of the complex of ATPase C-subunit, polyhydroxybutyrate and inorganic polyphosphate.</article-title>
<source><italic>Cell Death Discov.</italic></source>
<volume>2</volume>:<fpage>16070</fpage>. <pub-id pub-id-type="doi">10.1038/cddiscovery.2016.70</pub-id>
<pub-id pub-id-type="pmid">27924223</pub-id>
</mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>T.</given-names></name><name><surname>Smith</surname><given-names>J.</given-names></name><name><surname>Alves</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Targeting neuroinflammation via purinergic P2 receptors for disease modification in drug-refractory epilepsy.</article-title>
<source><italic>J. Inflamm. Res.</italic></source>
<volume>14</volume>
<fpage>3367</fpage>&#x02013;<lpage>3392</lpage>. <pub-id pub-id-type="doi">10.2147/JIR.S287740</pub-id>
<pub-id pub-id-type="pmid">34305404</pub-id>
</mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Marcos</surname><given-names>P.</given-names></name><name><surname>Auwerx</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Regulation of PGC-1&#x003b1;, a nodal regulator of mitochondrial biogenesis.</article-title>
<source><italic>Am. J. Clin. Nutr.</italic></source>
<volume>93</volume>
<fpage>884S</fpage>&#x02013;<lpage>890S</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.110.001917</pub-id>
<pub-id pub-id-type="pmid">21289221</pub-id>
</mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fesharaki-Zadeh</surname><given-names>A.</given-names></name></person-group> (<year>2022</year>). <article-title>Oxidative stress in traumatic brain injury.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>23</volume>:<fpage>13000</fpage>. <pub-id pub-id-type="doi">10.3390/ijms232113000</pub-id>
<pub-id pub-id-type="pmid">36361792</pub-id>
</mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiebich</surname><given-names>B.</given-names></name><name><surname>Akter</surname><given-names>S.</given-names></name><name><surname>Akundi</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>The two-hit hypothesis for neuroinflammation: Role of exogenous ATP in modulating inflammation in the brain.</article-title>
<source><italic>Front. Cell Neurosci.</italic></source>
<volume>8</volume>:<fpage>260</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00260</pub-id>
<pub-id pub-id-type="pmid">25225473</pub-id>
</mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fields</surname><given-names>M.</given-names></name><name><surname>Marcuzzi</surname><given-names>A.</given-names></name><name><surname>Gonelli</surname><given-names>A.</given-names></name><name><surname>Celeghini</surname><given-names>C.</given-names></name><name><surname>Maximova</surname><given-names>N.</given-names></name><name><surname>Rimondi</surname><given-names>E.</given-names></name></person-group> (<year>2023</year>). <article-title>Mitochondria-targeted antioxidants, an innovative class of antioxidant compounds for neurodegenerative diseases: Perspectives and limitations.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>24</volume>:<fpage>3739</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24043739</pub-id>
<pub-id pub-id-type="pmid">36835150</pub-id>
</mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>T.</given-names></name><name><surname>Hylin</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Moore</surname><given-names>A.</given-names></name><name><surname>Waxham</surname><given-names>M.</given-names></name><name><surname>Dash</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Altered mitochondrial dynamics and TBI pathophysiology.</article-title>
<source><italic>Front. Syst. Neurosci.</italic></source>
<volume>10</volume>:<fpage>29</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2016.00029</pub-id>
<pub-id pub-id-type="pmid">27065821</pub-id>
</mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froy</surname><given-names>O.</given-names></name><name><surname>Chapnik</surname><given-names>N.</given-names></name><name><surname>Miskin</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Effect of intermittent fasting on circadian rhythms in mice depends on feeding time.</article-title>
<source><italic>Mech. Ageing Dev.</italic></source>
<volume>130</volume>
<fpage>154</fpage>&#x02013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2008.10.006</pub-id>
<pub-id pub-id-type="pmid">19041664</pub-id>
</mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garone</surname><given-names>C.</given-names></name><name><surname>De Giorgio</surname><given-names>F.</given-names></name><name><surname>Carli</surname><given-names>S.</given-names></name></person-group> (<year>2024</year>). <article-title>Mitochondrial metabolism in neural stem cells and implications for neurodevelopmental and neurodegenerative diseases.</article-title>
<source><italic>J. Transl. Med.</italic></source>
<volume>22</volume>:<fpage>238</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-024-05041-w</pub-id>
<pub-id pub-id-type="pmid">38438847</pub-id>
</mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrido</surname><given-names>C.</given-names></name><name><surname>Galluzzi</surname><given-names>L.</given-names></name><name><surname>Brunet</surname><given-names>M.</given-names></name><name><surname>Puig</surname><given-names>P.</given-names></name><name><surname>Didelot</surname><given-names>C.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Mechanisms of cytochrome c release from mitochondria.</article-title>
<source><italic>Cell Death Differ.</italic></source>
<volume>13</volume>
<fpage>1423</fpage>&#x02013;<lpage>1433</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cdd.4401950</pub-id>
<pub-id pub-id-type="pmid">16676004</pub-id>
</mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gharbi</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name></person-group> (<year>2020</year>). <article-title>The function of astrocyte mediated extracellular vesicles in central nervous system diseases.</article-title>
<source><italic>Front. Cell Dev. Biol.</italic></source>
<volume>8</volume>:<fpage>568889</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2020.568889</pub-id>
<pub-id pub-id-type="pmid">33178687</pub-id>
</mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacomello</surname><given-names>M.</given-names></name><name><surname>Pyakurel</surname><given-names>A.</given-names></name><name><surname>Glytsou</surname><given-names>C.</given-names></name><name><surname>Scorrano</surname><given-names>L.</given-names></name></person-group> (<year>2020</year>). <article-title>The cell biology of mitochondrial membrane dynamics.</article-title>
<source><italic>Nat. Rev. Mol. Cell Biol.</italic></source>
<volume>21</volume>
<fpage>204</fpage>&#x02013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-020-0210-7</pub-id>
<pub-id pub-id-type="pmid">32071438</pub-id>
</mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgi</surname><given-names>C.</given-names></name><name><surname>Missiroli</surname><given-names>S.</given-names></name><name><surname>Patergnani</surname><given-names>S.</given-names></name><name><surname>Duszynski</surname><given-names>J.</given-names></name><name><surname>Wieckowski</surname><given-names>M.</given-names></name><name><surname>Pinton</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondria-associated membranes: Composition, molecular mechanisms, and physiopathological implications.</article-title>
<source><italic>Antioxid. Redox Signal.</italic></source>
<volume>22</volume>
<fpage>995</fpage>&#x02013;<lpage>1019</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2014.6223</pub-id>
<pub-id pub-id-type="pmid">25557408</pub-id>
</mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgi-Coll</surname><given-names>S.</given-names></name><name><surname>Amaral</surname><given-names>A.</given-names></name><name><surname>Hutchinson</surname><given-names>P.</given-names></name><name><surname>Kotter</surname><given-names>M.</given-names></name><name><surname>Carpenter</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>7</volume>:<fpage>1003</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-01149-w</pub-id>
<pub-id pub-id-type="pmid">28432362</pub-id>
</mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giuliani</surname><given-names>A.</given-names></name><name><surname>Sarti</surname><given-names>A.</given-names></name><name><surname>Di Virgilio</surname><given-names>F.</given-names></name></person-group> (<year>2021</year>). <article-title>Ectonucleotidases in acute and chronic inflammation.</article-title>
<source><italic>Front. Pharmacol.</italic></source>
<volume>11</volume>:<fpage>619458</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.619458</pub-id>
<pub-id pub-id-type="pmid">33613285</pub-id>
</mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golovynskyi</surname><given-names>S.</given-names></name><name><surname>Golovynska</surname><given-names>I.</given-names></name><name><surname>Stepanova</surname><given-names>L.</given-names></name><name><surname>Datsenko</surname><given-names>O.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Qu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Optical windows for head tissues in near-infrared and short-wave infrared regions: Approaching transcranial light applications.</article-title>
<source><italic>J. Biophotonics</italic></source>
<volume>11</volume>:<fpage>e201800141</fpage>. <pub-id pub-id-type="doi">10.1002/jbio.201800141</pub-id>
<pub-id pub-id-type="pmid">30098115</pub-id>
</mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L.</given-names></name><name><surname>Zou</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Guo</surname><given-names>S.</given-names></name><name><surname>Xing</surname><given-names>D.</given-names></name></person-group> (<year>2021</year>). <article-title>Photobiomodulation therapy ameliorates hyperglycemia and insulin resistance by activating cytochrome c oxidase-mediated protein kinase B in muscle.</article-title>
<source><italic>Aging</italic></source>
<volume>13</volume>
<fpage>10015</fpage>&#x02013;<lpage>10033</lpage>. <pub-id pub-id-type="doi">10.18632/aging.202760</pub-id>
<pub-id pub-id-type="pmid">33795530</pub-id>
</mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopalakrishnan</surname><given-names>S.</given-names></name><name><surname>Mehrvar</surname><given-names>S.</given-names></name><name><surname>Maleki</surname><given-names>S.</given-names></name><name><surname>Schmitt</surname><given-names>H.</given-names></name><name><surname>Summerfelt</surname><given-names>P.</given-names></name><name><surname>Dubis</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Photobiomodulation preserves mitochondrial redox state and is retinoprotective in a rodent model of retinitis pigmentosa.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>10</volume>:<fpage>20382</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-77290-w</pub-id>
<pub-id pub-id-type="pmid">33230161</pub-id>
</mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>R.</given-names></name><name><surname>Albornoz</surname><given-names>E.</given-names></name><name><surname>Christie</surname><given-names>D.</given-names></name><name><surname>Langley</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Mantovani</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Inflammasome inhibition prevents &#x003b1;-synuclein pathology and dopaminergic neurodegeneration in mice.</article-title>
<source><italic>Sci. Transl. Med.</italic></source>
<volume>10</volume>:<fpage>eaah4066</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aah4066</pub-id>
<pub-id pub-id-type="pmid">30381407</pub-id>
</mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouveia</surname><given-names>A.</given-names></name><name><surname>Bajwa</surname><given-names>E.</given-names></name><name><surname>Klegeris</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Extracellular cytochrome c as an intercellular signaling molecule regulating microglial functions.</article-title>
<source><italic>Biochim. Biophys. Acta Gen. Subj.</italic></source>
<volume>1861</volume>
<fpage>2274</fpage>&#x02013;<lpage>2281</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2017.06.017</pub-id>
<pub-id pub-id-type="pmid">28652078</pub-id>
</mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goyal</surname><given-names>M.</given-names></name><name><surname>Hawrylycz</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>J.</given-names></name><name><surname>Snyder</surname><given-names>A.</given-names></name><name><surname>Raichle</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Aerobic glycolysis in the human brain is associated with development and neotenous gene expression.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>19</volume>
<fpage>49</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2013.11.020</pub-id>
<pub-id pub-id-type="pmid">24411938</pub-id>
</mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granzotto</surname><given-names>A.</given-names></name><name><surname>Canzoniero</surname><given-names>L.</given-names></name><name><surname>Sensi</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>A neurotoxic M&#x000e9;nage-&#x000e0;-trois: Glutamate, calcium, and zinc in the excitotoxic cascade.</article-title>
<source><italic>Front. Mol. Neurosci.</italic></source>
<volume>13</volume>:<fpage>600089</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2020.600089</pub-id>
<pub-id pub-id-type="pmid">33324162</pub-id>
</mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudden</surname><given-names>J.</given-names></name><name><surname>Arias Vasquez</surname><given-names>A.</given-names></name><name><surname>Bloemendaal</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>The effects of intermittent fasting on brain and cognitive function.</article-title>
<source><italic>Nutrients</italic></source>
<volume>13</volume>:<fpage>3166</fpage>. <pub-id pub-id-type="doi">10.3390/nu13093166</pub-id>
<pub-id pub-id-type="pmid">34579042</pub-id>
</mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilhaume-Correa</surname><given-names>F.</given-names></name><name><surname>Pickrell</surname><given-names>A.</given-names></name><name><surname>VandeVord</surname><given-names>P.</given-names></name></person-group> (<year>2023</year>). <article-title>The imbalance of astrocytic mitochondrial dynamics following blast-induced traumatic brain injury.</article-title>
<source><italic>Biomedicines</italic></source>
<volume>11</volume>:<fpage>329</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines11020329</pub-id>
<pub-id pub-id-type="pmid">36830865</pub-id>
</mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyoneva</surname><given-names>S.</given-names></name><name><surname>Ransohoff</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Inflammatory reaction after traumatic brain injury: Therapeutic potential of targeting cell-cell communication by chemokines.</article-title>
<source><italic>Trends Pharmacol. Sci.</italic></source>
<volume>36</volume>
<fpage>471</fpage>&#x02013;<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2015.04.003</pub-id>
<pub-id pub-id-type="pmid">25979813</pub-id>
</mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Shining light on the head: Photobiomodulation for brain disorders.</article-title>
<source><italic>BBA Clin.</italic></source>
<volume>6</volume>
<fpage>113</fpage>&#x02013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbacli.2016.09.002</pub-id>
<pub-id pub-id-type="pmid">27752476</pub-id>
</mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Mechanisms and applications of the anti-inflammatory effects of photobiomodulation.</article-title>
<source><italic>AIMS Biophys.</italic></source>
<volume>4</volume>
<fpage>337</fpage>&#x02013;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.3934/biophy.2017.3.337</pub-id>
<pub-id pub-id-type="pmid">28748217</pub-id>
</mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Har-Even</surname><given-names>M.</given-names></name><name><surname>Rubovitch</surname><given-names>V.</given-names></name><name><surname>Ratliff</surname><given-names>W.</given-names></name><name><surname>Richmond-Hacham</surname><given-names>B.</given-names></name><name><surname>Citron</surname><given-names>B.</given-names></name><name><surname>Pick</surname><given-names>C.</given-names></name></person-group> (<year>2021</year>). <article-title>Ketogenic Diet as a potential treatment for traumatic brain injury in mice.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>11</volume>:<fpage>23559</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-02849-0</pub-id>
<pub-id pub-id-type="pmid">34876621</pub-id>
</mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>J.</given-names></name><name><surname>Jolivet</surname><given-names>R.</given-names></name><name><surname>Attwell</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Synaptic energy use and supply.</article-title>
<source><italic>Neuron</italic></source>
<volume>75</volume>
<fpage>762</fpage>&#x02013;<lpage>777</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.08.019</pub-id>
<pub-id pub-id-type="pmid">22958818</pub-id>
</mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haupt</surname><given-names>S.</given-names></name><name><surname>Eckstein</surname><given-names>M.</given-names></name><name><surname>Wolf</surname><given-names>A.</given-names></name><name><surname>Zimmer</surname><given-names>R.</given-names></name><name><surname>Wachsmuth</surname><given-names>N.</given-names></name><name><surname>Moser</surname><given-names>O.</given-names></name></person-group> (<year>2021</year>). <article-title>Eat, train, sleep-retreat? Hormonal interactions of intermittent fasting, exercise and circadian rhythm.</article-title>
<source><italic>Biomolecules</italic></source>
<volume>11</volume>:<fpage>516</fpage>. <pub-id pub-id-type="doi">10.3390/biom11040516</pub-id>
<pub-id pub-id-type="pmid">33808424</pub-id>
</mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>T.</given-names></name></person-group> (<year>2024</year>). <article-title>Can infrared light really be doing what we claim it is doing? Infrared light penetration principles, practices, and limitations.</article-title>
<source><italic>Front. Neurol.</italic></source>
<volume>15</volume>:<fpage>1398894</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2024.1398894</pub-id>
<pub-id pub-id-type="pmid">39263274</pub-id>
</mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>J.</given-names></name><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Photobiomodulation (660 nm) therapy reduces oxidative stress and induces BDNF expression in the hippocampus.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>9</volume>:<fpage>10114</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-46490-4</pub-id>
<pub-id pub-id-type="pmid">31300736</pub-id>
</mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herst</surname><given-names>P.</given-names></name><name><surname>Rowe</surname><given-names>M.</given-names></name><name><surname>Carson</surname><given-names>G.</given-names></name><name><surname>Berridge</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Functional mitochondria in health and disease.</article-title>
<source><italic>Front. Endocrinol.</italic></source>
<volume>8</volume>:<fpage>296</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2017.00296</pub-id>
<pub-id pub-id-type="pmid">29163365</pub-id>
</mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiebert</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>Q.</given-names></name><name><surname>Thimmesch</surname><given-names>A.</given-names></name><name><surname>Pierce</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Traumatic brain injury and mitochondrial dysfunction.</article-title>
<source><italic>Am. J. Med. Sci.</italic></source>
<volume>350</volume>
<fpage>132</fpage>&#x02013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1097/MAJ.0000000000000506</pub-id>
<pub-id pub-id-type="pmid">26083647</pub-id>
</mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>R.</given-names></name><name><surname>Kulbe</surname><given-names>J.</given-names></name><name><surname>Singh</surname><given-names>I.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Hall</surname><given-names>E. D.</given-names></name></person-group> (<year>2018</year>). <article-title>Synaptic mitochondria are more susceptible to traumatic brain injury-induced oxidative damage and respiratory dysfunction than non-synaptic mitochondria.</article-title>
<source><italic>Neuroscience</italic></source>
<volume>386</volume>
<fpage>265</fpage>&#x02013;<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.06.028</pub-id>
<pub-id pub-id-type="pmid">29960045</pub-id>
</mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hipskind</surname><given-names>S.</given-names></name><name><surname>Grover</surname><given-names>F.</given-names></name><name><surname>Fort</surname><given-names>T.</given-names></name><name><surname>Helffenstein</surname><given-names>D.</given-names></name><name><surname>Burke</surname><given-names>T.</given-names></name><name><surname>Quint</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Pulsed transcranial red/near-infrared light therapy using light-emitting diodes improves cerebral blood flow and cognitive function in veterans with chronic traumatic brain injury: A case series.</article-title>
<source><italic>Photomed. Laser Surg.</italic></source> [Online ahead of print.]. <pub-id pub-id-type="doi">10.1089/pho.2018.4489.</pub-id>
<pub-id pub-id-type="pmid">30418082</pub-id>
</mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffe</surname><given-names>B.</given-names></name><name><surname>Holahan</surname><given-names>M.</given-names></name></person-group> (<year>2022</year>). <article-title>Hyperacute excitotoxic mechanisms and synaptic dysfunction involved in traumatic brain injury.</article-title>
<source><italic>Front. Mol. Neurosci.</italic></source>
<volume>15</volume>:<fpage>831825</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2022.831825</pub-id>
<pub-id pub-id-type="pmid">35283730</pub-id>
</mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Yao</surname><given-names>X.</given-names></name><name><surname>Ni</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>K.</given-names></name></person-group> (<year>2022</year>). <article-title>Emerging role of STING signalling in CNS injury: Inflammation, autophagy, necroptosis, ferroptosis and pyroptosis.</article-title>
<source><italic>J. Neuroinflammation</italic></source>
<volume>19</volume>:<fpage>242</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-022-02602-y</pub-id>
<pub-id pub-id-type="pmid">36195926</pub-id>
</mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>P.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Seto</surname><given-names>S.</given-names></name><name><surname>Chang</surname><given-names>D.</given-names></name></person-group> (<year>2021</year>). <article-title>Hydroxysafflor yellow A alleviates cerebral ischemia reperfusion injury by suppressing apoptosis via mitochondrial permeability transition pore.</article-title>
<source><italic>Phytomedicine</italic></source>
<volume>85</volume>:<fpage>153532</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2021.153532</pub-id>
<pub-id pub-id-type="pmid">33735723</pub-id>
</mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubbard</surname><given-names>W.</given-names></name><name><surname>Harwood</surname><given-names>C.</given-names></name><name><surname>Geisler</surname><given-names>J.</given-names></name><name><surname>Vekaria</surname><given-names>H.</given-names></name><name><surname>Sullivan</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice.</article-title>
<source><italic>J. Neurosci. Res.</italic></source>
<volume>96</volume>
<fpage>1677</fpage>&#x02013;<lpage>1688</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.24271</pub-id>
<pub-id pub-id-type="pmid">30063076</pub-id>
</mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubbard</surname><given-names>W.</given-names></name><name><surname>Joseph</surname><given-names>B.</given-names></name><name><surname>Spry</surname><given-names>M.</given-names></name><name><surname>Vekaria</surname><given-names>H.</given-names></name><name><surname>Saatman</surname><given-names>K.</given-names></name><name><surname>Sullivan</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Acute mitochondrial impairment underlies prolonged cellular dysfunction after repeated mild traumatic brain injuries.</article-title>
<source><italic>J. Neurotrauma.</italic></source>
<volume>36</volume>
<fpage>1252</fpage>&#x02013;<lpage>1263</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2018.5990</pub-id>
<pub-id pub-id-type="pmid">30417732</pub-id>
</mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubbard</surname><given-names>W.</given-names></name><name><surname>Vekaria</surname><given-names>H.</given-names></name><name><surname>Velmurugan</surname><given-names>G.</given-names></name><name><surname>Kalimon</surname><given-names>O.</given-names></name><name><surname>Prajapati</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Mitochondrial dysfunction after repeated mild blast traumatic brain injury is attenuated by a mild mitochondrial uncoupling prodrug.</article-title>
<source><italic>J. Neurotrauma.</italic></source>
<volume>40</volume>
<fpage>2396</fpage>&#x02013;<lpage>2409</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2023.0102</pub-id>
<pub-id pub-id-type="pmid">37476976</pub-id>
</mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Illes</surname><given-names>P.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name></person-group> (<year>2019</year>). <article-title>Astroglia-derived ATP modulates CNS neuronal circuits.</article-title>
<source><italic>Trends Neurosci.</italic></source>
<volume>42</volume>
<fpage>885</fpage>&#x02013;<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2019.09.006</pub-id>
<pub-id pub-id-type="pmid">31704181</pub-id>
</mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahani Sherafat</surname><given-names>S.</given-names></name><name><surname>Mokmeli</surname><given-names>S.</given-names></name><name><surname>Rostami-Nejad</surname><given-names>M.</given-names></name><name><surname>Razaghi</surname><given-names>Z.</given-names></name><name><surname>Rezaei Tavirani</surname><given-names>M.</given-names></name><name><surname>Razzaghi</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>The effectiveness of photobiomudulation therapy (PBMT) in COVID-19 Infection.</article-title>
<source><italic>J. Lasers Med. Sci.</italic></source>
<volume>11</volume> (<issue>Suppl. 1</issue>), <fpage>S23</fpage>&#x02013;<lpage>S29</lpage>. <pub-id pub-id-type="doi">10.34172/jlms.2020.S4</pub-id>
<pub-id pub-id-type="pmid">33995965</pub-id>
</mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalloh</surname><given-names>I.</given-names></name><name><surname>Helmy</surname><given-names>A.</given-names></name><name><surname>Howe</surname><given-names>D.</given-names></name><name><surname>Shannon</surname><given-names>R.</given-names></name><name><surname>Grice</surname><given-names>P.</given-names></name><name><surname>Mason</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Focally perfused succinate potentiates brain metabolism in head injury patients.</article-title>
<source><italic>J. Cereb. Blood Flow Metab.</italic></source>
<volume>37</volume>
<fpage>2626</fpage>&#x02013;<lpage>2638</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X16672665</pub-id>
<pub-id pub-id-type="pmid">27798266</pub-id>
</mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamshed</surname><given-names>H.</given-names></name><name><surname>Beyl</surname><given-names>R.</given-names></name><name><surname>Della Manna</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>E.</given-names></name><name><surname>Ravussin</surname><given-names>E.</given-names></name><name><surname>Peterson</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>Early Time-restricted feeding improves 24-hour glucose levels and affects markers of the circadian clock, aging, and autophagy in humans.</article-title>
<source><italic>Nutrients</italic></source>
<volume>11</volume>:<fpage>1234</fpage>. <pub-id pub-id-type="doi">10.3390/nu11061234</pub-id>
<pub-id pub-id-type="pmid">31151228</pub-id>
</mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamwal</surname><given-names>S.</given-names></name><name><surname>Blackburn</surname><given-names>J.</given-names></name><name><surname>Elsworth</surname><given-names>J.</given-names></name></person-group> (<year>2021</year>). <article-title>PPAR&#x003b3;/PGC1&#x003b1; signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders.</article-title>
<source><italic>Pharmacol. Ther.</italic></source>
<volume>219</volume>:<fpage>107705</fpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2020.107705</pub-id>
<pub-id pub-id-type="pmid">33039420</pub-id>
</mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jassam</surname><given-names>Y.</given-names></name><name><surname>Izzy</surname><given-names>S.</given-names></name><name><surname>Whalen</surname><given-names>M.</given-names></name><name><surname>McGavern</surname><given-names>D.</given-names></name><name><surname>El Khoury</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuroimmunology of traumatic brain injury: Time for a paradigm shift.</article-title>
<source><italic>Neuron</italic></source>
<volume>95</volume>
<fpage>1246</fpage>&#x02013;<lpage>1265</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.07.010</pub-id>
<pub-id pub-id-type="pmid">28910616</pub-id>
</mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffs</surname><given-names>G.</given-names></name><name><surname>Meloni</surname><given-names>B.</given-names></name><name><surname>Bakker</surname><given-names>A.</given-names></name><name><surname>Knuckey</surname><given-names>N.</given-names></name></person-group> (<year>2007</year>). <article-title>The role of the Na(+)/Ca(2+) exchanger (NCX) in neurons following ischaemia.</article-title>
<source><italic>J. Clin. Neurosci.</italic></source>
<volume>14</volume>
<fpage>507</fpage>&#x02013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocn.2006.07.013</pub-id>
<pub-id pub-id-type="pmid">17430774</pub-id>
</mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>J.</given-names></name><name><surname>Koo</surname><given-names>J.</given-names></name><name><surname>Yook</surname><given-names>J.</given-names></name><name><surname>Cho</surname><given-names>J.</given-names></name><name><surname>Kang</surname><given-names>E.</given-names></name></person-group> (<year>2021</year>). <article-title>Neuroprotective benefits of exercise and mitoq on memory function, mitochondrial dynamics, oxidative stress, and neuroinflammation in D-Galactose-induced aging rats.</article-title>
<source><italic>Brain Sci.</italic></source>
<volume>11</volume>:<fpage>164</fpage>. <pub-id pub-id-type="doi">10.3390/brainsci11020164</pub-id>
<pub-id pub-id-type="pmid">33514020</pub-id>
</mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>S.</given-names></name><name><surname>Chokkalla</surname><given-names>A.</given-names></name><name><surname>Davis</surname><given-names>C.</given-names></name><name><surname>Jeong</surname><given-names>H.</given-names></name><name><surname>Chelluboina</surname><given-names>B.</given-names></name><name><surname>Arruri</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Circadian-dependent intermittent fasting influences ischemic tolerance and dendritic spine remodeling.</article-title>
<source><italic>Stroke</italic></source>
<volume>55</volume>
<fpage>2139</fpage>&#x02013;<lpage>2150</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.124.046400</pub-id>
<pub-id pub-id-type="pmid">38920050</pub-id>
</mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Rong</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name></person-group> (<year>2020</year>). <article-title>Activation of PGC-1&#x003b1; and mitochondrial biogenesis protects against prenatal hypoxic-ischemic brain injury.</article-title>
<source><italic>Neuroscience</italic></source>
<volume>432</volume>
<fpage>63</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2020.02.035</pub-id>
<pub-id pub-id-type="pmid">32114097</pub-id>
</mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>N.</given-names></name><name><surname>de Rivero Vaccari</surname><given-names>J.</given-names></name><name><surname>Bramlett</surname><given-names>H.</given-names></name><name><surname>Keane</surname><given-names>R.</given-names></name><name><surname>Dietrich</surname><given-names>W.</given-names></name></person-group> (<year>2023</year>). <article-title>Inflammasome activation in traumatic brain injury and Alzheimer&#x02019;s disease.</article-title>
<source><italic>Transl. Res.</italic></source>
<volume>254</volume>
<fpage>1</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.trsl.2022.08.014</pub-id>
<pub-id pub-id-type="pmid">36070840</pub-id>
</mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kansakar</surname><given-names>S.</given-names></name><name><surname>Sterben</surname><given-names>S.</given-names></name><name><surname>Anamala</surname><given-names>C.</given-names></name><name><surname>Thielen</surname><given-names>M.</given-names></name><name><surname>Liaudanskaya</surname><given-names>V.</given-names></name></person-group> (<year>2025</year>). <article-title>The silent saboteur: How mitochondria shape the long-term fate of the injured brain.</article-title>
<source><italic>bioRxiv [Preprint]</italic></source>
<pub-id pub-id-type="doi">10.1101/2025.03.19.644244</pub-id>
<pub-id pub-id-type="pmid">40166284</pub-id>
</mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayhanian</surname><given-names>S.</given-names></name><name><surname>Glynos</surname><given-names>A.</given-names></name><name><surname>Mair</surname><given-names>R.</given-names></name><name><surname>Lakatos</surname><given-names>A.</given-names></name><name><surname>Hutchinson</surname><given-names>P.</given-names></name><name><surname>Helmy</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Cell-free mitochondrial DNA in acute brain injury.</article-title>
<source><italic>Neurotrauma. Rep.</italic></source>
<volume>3</volume>
<fpage>415</fpage>&#x02013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1089/neur.2022.0032</pub-id>
<pub-id pub-id-type="pmid">36204389</pub-id>
</mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keating</surname><given-names>D.</given-names></name></person-group> (<year>2008</year>). <article-title>Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases.</article-title>
<source><italic>J. Neurochem.</italic></source>
<volume>104</volume>
<fpage>298</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04997.x</pub-id>
<pub-id pub-id-type="pmid">17961149</pub-id>
</mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>A.</given-names></name><name><surname>El Baradie</surname><given-names>K.</given-names></name><name><surname>Hamrick</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Targeting the mitochondrial permeability transition pore to prevent age-associated cell damage and neurodegeneration.</article-title>
<source><italic>Oxid. Med. Cell Longev.</italic></source>
<volume>2021</volume>:<fpage>6626484</fpage>. <pub-id pub-id-type="doi">10.1155/2021/6626484</pub-id>
<pub-id pub-id-type="pmid">33574977</pub-id>
</mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbaugh</surname><given-names>T.</given-names></name><name><surname>Karlsson</surname><given-names>M.</given-names></name><name><surname>Byro</surname><given-names>M.</given-names></name><name><surname>Bebee</surname><given-names>A.</given-names></name><name><surname>Ralston</surname><given-names>J.</given-names></name><name><surname>Sullivan</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Mitochondrial bioenergetic alterations after focal traumatic brain injury in the immature brain.</article-title>
<source><italic>Exp. Neurol.</italic></source>
<volume>271</volume>
<fpage>136</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2015.05.009</pub-id>
<pub-id pub-id-type="pmid">26028309</pub-id>
</mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Chang</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Shen</surname><given-names>N.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>mtDNA-STING axis mediates microglial polarization via IRF3/NF-&#x003ba;B signaling after ischemic stroke.</article-title>
<source><italic>Front. Immunol.</italic></source>
<volume>13</volume>:<fpage>860977</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.860977</pub-id>
<pub-id pub-id-type="pmid">35450066</pub-id>
</mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koulaeinejad</surname><given-names>N.</given-names></name><name><surname>Haddadi</surname><given-names>K.</given-names></name><name><surname>Ehteshami</surname><given-names>S.</given-names></name><name><surname>Shafizad</surname><given-names>M.</given-names></name><name><surname>Salehifar</surname><given-names>E.</given-names></name><name><surname>Emadian</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Effects of minocycline on neurological outcomes in patients with acute traumatic brain injury: A pilot study.</article-title>
<source><italic>Iran J. Pharm. Res.</italic></source>
<volume>18</volume>
<fpage>1086</fpage>&#x02013;<lpage>1096</lpage>. <pub-id pub-id-type="doi">10.22037/ijpr.2019.1100677</pub-id>
<pub-id pub-id-type="pmid">31531090</pub-id>
</mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kshirsagar</surname><given-names>V.</given-names></name><name><surname>Thingore</surname><given-names>C.</given-names></name><name><surname>Gursahani</surname><given-names>M.</given-names></name><name><surname>Gawali</surname><given-names>N.</given-names></name><name><surname>Juvekar</surname><given-names>A.</given-names></name></person-group> (<year>2021</year>). <article-title>Hydrogen sulfide ameliorates lipopolysaccharide-induced memory impairment in mice by reducing apoptosis, oxidative, and inflammatory effects.</article-title>
<source><italic>Neurotox. Res.</italic></source>
<volume>39</volume>
<fpage>1310</fpage>&#x02013;<lpage>1322</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-021-00374-6</pub-id>
<pub-id pub-id-type="pmid">34021860</pub-id>
</mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000fc;hlbrandt</surname><given-names>W.</given-names></name></person-group> (<year>2015</year>). <article-title>Structure and function of mitochondrial membrane protein complexes.</article-title>
<source><italic>BMC Biol.</italic></source>
<volume>13</volume>:<fpage>89</fpage>. <pub-id pub-id-type="doi">10.1186/s12915-015-0201-x</pub-id>
<pub-id pub-id-type="pmid">26515107</pub-id>
</mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Stoica</surname><given-names>B.</given-names></name><name><surname>Loane</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Abulwerdi</surname><given-names>G.</given-names></name><name><surname>Khan</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury.</article-title>
<source><italic>J. Neuroinflammation</italic></source>
<volume>14</volume>:<fpage>47</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-017-0819-4</pub-id>
<pub-id pub-id-type="pmid">28292310</pub-id>
</mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumari</surname><given-names>M.</given-names></name><name><surname>Arora</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Hasija</surname><given-names>Y.</given-names></name><name><surname>Rana</surname><given-names>P.</given-names></name><name><surname>D&#x02019;souza</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Acute metabolic alterations in the hippocampus are associated with decreased acetylation after blast induced TBI.</article-title>
<source><italic>Metabolomics</italic></source>
<volume>19</volume>:<fpage>5</fpage>. <pub-id pub-id-type="doi">10.1007/s11306-022-01970-z</pub-id>
<pub-id pub-id-type="pmid">36635559</pub-id>
</mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamade</surname><given-names>A.</given-names></name><name><surname>Anthonymuthu</surname><given-names>T.</given-names></name><name><surname>Hier</surname><given-names>Z.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Kagan</surname><given-names>V.</given-names></name><name><surname>Bay&#x00131;r</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>Mitochondrial damage &#x00026; lipid signaling in traumatic brain injury.</article-title>
<source><italic>Exp. Neurol.</italic></source>
<volume>329</volume>:<fpage>113307</fpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2020.113307</pub-id>
<pub-id pub-id-type="pmid">32289317</pub-id>
</mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazzarino</surname><given-names>G.</given-names></name><name><surname>Amorini</surname><given-names>A.</given-names></name><name><surname>Signoretti</surname><given-names>S.</given-names></name><name><surname>Musumeci</surname><given-names>G.</given-names></name><name><surname>Lazzarino</surname><given-names>G.</given-names></name><name><surname>Caruso</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Pyruvate dehydrogenase and tricarboxylic acid cycle enzymes are sensitive targets of traumatic brain injury induced metabolic derangement.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>20</volume>:<fpage>5774</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20225774</pub-id>
<pub-id pub-id-type="pmid">31744143</pub-id>
</mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Duan</surname><given-names>W.</given-names></name><name><surname>Mattson</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice.</article-title>
<source><italic>J Neurochem.</italic></source>
<volume>82</volume>
<fpage>1367</fpage>&#x02013;<lpage>1375</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2002.01085.x</pub-id>
<pub-id pub-id-type="pmid">12354284</pub-id>
</mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Devanney</surname><given-names>N.</given-names></name><name><surname>Golden</surname><given-names>L.</given-names></name><name><surname>Smith</surname><given-names>C.</given-names></name><name><surname>Schwartz</surname><given-names>J.</given-names></name><name><surname>Walsh</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge.</article-title>
<source><italic>Cell Rep.</italic></source>
<volume>42</volume>:<fpage>112196</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2023.112196</pub-id>
<pub-id pub-id-type="pmid">36871219</pub-id>
</mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leipnitz</surname><given-names>G.</given-names></name><name><surname>Mohsen</surname><given-names>A.</given-names></name><name><surname>Karunanidhi</surname><given-names>A.</given-names></name><name><surname>Seminotti</surname><given-names>B.</given-names></name><name><surname>Roginskaya</surname><given-names>V.</given-names></name><name><surname>Markantone</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulum-mitochondria crosstalk, and reactive oxygen species in fibroblasts from patients with complex I deficiency.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>8</volume>:<fpage>1165</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-19543-3</pub-id>
<pub-id pub-id-type="pmid">29348607</pub-id>
</mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lettieri-Barbato</surname><given-names>D.</given-names></name><name><surname>Minopoli</surname><given-names>G.</given-names></name><name><surname>Caggiano</surname><given-names>R.</given-names></name><name><surname>Izzo</surname><given-names>R.</given-names></name><name><surname>Santillo</surname><given-names>M.</given-names></name><name><surname>Aquilano</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Fasting Drives Nrf2-related antioxidant response in skeletal muscle.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>21</volume>:<fpage>7780</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21207780</pub-id>
<pub-id pub-id-type="pmid">33096672</pub-id>
</mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2022</year>). <article-title>Photobiomodulation enhances facial nerve regeneration via activation of PI3K/Akt signaling pathway-mediated antioxidant response.</article-title>
<source><italic>Lasers Med. Sci.</italic></source>
<volume>37</volume>
<fpage>993</fpage>&#x02013;<lpage>1006</lpage>. <pub-id pub-id-type="doi">10.1007/s10103-021-03344-8</pub-id>
<pub-id pub-id-type="pmid">34302577</pub-id>
</mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Sami</surname><given-names>A.</given-names></name><name><surname>Noristani</surname><given-names>H.</given-names></name><name><surname>Slattery</surname><given-names>K.</given-names></name><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Groves</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Glial metabolic rewiring promotes axon regeneration and functional recovery in the central nervous system.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>32</volume>
<fpage>767</fpage>&#x02013;<lpage>785.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2020.08.015.</pub-id>
<pub-id pub-id-type="pmid">32941799</pub-id>
</mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Liang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Photobiomodulation provides neuroprotection through regulating mitochondrial fission imbalance in the subacute phase of spinal cord injury.</article-title>
<source><italic>Neural Regen. Res.</italic></source>
<volume>18</volume>
<fpage>2005</fpage>&#x02013;<lpage>2010</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.366491</pub-id>
<pub-id pub-id-type="pmid">36926726</pub-id>
</mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Kong</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>HDAC3 inhibition ameliorates ischemia/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway.</article-title>
<source><italic>Theranostics</italic></source>
<volume>10</volume>
<fpage>9644</fpage>&#x02013;<lpage>9662</lpage>. <pub-id pub-id-type="doi">10.7150/thno.47651</pub-id>
<pub-id pub-id-type="pmid">32863951</pub-id>
</mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liaudanskaya</surname><given-names>V.</given-names></name><name><surname>Fiore</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Milton</surname><given-names>Y.</given-names></name><name><surname>Kelly</surname><given-names>M.</given-names></name><name><surname>Coe</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Mitochondria dysregulation contributes to secondary neurodegeneration progression post-contusion injury in human 3D in vitro triculture brain tissue model.</article-title>
<source><italic>Cell Death Dis.</italic></source>
<volume>14</volume>:<fpage>496</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-023-05980-0</pub-id>
<pub-id pub-id-type="pmid">37537168</pub-id>
</mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liesa</surname><given-names>M.</given-names></name><name><surname>Shirihai</surname><given-names>O.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>17</volume>
<fpage>491</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2013.03.002</pub-id>
<pub-id pub-id-type="pmid">23562075</pub-id>
</mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>L.</given-names></name></person-group> (<year>2024</year>). <article-title>Traumatic brain injury recovery with photobiomodulation: Cellular mechanisms, clinical evidence, and future potential.</article-title>
<source><italic>Cells</italic></source>
<volume>13</volume>:<fpage>385</fpage>. <pub-id pub-id-type="doi">10.3390/cells13050385</pub-id>
<pub-id pub-id-type="pmid">38474349</pub-id>
</mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name></person-group> (<year>2024</year>). <article-title>Hydrogen sulfide can scavenge free radicals to improve spinal cord injury by inhibiting the p38MAPK/mTOR/NF-&#x003ba;B signaling pathway.</article-title>
<source><italic>Neuromol. Med.</italic></source>
<volume>26</volume>:<fpage>26</fpage>. <pub-id pub-id-type="doi">10.1007/s12017-024-08794-1</pub-id>
<pub-id pub-id-type="pmid">38907170</pub-id>
</mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Beal</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.</article-title>
<source><italic>Nature</italic></source>
<volume>443</volume>
<fpage>787</fpage>&#x02013;<lpage>795</lpage>. <pub-id pub-id-type="doi">10.1038/nature05292</pub-id>
<pub-id pub-id-type="pmid">17051205</pub-id>
</mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Feng</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>An overview: The diversified role of mitochondria in cancer metabolism.</article-title>
<source><italic>Int. J. Biol. Sci.</italic></source>
<volume>19</volume>
<fpage>897</fpage>&#x02013;<lpage>915</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.81609</pub-id>
<pub-id pub-id-type="pmid">36778129</pub-id>
</mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname><given-names>V.</given-names></name><name><surname>Panda</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>23</volume>
<fpage>1048</fpage>&#x02013;<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2016.06.001</pub-id>
<pub-id pub-id-type="pmid">27304506</pub-id>
</mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luan</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Luan</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>K.</given-names></name></person-group> (<year>2023</year>). <article-title>Mitophagy and traumatic brain injury: Regulatory mechanisms and therapeutic potentials.</article-title>
<source><italic>Oxid. Med. Cell Longev.</italic></source>
<volume>2023</volume>:<fpage>1649842</fpage>. <pub-id pub-id-type="doi">10.1155/2023/1649842</pub-id>
<pub-id pub-id-type="pmid">36846712</pub-id>
</mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Dai</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Preso regulates NMDA receptor-mediated excitotoxicity via modulating nitric oxide and calcium responses after traumatic brain injury.</article-title>
<source><italic>Cell Death Dis.</italic></source>
<volume>10</volume>:<fpage>496</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-019-1731-x</pub-id>
<pub-id pub-id-type="pmid">31235685</pub-id>
</mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>D.</given-names></name><name><surname>Vekaria</surname><given-names>H.</given-names></name><name><surname>Macheda</surname><given-names>T.</given-names></name><name><surname>Bakshi</surname><given-names>V.</given-names></name><name><surname>Powell</surname><given-names>D.</given-names></name><name><surname>Gold</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>A mild traumatic brain injury in mice produces lasting deficits in brain metabolism.</article-title>
<source><italic>J. Neurotrauma.</italic></source>
<volume>35</volume>
<fpage>2435</fpage>&#x02013;<lpage>2447</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2018.5663</pub-id>
<pub-id pub-id-type="pmid">29808778</pub-id>
</mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Xin</surname><given-names>D.</given-names></name><name><surname>She</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Ge</surname><given-names>J.</given-names></name><name><surname>Mei</surname><given-names>Z.</given-names></name></person-group> (<year>2023</year>). <article-title>Novel insight into cGAS-STING pathway in ischemic stroke: From pre- to post-disease.</article-title>
<source><italic>Front. Immunol.</italic></source>
<volume>14</volume>:<fpage>1275408</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2023.1275408</pub-id>
<pub-id pub-id-type="pmid">37915571</pub-id>
</mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magistretti</surname><given-names>P.</given-names></name><name><surname>Allaman</surname><given-names>I.</given-names></name></person-group> (<year>2015</year>). <article-title>A cellular perspective on brain energy metabolism and functional imaging.</article-title>
<source><italic>Neuron</italic></source>
<volume>86</volume>
<fpage>883</fpage>&#x02013;<lpage>901</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.03.035</pub-id>
<pub-id pub-id-type="pmid">25996133</pub-id>
</mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maher</surname><given-names>P.</given-names></name><name><surname>van Leyen</surname><given-names>K.</given-names></name><name><surname>Dey</surname><given-names>P.</given-names></name><name><surname>Honrath</surname><given-names>B.</given-names></name><name><surname>Dolga</surname><given-names>A.</given-names></name><name><surname>Methner</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>The role of Ca2+ in cell death caused by oxidative glutamate toxicity and ferroptosis.</article-title>
<source><italic>Cell Calcium</italic></source>
<volume>70</volume>
<fpage>47</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2017.05.007</pub-id>
<pub-id pub-id-type="pmid">28545724</pub-id>
</mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannix</surname><given-names>R.</given-names></name><name><surname>Whalen</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Traumatic brain injury, microglia, and Beta amyloid.</article-title>
<source><italic>Int. J. Alzheimers Dis.</italic></source>
<volume>2012</volume>:<fpage>608732</fpage>. <pub-id pub-id-type="doi">10.1155/2012/608732</pub-id>
<pub-id pub-id-type="pmid">22666622</pub-id>
</mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-Reyes</surname><given-names>I.</given-names></name><name><surname>Chandel</surname><given-names>N.</given-names></name></person-group> (<year>2020</year>). <article-title>Mitochondrial TCA cycle metabolites control physiology and disease.</article-title>
<source><italic>Nat. Commun.</italic></source>
<volume>11</volume>:<fpage>102</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-13668-3</pub-id>
<pub-id pub-id-type="pmid">31900386</pub-id>
</mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattson</surname><given-names>M.</given-names></name><name><surname>Moehl</surname><given-names>K.</given-names></name><name><surname>Ghena</surname><given-names>N.</given-names></name><name><surname>Schmaedick</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Intermittent metabolic switching, neuroplasticity and brain health.</article-title>
<source><italic>Nat. Rev. Neurosci.</italic></source>
<volume>19</volume>
<fpage>63</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2017.156</pub-id>
<pub-id pub-id-type="pmid">29321682</pub-id>
</mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McArthur</surname><given-names>K.</given-names></name><name><surname>Whitehead</surname><given-names>L.</given-names></name><name><surname>Heddleston</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Padman</surname><given-names>B.</given-names></name><name><surname>Oorschot</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis.</article-title>
<source><italic>Science</italic></source>
<volume>359</volume>:<fpage>eaao6047</fpage>. <pub-id pub-id-type="doi">10.1126/science.aao6047</pub-id>
<pub-id pub-id-type="pmid">29472455</pub-id>
</mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGovern</surname><given-names>A. J.</given-names></name><name><surname>Barreto</surname><given-names>G. E.</given-names></name></person-group> (<year>2021</year>). <article-title>Mitochondria dysfunction and inflammation in traumatic brain injury: Androgens to the battlefront.</article-title>
<source><italic>Androgens</italic></source>
<volume>2</volume>
<fpage>304</fpage>&#x02013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1089/andro.2021.0017</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname><given-names>L.</given-names></name><name><surname>Du</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Mei</surname><given-names>Q.</given-names></name></person-group> (<year>2010</year>). <article-title>Purinergic signaling: A novel mechanism in immune surveillance.</article-title>
<source><italic>Acta Pharmacol. Sin.</italic></source>
<volume>31</volume>
<fpage>1149</fpage>&#x02013;<lpage>1153</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2010.128</pub-id>
<pub-id pub-id-type="pmid">20711224</pub-id>
</mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyrat</surname><given-names>A.</given-names></name><name><surname>von Ballmoos</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>ATP synthesis at physiological nucleotide concentrations.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>9</volume>:<fpage>3070</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-38564-0</pub-id>
<pub-id pub-id-type="pmid">30816129</pub-id>
</mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mira</surname><given-names>R.</given-names></name><name><surname>Quintanilla</surname><given-names>R.</given-names></name><name><surname>Cerpa</surname><given-names>W.</given-names></name></person-group> (<year>2023</year>). <article-title>Mild traumatic brain injury induces mitochondrial calcium overload and triggers the upregulation of NCLX in the hippocampus.</article-title>
<source><italic>Antioxidants</italic></source>
<volume>12</volume>:<fpage>403</fpage>. <pub-id pub-id-type="doi">10.3390/antiox12020403</pub-id>
<pub-id pub-id-type="pmid">36829963</pub-id>
</mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misgeld</surname><given-names>T.</given-names></name><name><surname>Schwarz</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>Mitostasis in neurons: Maintaining mitochondria in an extended cellular architecture.</article-title>
<source><italic>Neuron</italic></source>
<volume>96</volume>
<fpage>651</fpage>&#x02013;<lpage>666</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.09.055</pub-id>
<pub-id pub-id-type="pmid">29096078</pub-id>
</mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname><given-names>N.</given-names></name><name><surname>Ghavim</surname><given-names>S.</given-names></name><name><surname>Sutton</surname><given-names>R.</given-names></name></person-group> (<year>2021</year>). <article-title>Massive efflux of adenosine triphosphate into the extracellular space immediately after experimental traumatic brain injury.</article-title>
<source><italic>Exp. Ther. Med.</italic></source>
<volume>21</volume>:<fpage>575</fpage>. <pub-id pub-id-type="doi">10.3892/etm.2021.10007</pub-id>
<pub-id pub-id-type="pmid">33850547</pub-id>
</mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname><given-names>T.</given-names></name><name><surname>Tinsley</surname><given-names>G.</given-names></name><name><surname>Bianco</surname><given-names>A.</given-names></name><name><surname>Marcolin</surname><given-names>G.</given-names></name><name><surname>Pacelli</surname><given-names>Q.</given-names></name><name><surname>Battaglia</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males.</article-title>
<source><italic>J. Transl. Med.</italic></source>
<volume>14</volume>:<fpage>290</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-016-1044-0</pub-id>
<pub-id pub-id-type="pmid">27737674</pub-id>
</mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeser</surname><given-names>M.</given-names></name><name><surname>Saltmarche</surname><given-names>A.</given-names></name><name><surname>Krengel</surname><given-names>M.</given-names></name><name><surname>Hamblin</surname><given-names>M.</given-names></name><name><surname>Knight</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: Two case reports.</article-title>
<source><italic>Photomed. Laser Surg.</italic></source>
<volume>29</volume>
<fpage>351</fpage>&#x02013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1089/pho.2010.2814</pub-id>
<pub-id pub-id-type="pmid">21182447</pub-id>
</mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nairuz</surname><given-names>T.</given-names></name><name><surname>Sangwoo-Cho</surname></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group> (<year>2024</year>). <article-title>Photobiomodulation therapy on brain: Pioneering an innovative approach to revolutionize cognitive dynamics.</article-title>
<source><italic>Cells</italic></source>
<volume>13</volume>:<fpage>966</fpage>. <pub-id pub-id-type="doi">10.3390/cells13110966</pub-id>
<pub-id pub-id-type="pmid">38891098</pub-id>
</mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>H.</given-names></name><name><surname>Leech</surname><given-names>C.</given-names></name><name><surname>Kopp</surname><given-names>R.</given-names></name><name><surname>Roe</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Interplay between ER Ca2+ binding proteins, STIM1 and STIM2, Is Required for Store-Operated Ca2+ Entry.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>19</volume>:<fpage>1522</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19051522</pub-id>
<pub-id pub-id-type="pmid">29783744</pub-id>
</mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neupane</surname><given-names>P.</given-names></name><name><surname>Bhuju</surname><given-names>S.</given-names></name><name><surname>Thapa</surname><given-names>N.</given-names></name><name><surname>Bhattarai</surname><given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>ATP synthase: Structure, function and inhibition.</article-title>
<source><italic>Biomol. Concepts</italic></source>
<volume>10</volume>
<fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1515/bmc-2019-0001</pub-id>
<pub-id pub-id-type="pmid">30888962</pub-id>
</mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>M.</given-names></name><name><surname>Pavlov</surname><given-names>E.</given-names></name><name><surname>Robertson</surname><given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Tamoxifen-induced knockdown of the mitochondrial calcium uniporter in Thy1-expressing neurons protects mice from hypoxic/ischemic brain injury.</article-title>
<source><italic>Cell Death Dis.</italic></source>
<volume>9</volume>:<fpage>606</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-018-0607-9</pub-id>
<pub-id pub-id-type="pmid">29789575</pub-id>
</mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolson</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Mitochondrial dysfunction and chronic disease: Treatment with natural supplements.</article-title>
<source><italic>Integr. Med.</italic></source>
<volume>13</volume>
<fpage>35</fpage>&#x02013;<lpage>43</lpage>.</mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonarath</surname><given-names>H.</given-names></name><name><surname>Hall</surname><given-names>A.</given-names></name><name><surname>SenthilKumar</surname><given-names>G.</given-names></name><name><surname>Abroe</surname><given-names>B.</given-names></name><name><surname>Eells</surname><given-names>J.</given-names></name><name><surname>Liedhegner</surname><given-names>E.</given-names></name></person-group> (<year>2021</year>). <article-title>670nm photobiomodulation modulates bioenergetics and oxidative stress, in rat M&#x000fc;ller cells challenged with high glucose.</article-title>
<source><italic>PLoS One</italic></source>
<volume>16</volume>:<fpage>e0260968</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0260968</pub-id>
<pub-id pub-id-type="pmid">34860856</pub-id>
</mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norat</surname><given-names>P.</given-names></name><name><surname>Soldozy</surname><given-names>S.</given-names></name><name><surname>Sokolowski</surname><given-names>J.</given-names></name><name><surname>Gorick</surname><given-names>C.</given-names></name><name><surname>Kumar</surname><given-names>J.</given-names></name><name><surname>Chae</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation.</article-title>
<source><italic>NPJ Regen. Med.</italic></source>
<volume>5</volume>:<fpage>22</fpage>. <pub-id pub-id-type="doi">10.1038/s41536-020-00107-x</pub-id>
<pub-id pub-id-type="pmid">33298971</pub-id>
</mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunnari</surname><given-names>J.</given-names></name><name><surname>Suomalainen</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondria: In sickness and in health.</article-title>
<source><italic>Cell</italic></source>
<volume>148</volume>
<fpage>1145</fpage>&#x02013;<lpage>1159</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.035</pub-id>
<pub-id pub-id-type="pmid">22424226</pub-id>
</mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omelchenko</surname><given-names>A.</given-names></name><name><surname>Shrirao</surname><given-names>A.</given-names></name><name><surname>Bhattiprolu</surname><given-names>A.</given-names></name><name><surname>Zahn</surname><given-names>J.</given-names></name><name><surname>Schloss</surname><given-names>R.</given-names></name><name><surname>Dickson</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Dynamin and reverse-mode sodium calcium exchanger blockade confers neuroprotection from diffuse axonal injury.</article-title>
<source><italic>Cell Death Dis.</italic></source>
<volume>10</volume>:<fpage>727</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-019-1908-3</pub-id>
<pub-id pub-id-type="pmid">31562294</pub-id>
</mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ore&#x00161;i&#x0010d;</surname><given-names>M.</given-names></name><name><surname>Posti</surname><given-names>J.</given-names></name><name><surname>Kamstrup-Nielsen</surname><given-names>M.</given-names></name><name><surname>Takala</surname><given-names>R.</given-names></name><name><surname>Lingsma</surname><given-names>H.</given-names></name><name><surname>Mattila</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Human serum metabolites associate with severity and patient outcomes in traumatic brain injury.</article-title>
<source><italic>EBioMedicine</italic></source>
<volume>12</volume>
<fpage>118</fpage>&#x02013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2016.07.015</pub-id>
<pub-id pub-id-type="pmid">27665050</pub-id>
</mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyewole</surname><given-names>A.</given-names></name><name><surname>Birch-Machin</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondria-targeted antioxidants.</article-title>
<source><italic>FASEB J.</italic></source>
<volume>29</volume>
<fpage>4766</fpage>&#x02013;<lpage>4771</lpage>. <pub-id pub-id-type="doi">10.1096/fj.15-275404</pub-id>
<pub-id pub-id-type="pmid">26253366</pub-id>
</mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandya</surname><given-names>J.</given-names></name><name><surname>Leung</surname><given-names>L.</given-names></name><name><surname>Hwang</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Deng-Bryant</surname><given-names>Y.</given-names></name><name><surname>Shear</surname><given-names>D.</given-names></name></person-group> (<year>2021</year>). <article-title>Time-course evaluation of brain regional mitochondrial bioenergetics in a pre-clinical model of severe penetrating traumatic brain injury.</article-title>
<source><italic>J. Neurotrauma.</italic></source>
<volume>38</volume>
<fpage>2323</fpage>&#x02013;<lpage>2334</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2020.7379</pub-id>
<pub-id pub-id-type="pmid">33544034</pub-id>
</mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandya</surname><given-names>J.</given-names></name><name><surname>Leung</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Flerlage</surname><given-names>W.</given-names></name><name><surname>Gilsdorf</surname><given-names>J.</given-names></name><name><surname>Deng-Bryant</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Comprehensive profile of acute mitochondrial dysfunction in a preclinical model of severe penetrating TBI.</article-title>
<source><italic>Front. Neurol.</italic></source>
<volume>10</volume>:<fpage>605</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2019.00605</pub-id>
<pub-id pub-id-type="pmid">31244764</pub-id>
</mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandya</surname><given-names>J.</given-names></name><name><surname>Musyaju</surname><given-names>S.</given-names></name><name><surname>Modi</surname><given-names>H.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Flerlage</surname><given-names>W.</given-names></name><name><surname>Huynh</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Comprehensive evaluation of mitochondrial redox profile, calcium dynamics, membrane integrity and apoptosis markers in a preclinical model of severe penetrating traumatic brain injury.</article-title>
<source><italic>Free Radic. Biol. Med.</italic></source>
<volume>198</volume>
<fpage>44</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2023.02.001</pub-id>
<pub-id pub-id-type="pmid">36758906</pub-id>
</mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paumard</surname><given-names>P.</given-names></name><name><surname>Vaillier</surname><given-names>J.</given-names></name><name><surname>Coulary</surname><given-names>B.</given-names></name><name><surname>Schaeffer</surname><given-names>J.</given-names></name><name><surname>Soubannier</surname><given-names>V.</given-names></name><name><surname>Mueller</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>The ATP synthase is involved in generating mitochondrial cristae morphology.</article-title>
<source><italic>EMBO J.</italic></source>
<volume>21</volume>
<fpage>221</fpage>&#x02013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/21.3.221</pub-id>
<pub-id pub-id-type="pmid">11823415</pub-id>
</mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name></person-group> (<year>2022</year>). <article-title>Targeting mitochondrial oxidative phosphorylation eradicates acute myeloid leukemic stem cells.</article-title>
<source><italic>Front. Oncol.</italic></source>
<volume>12</volume>:<fpage>899502</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2022.899502</pub-id>
<pub-id pub-id-type="pmid">35574326</pub-id>
</mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peter</surname><given-names>C.</given-names></name><name><surname>Hongwan</surname><given-names>D.</given-names></name><name><surname>K&#x000fc;pfer</surname><given-names>A.</given-names></name><name><surname>Lauterburg</surname><given-names>B.</given-names></name></person-group> (<year>2000</year>). <article-title>Pharmacokinetics and organ distribution of intravenous and oral methylene blue.</article-title>
<source><italic>Eur. J. Clin. Pharmacol.</italic></source>
<volume>56</volume>
<fpage>247</fpage>&#x02013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1007/s002280000124</pub-id>
<pub-id pub-id-type="pmid">10952480</pub-id>
</mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picard</surname><given-names>M.</given-names></name><name><surname>Shirihai</surname><given-names>O.</given-names></name></person-group> (<year>2022</year>). <article-title>Mitochondrial signal transduction.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>34</volume>
<fpage>1620</fpage>&#x02013;<lpage>1653</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2022.10.008</pub-id>
<pub-id pub-id-type="pmid">36323233</pub-id>
</mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinggera</surname><given-names>D.</given-names></name><name><surname>Steiger</surname><given-names>R.</given-names></name><name><surname>Bauer</surname><given-names>M.</given-names></name><name><surname>Kerschbaumer</surname><given-names>J.</given-names></name><name><surname>Beer</surname><given-names>R.</given-names></name><name><surname>Rietzler</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Repeated 31P-magnetic resonance spectroscopy in severe traumatic brain injury: Insights into cerebral energy status and altered metabolism.</article-title>
<source><italic>J. Neurotrauma.</italic></source>
<volume>38</volume>
<fpage>2822</fpage>&#x02013;<lpage>2830</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2021.0143</pub-id>
<pub-id pub-id-type="pmid">34235953</pub-id>
</mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinggera</surname><given-names>D.</given-names></name><name><surname>Steiger</surname><given-names>R.</given-names></name><name><surname>Bauer</surname><given-names>M.</given-names></name><name><surname>Kerschbaumer</surname><given-names>J.</given-names></name><name><surname>Luger</surname><given-names>M.</given-names></name><name><surname>Beer</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Cerebral energy status and altered metabolism in early severe TBI: First results of a prospective 31P-MRS feasibility study.</article-title>
<source><italic>Neurocrit Care.</italic></source>
<volume>34</volume>
<fpage>432</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1007/s12028-020-01042-x</pub-id>
<pub-id pub-id-type="pmid">32617851</pub-id>
</mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>R.</given-names></name><name><surname>Goodenow</surname><given-names>D.</given-names></name><name><surname>Mixer</surname><given-names>H.</given-names></name><name><surname>Mckillop</surname><given-names>I.</given-names></name><name><surname>Evans</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Cytochrome c limits oxidative stress and decreases acidosis in a rat model of hemorrhagic shock and reperfusion injury.</article-title>
<source><italic>J. Trauma Acute Care Surg.</italic></source>
<volume>82</volume>
<fpage>35</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1097/TA.0000000000001257</pub-id>
<pub-id pub-id-type="pmid">27602909</pub-id>
</mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priemer</surname><given-names>D.</given-names></name><name><surname>Iacono</surname><given-names>D.</given-names></name><name><surname>Rhodes</surname><given-names>C.</given-names></name><name><surname>Olsen</surname><given-names>C.</given-names></name><name><surname>Perl</surname><given-names>D.</given-names></name></person-group> (<year>2022</year>). <article-title>Chronic traumatic encephalopathy in the brains of military personnel.</article-title>
<source><italic>N. Engl. J. Med.</italic></source>
<volume>386</volume>
<fpage>2169</fpage>&#x02013;<lpage>2177</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2203199</pub-id>
<pub-id pub-id-type="pmid">35675177</pub-id>
</mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>X.</given-names></name><name><surname>Qvit</surname><given-names>N.</given-names></name><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity.</article-title>
<source><italic>J. Cell Sci.</italic></source>
<volume>126</volume>(<issue>Pt 3</issue>), <fpage>789</fpage>&#x02013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.114439</pub-id>
<pub-id pub-id-type="pmid">23239023</pub-id>
</mixed-citation></ref><ref id="B181"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabinowitz</surname><given-names>J.</given-names></name><name><surname>Enerb&#x000e4;ck</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Lactate: The ugly duckling of energy metabolism.</article-title>
<source><italic>Nat. Metab.</italic></source>
<volume>2</volume>
<fpage>566</fpage>&#x02013;<lpage>571</lpage>. <pub-id pub-id-type="doi">10.1038/s42255-020-0243-4</pub-id>
<pub-id pub-id-type="pmid">32694798</pub-id>
</mixed-citation></ref><ref id="B182"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramlackhansingh</surname><given-names>A.</given-names></name><name><surname>Brooks</surname><given-names>D.</given-names></name><name><surname>Greenwood</surname><given-names>R.</given-names></name><name><surname>Bose</surname><given-names>S.</given-names></name><name><surname>Turkheimer</surname><given-names>F.</given-names></name><name><surname>Kinnunen</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Inflammation after trauma: Microglial activation and traumatic brain injury.</article-title>
<source><italic>Ann. Neurol.</italic></source>
<volume>70</volume>
<fpage>374</fpage>&#x02013;<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22455</pub-id>
<pub-id pub-id-type="pmid">21710619</pub-id>
</mixed-citation></ref><ref id="B183"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rana</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Traumatic brain injury altered normal brain signaling pathways: Implications for novel therapeutics approaches.</article-title>
<source><italic>Curr. Neuropharmacol.</italic></source>
<volume>17</volume>
<fpage>614</fpage>&#x02013;<lpage>629</lpage>. <pub-id pub-id-type="doi">10.2174/1570159X16666180911121847</pub-id>
<pub-id pub-id-type="pmid">30207236</pub-id>
</mixed-citation></ref><ref id="B184"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rana</surname><given-names>P.</given-names></name><name><surname>Rama Rao</surname><given-names>K.</given-names></name><name><surname>Ravula</surname><given-names>A.</given-names></name><name><surname>Trivedi</surname><given-names>R.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Oxidative stress contributes to cerebral metabolomic profile changes in animal model of blast-induced traumatic brain injury.</article-title>
<source><italic>Metabolomics</italic></source>
<volume>16</volume>:<fpage>39</fpage>. <pub-id pub-id-type="doi">10.1007/s11306-020-1649-4</pub-id>
<pub-id pub-id-type="pmid">32166461</pub-id>
</mixed-citation></ref><ref id="B185"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangaraju</surname><given-names>V.</given-names></name><name><surname>Calloway</surname><given-names>N.</given-names></name><name><surname>Ryan</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Activity-driven local ATP synthesis is required for synaptic function.</article-title>
<source><italic>Cell</italic></source>
<volume>156</volume>
<fpage>825</fpage>&#x02013;<lpage>835</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.12.042</pub-id>
<pub-id pub-id-type="pmid">24529383</pub-id>
</mixed-citation></ref><ref id="B186"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name><name><surname>Hui</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Su</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Downregulation of STIM2 improves neuronal survival after traumatic brain injury by alleviating calcium overload and mitochondrial dysfunction.</article-title>
<source><italic>Biochim. Biophys. Acta</italic></source>
<volume>1852</volume>
<fpage>2402</fpage>&#x02013;<lpage>2413</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2015.08.014</pub-id>
<pub-id pub-id-type="pmid">26300487</pub-id>
</mixed-citation></ref><ref id="B187"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>J.</given-names></name><name><surname>Bruchey</surname><given-names>A.</given-names></name><name><surname>Gonzalez-Lima</surname><given-names>F.</given-names></name></person-group> (<year>2012</year>). <article-title>Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.</article-title>
<source><italic>Prog. Neurobiol.</italic></source>
<volume>96</volume>
<fpage>32</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2011.10.007</pub-id>
<pub-id pub-id-type="pmid">22067440</pub-id>
</mixed-citation></ref><ref id="B188"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>J.</given-names></name><name><surname>Brian</surname><given-names>C.</given-names></name><name><surname>Pappa</surname><given-names>A.</given-names></name><name><surname>Panayiotidis</surname><given-names>M.</given-names></name><name><surname>Franco</surname><given-names>R.</given-names></name></person-group> (<year>2020</year>). <article-title>Mitochondrial metabolism in astrocytes regulates brain bioenergetics, neurotransmission and redox balance.</article-title>
<source><italic>Front. Neurosci.</italic></source>
<volume>14</volume>:<fpage>536682</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2020.536682</pub-id>
<pub-id pub-id-type="pmid">33224019</pub-id>
</mixed-citation></ref><ref id="B189"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>J.</given-names></name></person-group> (<year>2021</year>). <article-title>Mitochondria signaling to the epigenome: A novel role for an old organelle.</article-title>
<source><italic>Free Radic. Biol. Med.</italic></source>
<volume>170</volume>
<fpage>59</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2020.11.016</pub-id>
<pub-id pub-id-type="pmid">33271282</pub-id>
</mixed-citation></ref><ref id="B190"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirmer</surname><given-names>R.</given-names></name><name><surname>Adler</surname><given-names>H.</given-names></name><name><surname>Pickhardt</surname><given-names>M.</given-names></name><name><surname>Mandelkow</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Lest we forget you&#x02013;methylene blue.</article-title>
<source><italic>Neurobiol. Aging</italic></source>
<volume>32</volume>:<fpage>2325.e7-16</fpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2010.12.012.</pub-id>
<pub-id pub-id-type="pmid">21316815</pub-id>
</mixed-citation></ref><ref id="B191"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>R.</given-names></name><name><surname>Qayum</surname><given-names>S.</given-names></name><name><surname>Pliss</surname><given-names>A.</given-names></name><name><surname>Kuzmin</surname><given-names>A.</given-names></name><name><surname>Muthaiah</surname><given-names>V.</given-names></name><name><surname>Kaliyappan</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Mitochondrial dysfunction and apoptosis in brain microvascular endothelial cells following blast traumatic brain injury.</article-title>
<source><italic>Cell Mol. Neurobiol.</italic></source>
<volume>43</volume>
<fpage>3639</fpage>&#x02013;<lpage>3651</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-023-01372-2</pub-id>
<pub-id pub-id-type="pmid">37314617</pub-id>
</mixed-citation></ref><ref id="B192"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schurr</surname><given-names>A.</given-names></name><name><surname>Rigor</surname><given-names>B.</given-names></name></person-group> (<year>1998</year>). <article-title>Brain anaerobic lactate production: A suicide note or a survival kit?</article-title>
<source><italic>Dev. Neurosci.</italic></source>
<volume>20</volume>
<fpage>348</fpage>&#x02013;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1159/000017330</pub-id>
<pub-id pub-id-type="pmid">9778571</pub-id>
</mixed-citation></ref><ref id="B193"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shabkhizan</surname><given-names>R.</given-names></name><name><surname>Haiaty</surname><given-names>S.</given-names></name><name><surname>Moslehian</surname><given-names>M.</given-names></name><name><surname>Bazmani</surname><given-names>A.</given-names></name><name><surname>Sadeghsoltani</surname><given-names>F.</given-names></name><name><surname>Saghaei Bagheri</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>The beneficial and adverse effects of autophagic response to caloric restriction and fasting.</article-title>
<source><italic>Adv. Nutr.</italic></source>
<volume>14</volume>
<fpage>1211</fpage>&#x02013;<lpage>1225</lpage>. <pub-id pub-id-type="doi">10.1016/j.advnut.2023.07.006</pub-id>
<pub-id pub-id-type="pmid">37527766</pub-id>
</mixed-citation></ref><ref id="B194"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaito</surname><given-names>A.</given-names></name><name><surname>Hasan</surname><given-names>H.</given-names></name><name><surname>Habashy</surname><given-names>K.</given-names></name><name><surname>Fakih</surname><given-names>W.</given-names></name><name><surname>Abdelhady</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Western diet aggravates neuronal insult in post-traumatic brain injury: Proposed pathways for interplay.</article-title>
<source><italic>EBioMedicine</italic></source>
<volume>57</volume>:<fpage>102829</fpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2020.102829</pub-id>
<pub-id pub-id-type="pmid">32574954</pub-id>
</mixed-citation></ref><ref id="B195"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamloo</surname><given-names>S.</given-names></name><name><surname>Defensor</surname><given-names>E.</given-names></name><name><surname>Ciari</surname><given-names>P.</given-names></name><name><surname>Ogawa</surname><given-names>G.</given-names></name><name><surname>Vidano</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>The anti-inflammatory effects of photobiomodulation are mediated by cytokines: Evidence from a mouse model of inflammation.</article-title>
<source><italic>Front. Neurosci.</italic></source>
<volume>17</volume>:<fpage>1150156</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2023.1150156</pub-id>
<pub-id pub-id-type="pmid">37090796</pub-id>
</mixed-citation></ref><ref id="B196"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Gibson</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Oxidative stress and transcriptional regulation in Alzheimer disease.</article-title>
<source><italic>Alzheimer Dis. Assoc. Disord.</italic></source>
<volume>21</volume>
<fpage>276</fpage>&#x02013;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1097/WAD.0b013e31815721c3</pub-id>
<pub-id pub-id-type="pmid">18090434</pub-id>
</mixed-citation></ref><ref id="B197"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siedhoff</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Cernak</surname><given-names>I.</given-names></name><name><surname>Cifu</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Perspectives on primary blast injury of the brain: Translational insights into non-inertial low-intensity blast injury.</article-title>
<source><italic>Front. Neurol.</italic></source>
<volume>12</volume>:<fpage>818169</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2021.818169</pub-id>
<pub-id pub-id-type="pmid">35095749</pub-id>
</mixed-citation></ref><ref id="B198"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva Macedo</surname><given-names>R.</given-names></name><name><surname>Peres Leal</surname><given-names>M.</given-names></name><name><surname>Braga</surname><given-names>T.</given-names></name><name><surname>Barioni</surname><given-names>&#x000c9;</given-names></name><name><surname>de Oliveira Duro</surname><given-names>S.</given-names></name><name><surname>Ratto Tempestini Horliana</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Photobiomodulation therapy decreases oxidative stress in the lung tissue after formaldehyde exposure: Role of oxidant/antioxidant enzymes.</article-title>
<source><italic>Mediat. Inflamm.</italic></source>
<volume>2016</volume>:<fpage>9303126</fpage>. <pub-id pub-id-type="doi">10.1155/2016/9303126</pub-id>
<pub-id pub-id-type="pmid">27293324</pub-id>
</mixed-citation></ref><ref id="B199"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>E.</given-names></name><name><surname>Scholpa</surname><given-names>N.</given-names></name><name><surname>Schnellmann</surname><given-names>R.</given-names></name></person-group> (<year>2020</year>). <article-title>Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.</article-title>
<source><italic>Exp. Neurol.</italic></source>
<volume>329</volume>:<fpage>113309</fpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2020.113309</pub-id>
<pub-id pub-id-type="pmid">32289315</pub-id>
</mixed-citation></ref><ref id="B200"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skemiene</surname><given-names>K.</given-names></name><name><surname>Rekuviene</surname><given-names>E.</given-names></name><name><surname>Jekabsone</surname><given-names>A.</given-names></name><name><surname>Cizas</surname><given-names>P.</given-names></name><name><surname>Morkuniene</surname><given-names>R.</given-names></name><name><surname>Borutaite</surname><given-names>V.</given-names></name></person-group> (<year>2020</year>). <article-title>Comparison of effects of metformin, phenformin, and inhibitors of mitochondrial complex I on mitochondrial permeability transition and ischemic brain injury.</article-title>
<source><italic>Biomolecules</italic></source>
<volume>10</volume>:<fpage>1400</fpage>. <pub-id pub-id-type="doi">10.3390/biom10101400</pub-id>
<pub-id pub-id-type="pmid">33019635</pub-id>
</mixed-citation></ref><ref id="B201"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>R.</given-names></name><name><surname>Murphy</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Animal and human studies with the mitochondria-targeted antioxidant MitoQ.</article-title>
<source><italic>Ann. N. Y. Acad. Sci.</italic></source>
<volume>1201</volume>
<fpage>96</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2010.05627.x</pub-id>
<pub-id pub-id-type="pmid">20649545</pub-id>
</mixed-citation></ref><ref id="B202"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sowers</surname><given-names>J.</given-names></name><name><surname>Sowers</surname><given-names>M.</given-names></name><name><surname>Shavkunov</surname><given-names>A.</given-names></name><name><surname>Hawkins</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>DeWitt</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Traumatic brain injury induces region-specific glutamate metabolism changes as measured by multiple mass spectrometry methods.</article-title>
<source><italic>iScience</italic></source>
<volume>24</volume>:<fpage>103108</fpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2021.103108</pub-id>
<pub-id pub-id-type="pmid">34622161</pub-id>
</mixed-citation></ref><ref id="B203"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname><given-names>J.</given-names></name><name><surname>Prajapati</surname><given-names>P.</given-names></name><name><surname>Sullivan</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Targeting the mitochondrial permeability transition pore in traumatic central nervous system injury.</article-title>
<source><italic>Neural Regen. Res.</italic></source>
<volume>13</volume>
<fpage>1338</fpage>&#x02013;<lpage>1341</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.235218</pub-id>
<pub-id pub-id-type="pmid">30106036</pub-id>
</mixed-citation></ref><ref id="B204"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanika</surname><given-names>R.</given-names></name><name><surname>Villanueva</surname><given-names>I.</given-names></name><name><surname>Kazanina</surname><given-names>G.</given-names></name><name><surname>Andrews</surname><given-names>S.</given-names></name><name><surname>Pivovarova</surname><given-names>N.</given-names></name></person-group> (<year>2012</year>). <article-title>Comparative impact of voltage-gated calcium channels and NMDA receptors on mitochondria-mediated neuronal injury.</article-title>
<source><italic>J. Neurosci.</italic></source>
<volume>32</volume>
<fpage>6642</fpage>&#x02013;<lpage>6650</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6008-11.2012</pub-id>
<pub-id pub-id-type="pmid">22573686</pub-id>
</mixed-citation></ref><ref id="B205"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Brain fuel utilization in the developing brain.</article-title>
<source><italic>Ann. Nutr. Metab.</italic></source>
<volume>75</volume> (<issue>Suppl. 1</issue>), <fpage>8</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1159/000508054</pub-id>
<pub-id pub-id-type="pmid">32564020</pub-id>
</mixed-citation></ref><ref id="B206"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stovell</surname><given-names>M.</given-names></name><name><surname>Howe</surname><given-names>D.</given-names></name><name><surname>Thelin</surname><given-names>E.</given-names></name><name><surname>Jalloh</surname><given-names>I.</given-names></name><name><surname>Helmy</surname><given-names>A.</given-names></name><name><surname>Guilfoyle</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>High-physiological and supra-physiological 1,2-13C2 glucose focal supplementation to the traumatised human brain.</article-title>
<source><italic>J. Cereb. Blood Flow Metab.</italic></source>
<volume>43</volume>
<fpage>1685</fpage>&#x02013;<lpage>1701</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X231173584</pub-id>
<pub-id pub-id-type="pmid">37157814</pub-id>
</mixed-citation></ref><ref id="B207"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stovell</surname><given-names>M.</given-names></name><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Sleigh</surname><given-names>A.</given-names></name><name><surname>Mada</surname><given-names>M.</given-names></name><name><surname>Carpenter</surname><given-names>T.</given-names></name><name><surname>Hutchinson</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Assessing metabolism and injury in acute human traumatic brain injury with magnetic resonance spectroscopy: Current and future applications.</article-title>
<source><italic>Front. Neurol.</italic></source>
<volume>8</volume>:<fpage>426</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2017.00426</pub-id>
<pub-id pub-id-type="pmid">28955291</pub-id>
</mixed-citation></ref><ref id="B208"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strope</surname><given-names>T.</given-names></name><name><surname>Birky</surname><given-names>C.</given-names></name><name><surname>Wilkins</surname><given-names>H.</given-names></name></person-group> (<year>2022</year>). <article-title>The role of bioenergetics in neurodegeneration.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>23</volume>:<fpage>9212</fpage>. <pub-id pub-id-type="doi">10.3390/ijms23169212</pub-id>
<pub-id pub-id-type="pmid">36012480</pub-id>
</mixed-citation></ref><ref id="B209"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>E.</given-names></name><name><surname>Beyl</surname><given-names>R.</given-names></name><name><surname>Early</surname><given-names>K.</given-names></name><name><surname>Cefalu</surname><given-names>W.</given-names></name><name><surname>Ravussin</surname><given-names>E.</given-names></name><name><surname>Peterson</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>27</volume>
<fpage>1212</fpage>&#x02013;<lpage>1221.e3</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2018.04.010.</pub-id>
<pub-id pub-id-type="pmid">29754952</pub-id>
</mixed-citation></ref><ref id="B210"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szeto</surname><given-names>H.</given-names></name></person-group> (<year>2014</year>). <article-title>First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.</article-title>
<source><italic>Br. J. Pharmacol.</italic></source>
<volume>171</volume>
<fpage>2029</fpage>&#x02013;<lpage>2050</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12461</pub-id>
<pub-id pub-id-type="pmid">24117165</pub-id>
</mixed-citation></ref><ref id="B211"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szrok-Jurga</surname><given-names>S.</given-names></name><name><surname>Turyn</surname><given-names>J.</given-names></name><name><surname>Hebanowska</surname><given-names>A.</given-names></name><name><surname>Swierczynski</surname><given-names>J.</given-names></name><name><surname>Czumaj</surname><given-names>A.</given-names></name><name><surname>Sledzinski</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>The role of Acyl-CoA &#x003b2;-oxidation in brain metabolism and neurodegenerative diseases.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>24</volume>:<fpage>13977</fpage>. <pub-id pub-id-type="doi">10.3390/ijms241813977</pub-id>
<pub-id pub-id-type="pmid">37762279</pub-id>
</mixed-citation></ref><ref id="B212"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talley Watts</surname><given-names>L.</given-names></name><name><surname>Long</surname><given-names>J.</given-names></name><name><surname>Chemello</surname><given-names>J.</given-names></name><name><surname>Van Koughnet</surname><given-names>S.</given-names></name><name><surname>Fernandez</surname><given-names>A.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Methylene blue is neuroprotective against mild traumatic brain injury.</article-title>
<source><italic>J. Neurotrauma.</italic></source>
<volume>31</volume>
<fpage>1063</fpage>&#x02013;<lpage>1071</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2013.3193</pub-id>
<pub-id pub-id-type="pmid">24479842</pub-id>
</mixed-citation></ref><ref id="B213"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Agarwal</surname><given-names>D.</given-names></name><name><surname>Tharzeen</surname><given-names>A.</given-names></name><name><surname>Patrikeev</surname><given-names>I.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Serum amyloid A and mitochondrial DNA in extracellular vesicles are novel markers for detecting traumatic brain injury in a mouse model.</article-title>
<source><italic>iScience</italic></source>
<volume>27</volume>:<fpage>108932</fpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2024.108932</pub-id>
<pub-id pub-id-type="pmid">38323004</pub-id>
</mixed-citation></ref><ref id="B214"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavazzi</surname><given-names>B.</given-names></name><name><surname>Signoretti</surname><given-names>S.</given-names></name><name><surname>Lazzarino</surname><given-names>G.</given-names></name><name><surname>Amorini</surname><given-names>A.</given-names></name><name><surname>Delfini</surname><given-names>R.</given-names></name><name><surname>Cimatti</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Cerebral oxidative stress and depression of energy metabolism correlate with severity of diffuse brain injury in rats.</article-title>
<source><italic>Neurosurgery</italic></source>
<volume>56</volume> 582-9; discussion 582-9. <pub-id pub-id-type="doi">10.1227/01.neu.0000156715.04900.e6</pub-id>
<pub-id pub-id-type="pmid">15730584</pub-id>
</mixed-citation></ref><ref id="B215"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thau-Zuchman</surname><given-names>O.</given-names></name><name><surname>Svendsen</surname><given-names>L.</given-names></name><name><surname>Dyall</surname><given-names>S.</given-names></name><name><surname>Paredes-Esquivel</surname><given-names>U.</given-names></name><name><surname>Rhodes</surname><given-names>M.</given-names></name><name><surname>Priestley</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>A new ketogenic formulation improves functional outcome and reduces tissue loss following traumatic brain injury in adult mice.</article-title>
<source><italic>Theranostics</italic></source>
<volume>11</volume>
<fpage>346</fpage>&#x02013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.7150/thno.48995</pub-id>
<pub-id pub-id-type="pmid">33391479</pub-id>
</mixed-citation></ref><ref id="B216"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thunshelle</surname><given-names>C.</given-names></name><name><surname>Hamblin</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Transcranial low-level laser (Light) therapy for brain injury.</article-title>
<source><italic>Photomed. Laser Surg.</italic></source>
<volume>34</volume>
<fpage>587</fpage>&#x02013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1089/pho.2015.4051</pub-id>
<pub-id pub-id-type="pmid">28001759</pub-id>
</mixed-citation></ref><ref id="B217"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tretter</surname><given-names>L.</given-names></name><name><surname>Patocs</surname><given-names>A.</given-names></name><name><surname>Chinopoulos</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis.</article-title>
<source><italic>Biochim. Biophys. Acta</italic></source>
<volume>1857</volume>
<fpage>1086</fpage>&#x02013;<lpage>1101</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2016.03.012</pub-id>
<pub-id pub-id-type="pmid">26971832</pub-id>
</mixed-citation></ref><ref id="B218"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trushina</surname><given-names>E.</given-names></name><name><surname>McMurray</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases.</article-title>
<source><italic>Neuroscience</italic></source>
<volume>145</volume>
<fpage>1233</fpage>&#x02013;<lpage>1248</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.10.056</pub-id>
<pub-id pub-id-type="pmid">17303344</pub-id>
</mixed-citation></ref><ref id="B219"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vakifahmetoglu-Norberg</surname><given-names>H.</given-names></name><name><surname>Ouchida</surname><given-names>A.</given-names></name><name><surname>Norberg</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of mitochondria in metabolism and cell death.</article-title>
<source><italic>Biochem. Biophys. Res. Commun.</italic></source>
<volume>482</volume>
<fpage>426</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.11.088</pub-id>
<pub-id pub-id-type="pmid">28212726</pub-id>
</mixed-citation></ref><ref id="B220"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasim</surname><given-names>I.</given-names></name><name><surname>Majeed</surname><given-names>C.</given-names></name><name><surname>DeBoer</surname><given-names>M.</given-names></name></person-group> (<year>2022</year>). <article-title>Intermittent fasting and metabolic health.</article-title>
<source><italic>Nutrients</italic></source>
<volume>14</volume>:<fpage>631</fpage>. <pub-id pub-id-type="doi">10.3390/nu14030631</pub-id>
<pub-id pub-id-type="pmid">35276989</pub-id>
</mixed-citation></ref><ref id="B221"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vekaria</surname><given-names>H.</given-names></name><name><surname>Hubbard</surname><given-names>W.</given-names></name><name><surname>Scholpa</surname><given-names>N.</given-names></name><name><surname>Spry</surname><given-names>M.</given-names></name><name><surname>Gooch</surname><given-names>J.</given-names></name><name><surname>Prince</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Formoterol, a &#x003b2;2-adrenoreceptor agonist, induces mitochondrial biogenesis and promotes cognitive recovery after traumatic brain injury.</article-title>
<source><italic>Neurobiol. Dis.</italic></source>
<volume>140</volume>:<fpage>104866</fpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2020.104866</pub-id>
<pub-id pub-id-type="pmid">32289370</pub-id>
</mixed-citation></ref><ref id="B222"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>T.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name></person-group> (<year>2022</year>). <article-title>Microglia polarization: A novel target of exosome for stroke treatment.</article-title>
<source><italic>Front. Cell Dev. Biol.</italic></source>
<volume>10</volume>:<fpage>842320</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2022.842320</pub-id>
<pub-id pub-id-type="pmid">35356292</pub-id>
</mixed-citation></ref><ref id="B223"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Altered calcium signaling following traumatic brain injury.</article-title>
<source><italic>Front. Pharmacol.</italic></source>
<volume>3</volume>:<fpage>60</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2012.00060</pub-id>
<pub-id pub-id-type="pmid">22518104</pub-id>
</mixed-citation></ref><ref id="B224"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Miao</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Mao</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Aerobic glycolysis is the predominant means of glucose metabolism in neuronal somata, which protects against oxidative damage.</article-title>
<source><italic>Nat. Neurosci.</italic></source>
<volume>26</volume>
<fpage>2081</fpage>&#x02013;<lpage>2089</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-023-01476-4</pub-id>
<pub-id pub-id-type="pmid">37996529</pub-id>
</mixed-citation></ref><ref id="B225"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>T.</given-names></name><name><surname>Bajwa</surname><given-names>E.</given-names></name><name><surname>Klegeris</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Cytochrome c can be released into extracellular space and modulate functions of human astrocytes in a toll-like receptor 4-dependent manner.</article-title>
<source><italic>Biochim. Biophys. Acta Gen. Subj.</italic></source>
<volume>1863</volume>:<fpage>129400</fpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2019.07.009</pub-id>
<pub-id pub-id-type="pmid">31344401</pub-id>
</mixed-citation></ref><ref id="B226"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong-Riley</surname><given-names>M.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name><name><surname>Eells</surname><given-names>J.</given-names></name><name><surname>Chance</surname><given-names>B.</given-names></name><name><surname>Henry</surname><given-names>M.</given-names></name><name><surname>Buchmann</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: Role of cytochrome c oxidase.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>280</volume>
<fpage>4761</fpage>&#x02013;<lpage>4771</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M409650200</pub-id>
<pub-id pub-id-type="pmid">15557336</pub-id>
</mixed-citation></ref><ref id="B227"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>X.</given-names></name><name><surname>Jiao</surname><given-names>W.</given-names></name></person-group> (<year>2023</year>). <article-title>Omega-3 polyunsaturated fatty acids alleviate early brain injury after traumatic brain injury by inhibiting neuroinflammation and necroptosis.</article-title>
<source><italic>Transl Neurosci.</italic></source>
<volume>14</volume>:<fpage>20220277</fpage>. <pub-id pub-id-type="doi">10.1515/tnsci-2022-0277</pub-id>
<pub-id pub-id-type="pmid">36895263</pub-id>
</mixed-citation></ref><ref id="B228"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Ho</surname><given-names>W.</given-names></name><name><surname>Lu</surname><given-names>R.</given-names></name></person-group> (<year>2022</year>). <article-title>Targeting mitochondrial oxidative phosphorylation in glioblastoma therapy.</article-title>
<source><italic>Neuromol. Med.</italic></source>
<volume>24</volume>
<fpage>18</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1007/s12017-021-08678-8</pub-id>
<pub-id pub-id-type="pmid">34487301</pub-id>
</mixed-citation></ref><ref id="B229"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Fatty acid oxidation in cell fate determination.</article-title>
<source><italic>Trends Biochem. Sci.</italic></source>
<volume>43</volume>
<fpage>854</fpage>&#x02013;<lpage>857</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2018.04.006</pub-id>
<pub-id pub-id-type="pmid">29735398</pub-id>
</mixed-citation></ref><ref id="B230"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>Q.</given-names></name><name><surname>Peterson</surname><given-names>P. L.</given-names></name><name><surname>Muizelaar</surname><given-names>J. P.</given-names></name><name><surname>Lee</surname><given-names>C. P.</given-names></name></person-group> (<year>1997</year>). <article-title>Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury</article-title>. <source><italic>J. Neurotrauma</italic></source>. <volume>14</volume>, <fpage>23</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1089/neu.1997.14.23</pub-id>
<pub-id pub-id-type="pmid">9048308</pub-id>
</mixed-citation></ref><ref id="B231"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Niu</surname><given-names>F.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name></person-group> (<year>2021</year>). <article-title>Glucose metabolism: A link between traumatic brain injury and Alzheimer&#x02019;s disease.</article-title>
<source><italic>Chin. J. Traumatol.</italic></source>
<volume>24</volume>
<fpage>5</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.cjtee.2020.10.001</pub-id>
<pub-id pub-id-type="pmid">33358332</pub-id>
</mixed-citation></ref><ref id="B232"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Cao</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Scientific evidences of calorie restriction and intermittent fasting for neuroprotection in traumatic brain injury animal models: A review of the literature.</article-title>
<source><italic>Nutrients</italic></source>
<volume>14</volume>:<fpage>1431</fpage>. <pub-id pub-id-type="doi">10.3390/nu14071431</pub-id>
<pub-id pub-id-type="pmid">35406044</pub-id>
</mixed-citation></ref><ref id="B233"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Sirtuin 3 and mitochondrial permeability transition pore (mPTP): A systematic review.</article-title>
<source><italic>Mitochondrion</italic></source>
<volume>64</volume>
<fpage>103</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2022.03.004</pub-id>
<pub-id pub-id-type="pmid">35346868</pub-id>
</mixed-citation></ref><ref id="B234"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonutas</surname><given-names>H.</given-names></name><name><surname>Vekaria</surname><given-names>H.</given-names></name><name><surname>Sullivan</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Mitochondrial specific therapeutic targets following brain injury.</article-title>
<source><italic>Brain Res.</italic></source>
<volume>1640</volume>(<issue>Pt A</issue>), <fpage>77</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2016.02.007</pub-id>
<pub-id pub-id-type="pmid">26872596</pub-id>
</mixed-citation></ref><ref id="B235"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarrinmayeh</surname><given-names>H.</given-names></name><name><surname>Territo</surname><given-names>P.</given-names></name></person-group> (<year>2020</year>). <article-title>Purinergic receptors of the central nervous system: Biology, PET ligands, and their applications.</article-title>
<source><italic>Mol. Imaging</italic></source>
<volume>19</volume>:<fpage>1536012120927609</fpage>. <pub-id pub-id-type="doi">10.1177/1536012120927609</pub-id>
<pub-id pub-id-type="pmid">32539522</pub-id>
</mixed-citation></ref><ref id="B236"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>E.</given-names></name><name><surname>Wan</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Omega-3 polyunsaturated fatty acids alleviate traumatic brain injury by regulating the glymphatic pathway in mice.</article-title>
<source><italic>Front. Neurol.</italic></source>
<volume>11</volume>:<fpage>707</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2020.00707</pub-id>
<pub-id pub-id-type="pmid">32765412</pub-id>
</mixed-citation></ref><ref id="B237"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Hamblin</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Low-level laser therapy effectively prevents secondary brain injury induced by immediate early responsive gene X-1 deficiency.</article-title>
<source><italic>J. Cereb. Blood Flow Metab.</italic></source>
<volume>34</volume>
<fpage>1391</fpage>&#x02013;<lpage>1401</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2014.95</pub-id>
<pub-id pub-id-type="pmid">24849666</pub-id>
</mixed-citation></ref><ref id="B238"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Hong</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name></person-group> (<year>2021</year>). <article-title>Astrocyte-derived exosomes protect hippocampal neurons after traumatic brain injury by suppressing mitochondrial oxidative stress and apoptosis.</article-title>
<source><italic>Aging</italic></source>
<volume>13</volume>
<fpage>21642</fpage>&#x02013;<lpage>21658</lpage>. <pub-id pub-id-type="doi">10.18632/aging.203508</pub-id>
<pub-id pub-id-type="pmid">34516406</pub-id>
</mixed-citation></ref><ref id="B239"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Savvidou</surname><given-names>M.</given-names></name><name><surname>Liaudanskaya</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Nasreen</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Synergistic label-free fluorescence imaging and miRNA studies reveal dynamic human neuron-glial metabolic interactions following injury.</article-title>
<source><italic>Sci. Adv.</italic></source>
<volume>10</volume>:<fpage>ead1980</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.adp1980</pub-id>
<pub-id pub-id-type="pmid">39661671</pub-id>
</mixed-citation></ref><ref id="B240"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Shen</surname><given-names>R.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Dai</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Mitochondrial-targeted antioxidant MitoQ provides neuroprotection and reduces neuronal apoptosis in experimental traumatic brain injury possibly via the Nrf2-ARE pathway.</article-title>
<source><italic>Am. J. Transl. Res.</italic></source>
<volume>10</volume>
<fpage>1887</fpage>&#x02013;<lpage>1899</lpage>.<pub-id pub-id-type="pmid">30018728</pub-id>
</mixed-citation></ref><ref id="B241"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Shan</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name></person-group> (<year>2022</year>). <article-title>Mitophagy in traumatic brain injury: A new target for therapeutic intervention.</article-title>
<source><italic>Oxid. Med. Cell Longev.</italic></source>
<volume>2022</volume>:<fpage>4906434</fpage>. <pub-id pub-id-type="doi">10.1155/2022/4906434</pub-id>
<pub-id pub-id-type="pmid">35126814</pub-id>
</mixed-citation></ref><ref id="B242"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zong</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Liao</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Mitochondrial dysfunction: Mechanisms and advances in therapy.</article-title>
<source><italic>Signal. Transduct. Target Ther.</italic></source>
<volume>9</volume>:<fpage>124</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-024-01839-8</pub-id>
<pub-id pub-id-type="pmid">38744846</pub-id>
</mixed-citation></ref></ref-list></back></article>